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Abstract 
With persistent and chronic use of alcohol and drugs, structural and functional changes occur 
in the brain, contributing to the development and maintenance of substance use disorder (SUD). 
The cyclic nature of addiction is increasingly understood in a neuroscientific framework. 
Influential theories describe allostatic changes that occur over time as the initial highly 
rewarding effects of substances subsequently lead to reduced capacity of prefrontal brain 
regions to exert effective self-regulation, while an increasingly reactive amygdala-striatum 
system becomes progressively more vulnerable to substance-cues, stress, negative affect, and 
compulsive substance use (Koob & Volkow, 2016; Noël, Brevers, & Bechara, 2013; Volkow 
& Morales, 2015). The resulting cognitive deficits are one of the most commonly reported risk 
factors for dropout from addiction treatment (Brorson, Ajo Arnevik, Rand-Hendriksen, & 
Duckert, 2013). Recently it has been proposed that interventions designed to improve cognition 
may bolster SUD treatment outcomes and increase the likelihood of long-term recovery from 
addiction (Verdejo-García, 2016). This thesis aimed to investigate the potential for 
neuropsychological screening and cognitive training interventions to improve SUD treatment 
outcomes. The first study of this thesis (Chapter 2) assessed cognitive functioning in an SUD 
sample in residential treatment (N = 128), with findings indicating that almost half (43.8%) 
were identified as cognitively impaired, compared to 16.2% of controls (N = 37). History of 
head injury was a significant determinant of cognitive impairment and cognitive impairment 
was associated with higher levels of psychological distress. Study two evaluated a cognitive 
remediation intervention developed to specifically target executive dysfunction and delivered 
within residential SUD treatment – in an all-female sample inclusive of those with 
comorbidities including psychiatric diagnoses and history of head injury (Chapter 3). A three-
month follow-up was included to assess outcomes over time (Chapter 4). Lastly, the 
relationships between executive functions (EFs) and emotion regulation were investigated 
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(Chapter 5), given the proposed links between EFs and self-regulation capacity (Hofmann, 
Schmeichel, & Baddeley, 2012), and the significant role of emotion dysregulation in the 
aetiology and maintenance of SUDs (Wilcox, Pommy, & Adinoff, 2016). Findings regarding 
the evaluation of the intervention indicated that the cognitive remediation group (CR; N = 16) 
improved in an inhibition task, inventory-based assessment of EFs, self-reported impulsivity 
and self-control, and quality of life, relative to controls, who participated in treatment as usual 
(TAU; N = 17). Three-month follow-up outcomes of the intervention indicated no significant 
differences between the CR (N = 12) and TAU (N = 12) groups with regard to quality of life 
and self-reported self-control, cravings, and likelihood of relapse. The CR group demonstrated 
sustained improvements in inventory-based assessment of EFs and a higher rate of treatment 
completion (37.5%) compared to the TAU group (5.9%), however, treatment completion may 
have been confounded by the unexpectedly longer duration of treatment at baseline observed 
in the CR vs. TAU group. Investigation of relationships between EFs and emotion regulation 
at baseline in the entire sample (N = 50) indicated that task-switching, inventory-based 
assessment of EFs, and personality disorder indicators uniquely predicted emotion regulation 
difficulties. Mediation analysis found a significant indirect effect of task-switching 
performance on emotion regulation difficulties, through personality disorder indicators. Taken 
together, these findings provide preliminary evidence for the use of cognitive remediation to 
improve cognition in a residential SUD sample, including those with the often-excluded 
comorbidities of psychiatric diagnoses and history of head injury. These findings have utility 
in informing the continued development and evaluation of novel cognitive remediation 
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CHAPTER 1: CRITICAL OVERVIEW 
 
	 2	
1.1. SUBSTANCE USE: HISTORY, IMPACT, AND TREATMENT 
 Our relationship with psychoactive substances can be traced to the beginning of 
recorded human history, when our ancestors discovered the process of fermenting fruit 
and grain to create intoxicating beverages (Nathan, Conrad, & Skinstad, 2016). 
Culturally, this relationship has been complex and has involved the use of psychoactive 
substances in religious ceremonies, medicinally, and in a socially acceptable manner by 
the general population (Crocq, 2007). Substance use is now highly prevalent for primarily 
recreational purposes: The United Nations Office on Drugs and Crime (2016) estimates 
that 247 million adults (aged 15 to 64 years) used at least one drug in 2014, with 
approximately 29 million people meeting criteria for a substance use disorder (SUD), and 
roughly 207,400 drug-related deaths. The World Health Organisation (2016) reports that 
in 2012 approximately 3.3 million deaths (i.e., 5.9% of all global deaths) were attributable 
to alcohol consumption. The consequences of the widespread misuse of psychoactive 
substances are far-reaching, with significant harm to individuals, families, and 
communities, as well as economic burden resulting from attempts to alleviate these 
problems. A variety of SUD treatments exist, including detoxification programs, 
outpatient interventions (e.g., targeted group or individual psychotherapies), harm 
reduction services, methadone maintenance therapy, and inpatient modalities (e.g., 
residential rehabilitation programs). 
 
1.2. THERAPEUTIC COMMUNITIES FOR SUBSTANCE USE DISORDER 
 Therapeutic communities (TCs) are a type of residential rehabilitation program. 
They typically involve a duration of residence of between 4 to 12 months and they utilise 
a “recovery-oriented” approach. TC’s aim to produce positive change in the domains of 
“substance use, legal, employment, and psychological well-being” for people with 
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alcohol or other substance use disorders (Vanderplasschen et al., 2013, p. 20), with 
residents often meeting criteria for multiple SUDs and additional medical, social, and 
psychiatric comorbidities (Fernández-Calderón, Fernández, Ruiz-Curado, Verdejo-
García, & Lozano, 2015). The key distinguishing feature of TCs is “the purposive use of 
the peer community to facilitate social and psychological change in individuals” (De 
Leon, 2003, p. 18). 
 
1.3. THEORIES OF ADDICTION 
 Treatment approaches for SUD have been influenced by our understanding of 
addiction, which has evolved over time and has often been fraught with shifts between 
polar positions, as summarised by the questions posed by Crocq (2007, p. 355): “Is 
addiction a sin or a disease; should treatment be moral or medical; is addiction caused by 
the substance, the individual’s vulnerability and psychology, or social factors; should 
substances be regulated or freely available?” 
 Research in the field of addiction has generally utilised symptoms that reflect the 
consequences of substance use (e.g., impaired occupational or interpersonal functioning) 
to diagnose SUD, as a comprehensive understanding of the underlying mechanisms of 
addiction (e.g., locating biomarkers to distinguish SUD) has not yet been accomplished 
(DeVito, Carroll, & Sofuoglu, 2016). The issues that arise as a result of using presenting 
symptoms as the basis for establishing a diagnosis have been documented in the broader 
field of mental health (Cuthbert & Insel, 2013); namely, this kind of nosology may hinder 
the discovery of aetiological factors that could guide accurate diagnostic classification, 
the delivery of effective treatment, and appropriate methods to monitor treatment 
outcomes. 
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 Currently, an array of heterogeneous theories of addiction exist and implicate 
various combinations of neurobiological, genetic, sociocultural, behavioural, and 
psychological factors involved in the onset and maintenance of addiction (for a review 
see Ouzir & Errami, 2016). This multiplicity of addiction theories can be understood in 
light of the evolving social and cultural context of substance use over time, as well as the 
scientific and technological developments in characterising psychiatric disorders that 
have occurred. A literature search at the turn of the 21st century found an abundance of 
theories and models of addiction that could be roughly classified into five distinct groups: 
behavioural/social theories, biological theories, theories of individual susceptibility, 
theories focussing on environmental factors, and theories of recovery/relapse (West, 
2001). Broadly speaking, these theories tend to locate the mechanisms of addiction within 
biological processes, the psychoactive constituents of substances, individual 
psychological factors, and/or the social/cultural environment, with varying levels of 
integration of these components across theories. 
 While a range of theories and models of addiction have been proposed, recent 
findings have converged on common mechanisms through which the progression from 
substance use to addiction unfolds, with a number of authors proposing similar theories 
(e.g., Feil et al., 2010; George & Koob, 2010; Hester, Lubman, & Yücel, 2010; Koob, 
2015; Koob & Volkow, 2016; Noël, Brevers, & Bechara, 2013; Volkow & Morales, 
2015). The transition from initial substance use to the cycle of addiction is believed to 
unfold in three stages: binge/intoxication, withdrawal/negative affect, and 
preoccupation/anticipation (i.e., cravings), with allostatic changes in hedonic set point 
occurring during this process (George & Koob, 2010). The construct of craving has 
played a significant role in addiction research, and has been investigated using a diverse 
range of models that can be classified under four broad categories: conditioning-based, 
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cognitive, psychobiological, and motivation models (Skinner & Aubin, 2010) – with 
craving generally defined as “a desire of any intensity to consume a substance” (Skinner 
& Aubin, 2010, p. 620). 
 Typically, initial experimentation with alcohol or drugs is under voluntary control 
and is associated with the acutely rewarding effects of these substances, which are driven 
by mechanisms at the brain circuit- and cell-level, involving surges of dopamine release 
in the nucleus accumbens (Volkow & Morales, 2015). Individuals may be susceptible to 
continued use of alcohol and drugs for a number of reasons, including sociocultural 
factors, pre-existing vulnerabilities, and environmental stress. With continued use, greater 
quantities may be consumed due to habituation of intoxicating effects and resultant 
dependence. This stage is thought to involve neuroadaptations related to repeated 
exposure to substance-cues (Volkow & Morales, 2015), and the neuroplastic changes 
serve to increase sensitivity to substance-cues, reduce sensitivity to non-drug rewards, 
compromise self-regulatory abilities, and increase sensitivity to environmental stress and 
negative affect (Koob & Volkow, 2016). The mechanism through which substance-cues 
trigger cravings and increase the likelihood of substance consumption is thought to 
involve glutamatergic inputs from the amygdala, ventral prefrontal cortex, and ventral 
hippocampus to striatal projections that are associated with increased dopamine 
signalling and release in the nucleus accumbens and dorsal striatum. With repeated 
substance use, however, the ventromedial prefrontal cortex becomes hypofunctional in 
the absence of substance use or related cues (Volkow & Morales, 2015). Addicted 
individuals may experience physical and psychological symptoms of withdrawal (e.g., 
cravings) if substance use is reduced or discontinued, and relapse to substance use may 
occur in order to reduce these aversive symptoms, perpetuating the cyclic nature of SUD 
(Koob, 2015). 
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 Neuroscience theories of addiction have been informed by research investigating 
the neurocognitive mechanisms involved in the onset and maintenance of addiction 
(Bechara, 2005; Goldstein et al., 2009; Goldstein & Volkow, 2011; Kwako, Momenan, 
Litten, Koob, & Goldman, 2016; Miquel et al., 2016; Naqvi & Bechara, 2009; Noël et al., 
2013; Verdejo-García & Bechara, 2009; Verdejo-García, Lawrence, & Clark, 2008). 
Broadly speaking, these findings highlight the role of three interacting neural systems: an 
impulsive amygdala-striatum system, a reflective prefrontal cortex system, and the role 
of the insula in translating the body’s interoceptive signals into subjective feelings of 
craving (Noël et al., 2013). The cyclic nature of addiction is understood in the context of 
chronic use resulting in aberrant neurocognitive changes, with the reflective system 
reduced in its capacity to effect self-control, the impulsive system more reactive to states 
and cues that trigger compulsive substance use, and an associated increase in the strength 
of cravings and difficulties in their effective regulation. 
 While amygdala-striatum and prefrontal cortex systems, as well as the insula, 
have been the main focus of neurocognitive addiction research, it has been proposed that 
data-driven neuroscientific approaches (i.e., neuroimaging and/or genetic studies without 
a priori hypotheses; e.g., Huys, Deserno, Obermayer, Schlagenhauf, & Heinz, 2016) may 
aid the discovery of other brain regions or genes implicated in the onset, maintenance, 
and treatment of addiction (DeVito et al., 2016). As an example of an alternate brain 
region potentially implicated in addiction, Miquel and colleagues (2016) assert that the 
cerebellum may play a key role in the neuroscience of addiction, given evidence 
suggesting that drugs of abuse affect cerebellar functioning, its relationship to drug-
related memory cues, and contribution to functions involving the reflective prefrontal 
cortex system. A further line of research has investigated the mechanisms of addiction at 
the level of neurocircuitry, investigating complex relationships between cell-specific and 
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synapse-specific processes that are implicated in addiction, with a particular focus on the 
role of dopaminergic and glutamatergic neurotransmission in the striatum (Yager, Garcia, 
Wunsch, & Ferguson, 2015). 
 These research developments promote neuroscience-based approaches to SUD 
diagnosis and treatment, and may facilitate the use of neuroimaging methods to detect 
potential biomarkers for addiction (e.g., Kwako et al., 2016), aiding in resolving some of 
the pitfalls associated with using the presenting symptoms of SUD to establish diagnosis. 
Despite the benefits associated with the use of biomarkers to guide clinical practice 
(Huys, Maia, & Frank, 2016; Perlis, 2011), the translation of these findings has 
progressed slowly and inconsistently (Franken & van de Wetering, 2015; Kwako et al., 
2016). 
  
1.4. BARRIERS TO EFFECTIVE TREATMENT 
 There are a variety of treatment approaches targeting SUD, yet significant barriers 
to long-term recovery from addiction are commonly encountered during the treatment 
process. Addictions are conceptualised as “chronic relapsing disorders” (Brandon, 
Vidrine, & Litvin, 2007, p. 269), with high rates of relapse reported in the literature (Hunt, 
Barnett, & Branch, 1971; Kirshenbaum, Olsen, & Bickel, 2009; Polivy & Herman, 2002). 
For this reason, relapse prevention is a core component of SUD treatment (Hendershot, 
Witkiewitz, George, & Marlatt, 2011). Multiple theories of relapse have been 
documented, including learning theories, trait and individual-difference theories, and 
self-regulatory theories (Brandon et al., 2007). Of these relapse theories, Marlatt and 
Gordon’s (1985) cognitive-behavioural model of relapse has been the most influential in 
the field of addiction treatment. This theory proposes that relapse occurs under high-risk 
situations and involves a reduction in effective coping behaviour, leading to both reduced 
	 8	
self-efficacy and increased incentive salience of substance use. These conditions may 
lead the individual to engage in a lapse (i.e., a momentary rather than sustained return to 
substance use), which Marlatt and Gordon’s model delineates from full-blown relapse. In 
the event of a lapse, an individual’s cognitions and self-attributions influence the 
likelihood of progression to relapse, with cognitive dissonance potentially leading to 
dichotomous thinking (e.g., a shift from complete control vs. complete loss of control) 
and an increase in the likelihood of relapse. A revised and expanded version of this 
influential cognitive-behavioural model of relapse was subsequently developed, with 
particular emphasis placed on the complexities and dynamic processes surrounding 
relapse (Witkiewitz & Marlatt, 2004). The updated model considers the role of both intra- 
and inter-personal processes in relapse, along with a distinction between distal and 
proximal risk factors, and a greater focus on the temporal relationships between risk 
factors. 
 While relapse is an important concept in the delivery of effective SUD treatment, 
a further potential barrier to long-term recovery concerns the high rates of dropout from 
treatment programs. The dropout rate in inpatient SUD treatment settings has been 
estimated to be as high as 57% (Deane, Wootton, Hsu, & Kelly, 2012) and treatment 
retention has been identified as an important factor in recovery from SUD (Brorson, Ajo 
Arnevik, Rand-Hendriksen, & Duckert, 2013; Stark, 1992). For this reason, establishing 
an understanding of factors associated with treatment completion and, conversely, early 
dropout has been a research priority. Brorson and colleagues (2013) conducted a 
systematic review of risk factors for dropout from addiction treatment, which included 
122 studies from 1992 to 2013, involving 199,331 participants. The most consistently 
reported risk factors were cognitive deficits, personality disorder, low treatment alliance, 
and younger age. 
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1.4.1. COGNITIVE DEFICITS 
 While the immediate effects of intoxication may produce acute behavioural and 
cognitive changes, frequent and chronic substance use results in persistent alterations in 
brain function, structure, and cognition as detected by neuroimaging and 
neuropsychological assessment (Baldacchino, Balfour, Passetti, Humphris, & Matthews, 
2012; Broyd, van Hell, Beale, Yücel, & Solowij, 2016; Caplan, Epstein, Quinn, Stevens, 
& Stern, 2007; Ersche & Sahakian, 2007; Hart, Marvin, Silver, & Smith, 2012; 
Lorenzetti, Fornito, Yücel, Solowij, & Lubman, 2014; Oscar-Berman & Marinković, 
2007). As well as substance-specific effects, substance use may lead to broad changes in 
cognition irrespective of the type of substance used; namely increased impulsivity and 
deficits in episodic memory, decision-making, and inhibitory control (Fernández-
Serrano, Pérez-García, & Verdejo-García, 2011; Yücel & Lubman, 2007). 
 Deficits in behavioural inhibition are commonly observed in SUD, and may be 
related to the onset and maintenance of the disorder (Smith, Mattick, Jamadar, & Iredale, 
2014). These effects may be substance-specific, however, as they are commonly observed 
in cocaine, methamphetamine, MDMA, tobacco, and alcohol users, but not consistently 
in opioid or cannabis users. Higher levels of impulsivity, as assessed by delay discounting 
tasks, which investigate the value assigned to future rewards as a function of temporal 
delay, are also commonly observed in SUD populations and may be particularly 
heightened in polysubstance users (Moody, Franck, Hatz, & Bickel, 2016). 
 Though cognitive deficits are commonly observed in chronic substance use, 
findings indicate recovery of functioning in specific cognitive domains with abstinence, 
with varying effects depending on the type of substance used (Schulte et al., 2014). For 
example, with sustained abstinence, improvements in inhibition, verbal short-term 
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memory, visuospatial abilities, and cognitive flexibly occur following cocaine 
dependence; improvements in working memory, episodic memory, and sustained 
attention following methamphetamine dependence; and selective attention following 
heroin dependence (Schulte et al., 2014). 
 In addition to the cognitive deficits associated with chronic use of psychoactive 
substances, additional comorbidities (pre-existing or substance-related) may also 
contribute to impaired cognition in SUD populations; for example, neurodevelopmental 
disorders (e.g., Molina & Pelham Jr., 2014), neurological conditions (e.g., Wang et al., 
2015), dementias (e.g., Kalapatapu et al., 2016), and traumatic brain injury (TBI). TBIs 
refer to “a physiologically significant disruption of brain function resulting from the 
application of external physical force” (Silver, McAllister, & Arciniegas, 2009, p. 653) 
and frequently co-occur with SUD. SUD and TBI share a bidirectional relationship and 
create significant challenges in the treatment process (Weil, Corrigan, & Karelina, 2016). 
 Of note, premorbid impairments in cognition may precede and be associated with 
the development of SUD. In parallel with the association between low childhood IQ and 
subsequent increased risk of certain adult mental disorders (Koenen et al., 2009), some 
studies suggest a link between low premorbid IQ and the development of SUD (Chen, 
Lawlor, Duggan, Hardy, & Eaton, 2006; Mahoney, Kalechstein, De Marco, Newton, & 
De La Garza, 2017; Mortensen, Sørensen, Jensen, Reinisch, & Mednick, 2005). 
Significantly, the recovery of cognitive functions associated with abstinence may be 
related to premorbid functioning (Schulte et al., 2014). 
 Substance use during adolescence presents a unique risk regarding the 
development of cognitive deficits in terms of the effects of psychoactive substances on 
the developing brain. During this period of neuromaturation, adolescents are both more 
likely to engage in substance use and also more vulnerable to the resulting detrimental 
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effects on the brain (Conrod & Nikolaou, 2016). Persistent cognitive deficits in capacities 
such as executive function may arise, representing a failure in the normal 
neuromaturational process (Lubman, Cheetham, & Yücel, 2015; Lubman & Yücel, 2008; 
Lubman, Yücel, & Hall, 2007). 
 
1.4.1.1. Executive dysfunction 
 The study of executive functions (EFs) has a long history, involving contributions 
from several disciplines (e.g., neuropsychology, cognitive psychology, cognitive 
neuroscience). For this reason, multiple models of EFs and respective forms of 
assessment exist (Snyder, Miyake, & Hankin, 2015). Aside from theoretical differences 
in the study of EFs, some epistemological issues have also been raised with regards to 
paradigmatic differences between the disciplines noted above and the ensuing difficulties 
that may arise in attempting to translate findings from the context of one discipline to 
another (Labra-Spröhnle, 2016). 
 Traditionally, the role of EFs in human behaviour and cognition were explored 
within neuropsychological studies of patients with frontal lobe damage, with the 
observation that although several cognitive abilities remained intact, these patients 
demonstrated personality changes and difficulties with goal-directed behaviour (Miyake 
et al., 2000). A widely accepted conceptualisation of EFs within the field of clinical 
neuropsychology recognises four broad behavioural components: volition, 
planning/decision making, purposive action, and effective performance (Lezak, 
Howieson, Bigler, & Tranel, 2012, p. 666). Various detailed neuropsychological models 
and assessment methods for the study of EFs exist (for a review of models for adult 
populations see Chan, Shum, Toulopoulou, & Chen, 2008). 
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 Within cognitive psychology, an influential model associated with EFs is 
Baddeley’s (1986) multi-component working memory model, with the central executive 
component postulated to control and integrate cognitive processes, including the activity 
of the two other components, the phonological loop and the visuospatial sketchpad. A 
key theoretical concern as the study of EFs progressed in both cognitive psychology and 
neuropsychology, was the extent to which EFs could be considered as unitary in nature; 
linked to a common, underlying mechanism (Miyake et al., 2000). Subsequently, a 
prominent theory of EFs, known as the unity/diversity framework (Miyake & Friedman, 
2012; Miyake et al., 2000), identified three core cognitive abilities linked to EFs and 
moderately correlated, yet distinct: “updating (constant monitoring and rapid 
addition/deletion of working memory contents), shifting (switching flexibly between 
tasks or mental sets), and inhibition (deliberate overriding of dominant or prepotent 
responses)” (Miyake & Friedman, 2012, p. 9). 
 In the study of EFs, cognitive neuroscience research has utilised neuroimaging 
methods to identify the key brain regions and networks that may be implicated. A wealth 
of research has examined the neural substrates of EFs, with multiple studies indicating 
consistent involvement of frontal and parietal brain regions across a number of EF tasks, 
but also some distinct brain regions associated with specific EF tasks (Friedman & 
Miyake, 2017). For example, a review of the neural correlates of task-switching (i.e., 
effectively switching between multiple tasks) suggests that the inferior frontal junction 
and posterior parietal cortex are consistently implicated (Kim, Cilles, Johnson, & Gold, 
2012). Other studies have examined the role of cognitive control (i.e., the process of 
regulating cognition and behaviour to reach internally represented goals) in EFs. For 
example, the dual mechanisms of control framework (Braver, 2012), postulates that two 
key modes are involved in cognitive control: proactive control and reactive control. The 
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neural basis of proactive control is thought to involve sustained and anticipatory 
maintenance of goal-related information within the lateral prefrontal cortex, whereas 
reactive control involves this brain region and also a wider brain network, in the transient 
detection of stimuli that may interfere with goal-pursuit. 
 Along with the general impairments in cognition observed in SUD populations 
described above, findings indicate that specific impairment of EFs is commonly 
associated with chronic substance use, and is implicated in the maintenance of the 
disorder (Blume & Marlatt, 2009; Fernández-Serrano, Pérez-García, Perales, & Verdejo-
García, 2010; Fernández-Serrano, Pérez-García, Río-Valle, & Verdejo-García, 2010; 
Gierski et al., 2013; Hester et al., 2010; Moreno-López et al., 2012; Perry et al., 2011). It 
is proposed that EF deficits may impede the process of addiction treatment, as the 
cognitive abilities required for optimal treatment engagement and benefit may be 
compromised (Blume & Marlatt, 2009). For these reasons, EF deficits may play a key 
role in determining treatment outcomes and long-term abstinence. For example, a recent 
systematic review examined the role of EF deficits in SUD treatment outcomes and found 
that reward-based decision-making was linked to relapse, while general cognition was 
associated with adherence to treatment (Domínguez-Salas, Díaz-Batanero, Lozano-
Rojas, & Verdejo-García, 2016). Given the prevalence and impact of EFs on the process 
of SUD treatment and long-term recovery from addiction, it is proposed that the 
development of interventions to improve EFs may increase the likelihood of individuals 
engaging with and benefitting from treatment, while capitalising on the neuroplasticity of 
the brain and potential recovery of cognitive abilities associated with abstinence 
(Copersino, 2017; Manning, Verdejo-García, & Lubman, 2017). 
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1.4.2. COMORBID PSYCHIATRIC DISORDERS 
 Along with the general deficits in cognition and specific impairment of EFs 
commonly observed in SUD populations that may interfere with SUD treatment, 
psychiatric disorders also frequently co-occur with SUDs and impede the treatment 
process (Baingana, al'Absi, Becker, & Pringle, 2015; Baker, Thornton, Hiles, Hides, & 
Lubman, 2012; Burns & Teesson, 2002; Grant et al., 2015; Grant et al., 2016; Grant et 
al., 2004; Lubman, Allen, Rogers, Cementon, & Bonomo, 2007). These include major 
depressive disorder, dysthymia, bipolar I, generalised anxiety disorder, panic disorder, 
social phobia, posttraumatic stress disorder, and antisocial, schizotypal, and borderline 
personality disorders (Grant et al., 2015; Grant et al., 2016). As well as adding complexity 
to the process of treatment (Flynn & Brown, 2008; McGovern, Xie, Segal, Siembab, & 
Drake, 2006), comorbid psychiatric and SU disorders are associated with poorer 
treatment outcomes (González-Saiz, Vergara-Moragues, Verdejo-García, Fernández-
Calderón, & Lozano, 2014; Melchior, Prokofyeva, Younès, Surkan, & Martins, 2014). 
 Comorbid personality disorder, in particular, is highly prevalent within SUD 
populations (Bowden-Jones et al., 2004; Grant et al., 2015; Grant et al., 2016; Tomko, 
Trull, Wood, & Sher, 2014) and has been identified as one of the most consistently 
reported risk factors for early dropout from SUD treatment (Brorson et al., 2013). The 
clinical and aetiological complexities surrounding comorbid personality disorder and 
SUD have been documented (Lee, Cameron, & Jenner, 2015; McMain & Ellery, 2008; 
Pennay et al., 2011; Trull, Sher, Minks-Brown, Durbin, & Burr, 2000; Verheul, 2001). 
For example, comorbid personality disorders and SUDs are associated with complex 
clinical presentation and poor prognosis (McMain & Ellery, 2008). Additionally, there is 
significant overlap between aetiological factors involved in both disorders (Trull et al., 
2000). 
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 Borderline personality disorder (BPD) is estimated to occur in up to 65% of those 
in SUD treatment (Trull et al., 2000). Trull and colleagues (2000) proposed a theoretical 
model recognising the significant role played by emotion regulation deficits and increased 
impulsivity in the aetiology of both BPD and SUD. This model recognises the interaction 
between neurobiological vulnerabilities and family-environmental factors in 
predisposing an individual to develop comorbid BPD and SUD. 
 While comorbid personality disorder, particularly BPD, and SUD are common, 
may share aetiological factors, and lead to poorer addiction treatment outcomes, a 
separate line of research has investigated the neurocognitive deficits specifically 
associated with BPD (Fertuck, Lenzenweger, Clarkin, Hoermann, & Stanley, 2006; 
Ruocco, 2005; Ruocco & Carcone, 2016; Unoka & Richman, 2016). In general, BPD 
populations demonstrate global neurocognitive deficits, with the most robust evidence of 
dysfunction in EFs, decision-making, and memory domains (Unoka & Richman, 2016). 
Furthermore, neuroimaging techniques have identified structural and functional 
abnormalities in frontomedial and temporolimbic structures and their connectivity in 
BPD (Ruocco, Amirthavasagam, Choi-Kain, & McMain, 2013; Salvador et al., 2016; 
Schulze, Schmahl, & Niedtfeld, 2016; van Zutphen, Siep, Jacob, Goebel, & Arntz, 2015; 
Winsper et al., 2016). 
 SUD and personality disorder are associated with specific cognitive deficits, are 
commonly comorbid, and create significant complexities in the process of addiction 
treatment. Studies have also examined the neurocognitive deficits that occur in comorbid 
personality disorder and SUD. For example, cognition in cocaine-dependent samples 
including those with comorbid personality disorders has been investigated (Albein-Urios, 
Martínez-González, Lozano-Rojas, & Verdejo-García, 2014; Albein-Urios et al., 2013). 
The profile of EFs in an SUD sample with comorbid cluster B (e.g., BPD, antisocial) and 
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cluster C (e.g., avoidant and obsessive-compulsive) personality disorders was explored, 
with poorer outcomes in attention/inhibition and working memory found in cluster B and 
cluster C groups, respectively (Albein-Urios et al., 2014). Additionally, cocaine-
dependent participants with comorbid personality disorders, compared to those without 
comorbidities, demonstrated poorer response inhibition and attention regulation, as well 
as reduced grey matter of the right temporal pole (Albein-Urios et al., 2013). Further 
neuroimaging research has demonstrated that readiness to change problematic substance 
use in cocaine-dependent individuals is correlated with ventromedial prefrontal grey 
matter and is modulated by comorbid personality disorder (Moreno-López, Albein-Urios, 
Martinez-Gonzalez, Soriano-Mas, & Verdejo-García, 2014). 
 
1.5. SELF-REGULATION AND EXECUTIVE FUNCTIONS 
 The fields of social and personality psychology have studied the protective 
capacity of self-regulation, broadly defined as those qualities enabling humans “to live 
cooperatively, achieve important goals and maintain health throughout their life span” 
(Heatherton & Wagner, 2011, p. 132). Addiction can be understood as a failure of self-
regulation. A theoretical account of addiction as self-regulation failure proposes a major 
distinction between underregulation and misregulation, with the former corresponding to 
instances in which an individual fails to exert appropriate regulatory actions, and the latter 
to the misguided or counterproductive exertion of regulatory actions (Baumeister & 
Heatherton, 1996). This theory postulates that effective self-regulation entails three core 
ingredients: standards, monitoring, and operating. Standards refer to the process of 
establishing internalised goals and objectives, monitoring involves comparing these goals 
with current actions and states, and operating refers to initiating alternative behaviours in 
situations where discrepancies between goals and current behaviours are identified. 
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Strength models of self-regulation posit that self-regulatory capacity is a limited resource 
that is renewable over time, is affected by the strength of an impulse, and can be increased 
or decreased in relation to situational factors and individual differences (Baumeister & 
Heatherton, 1996). More recently, the cognitive neuroscience of addiction has aided in 
refining models of self-regulation. These findings support balance models of self-
regulation, in which top-down control arising from prefrontal brain regions is involved in 
a dynamic relationship with subcortical brain regions involved in emotional and reward-
based responding (Heatherton & Wagner, 2011; Kelley, Wagner, & Heatherton, 2015). 
 Recently, the study of EFs in cognitive psychology and neuroscience has started 
to converge with the study of self-regulation, which has historically been investigated in 
social and personality psychology (Heatherton & Wagner, 2011; Hofmann, Schmeichel, 
& Baddeley, 2012). Specifically, it has been proposed that EFs may provide a 
neurocognitive basis for self-regulation and that, consequently, training of EFs may 
improve self-regulation (Hofmann et al., 2012). Effective self-regulation enables 
individuals to successfully navigate tempting situations in which the strength of an 
impulse that conflicts with an internalised standard or goal threatens to result in a loss of 
behavioural control. There are several capacities related to effective self-regulation; for 
example, emotion regulation, self-control, and regulation of cravings (Hofmann et al., 
2012). 
 Emotions have been defined as “sets of cognitive, subjective, physiological and 
motor changes that arise from an individual's conscious or non-conscious determination 
that a stimulus has a positive or negative value in a particular context and with respect to 
that individual's currently active goals” (Etkin, Büchel, & Gross, 2015, p. 693). Emotion 
regulation, therefore, is the process of managing emotions; altering their intensity and 
duration, according to our goals (Gross, 2013; Gross, Sheppes, & Urry, 2011). 
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Neuroimaging studies have identified two broad types of emotion regulation: implicit and 
explicit (Etkin et al., 2015). Explicit regulation is characterised by a conscious, effortful 
implementation of regulation strategies and is associated with activation of regions in the 
frontoparietal executive network of the brain, whereas implicit regulation is evoked 
automatically, without conscious awareness, and with a neural basis of activation in the 
ventral anterior cingulate and ventromedial prefrontal cortex (Etkin et al., 2015). 
 Emotion dysregulation is increasingly acknowledged as a transdiagnostic process 
playing a central role in the onset and maintenance of diverse psychopathologies (Aldao, 
Nolen-Hoeksema, & Schweizer, 2010; Broome, He, Iftikhar, Eyden, & Marwaha, 2015; 
Kret & Ploeger, 2015). In the realm of addiction, emotion dysregulation is considered to 
substantially influence an individual’s vulnerability to SUD, the progression from 
experimentation to abuse, and the continuing maintenance of the disorder; for this reason 
SUD has also been conceptualised as “a disorder of affect” (Cheetham, Allen, Yücel, & 
Lubman, 2010, p. 631). 
 Self-control and regulation of cravings arising in the context of substance-cues 
are further aspects of self-regulation that play a significant role in addiction. Deficits in 
self-control are pronounced in SUD populations, associated with compulsive drug-
seeking behaviour, and reflect neuroadaptations in brain regions implicated in cognitive 
control, particularly the anterior cingulate and adjacent prefrontal cortex (Tang, Posner, 
Rothbart, & Volkow, 2015). Furthermore, the role of substance-cues and related cravings 
play a significant role in the self-regulation failure inherent to addiction (Heatherton & 
Wagner, 2011). It is proposed that self-control may be increased through targeted 
interventions that strengthen the corresponding brain regions, to potentially reduce 
problematic substance use (Tang et al., 2015). 
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 In light of the significant connections between EFs, associated brain regions, and 
self-regulatory capacities such as emotion regulation, self-control, and regulation of 
cravings arising in the context of substance-cues – and the potential to strengthen these 
capacities through targeted interventions – it is plausible that individuals with SUD may 
benefit from interventions designed to improve EFs and potentially boost self-regulation 
capacity. 
 
1.6. INTERVENTIONS TO IMPROVE COGNITION 
 In the context of this thesis, the term cognitive training will be defined as 
“behavioral treatment for cognitive impairment that targets cognitive skills and fosters 
improvement through the practice of compensatory and/or restorative strategies” (Choi 
& Twamley, 2013, p. 49). Interventions targeting cognition tend to utilise two broad 
methods: drill and practice and strategy-based (Wykes, Huddy, Cellard, McGurk, & 
Czobor, 2011). Drill and practice methods refer to repeated practice of cognitive skills 
with the aim of restoring premorbid abilities whereas strategy-based approaches entail 
learning compensatory strategies to minimise cognitive demands (Choi & Twamley, 
2013). Cognitive remediation was borne out of the field of neuropsychology and may 
utilise either drill and practice or strategy-based methods, and often includes a 
combination of these approaches, with the aim of facilitating durable improvements in 
cognition that generalise to functional outcomes (Wykes et al., 2011). In this thesis, the 
term cognitive remediation will be used to refer to cognitive training interventions that 
include strategy-based methods – alone or in combination with drill and practice methods. 
Sometimes the term cognitive rehabilitation is used interchangeably with cognitive 
remediation, and there is some disagreement in regards to the specificity of these broad 
definitions (Bryce, Lee, Ponsford, & Rossell, 2016).  
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 A range of cognitive training interventions have been utilised in various clinical 
populations in attempts to improve cognition and clinical outcomes. Cognitive 
remediation interventions have been most notably applied in schizophrenia (e.g., Wykes 
et al., 2011) and acquired brain injury (ABI) populations (e.g., Virk, Williams, Brunsdon, 
Suh, & Morrow, 2015). An early meta-analysis of cognitive remediation for 
schizophrenia populations yielded medium effect sizes for cognitive performance, 
slightly lower effect sizes for psychosocial functioning, and small effect sizes for 
symptoms (McGurk, Twamley, Sitzer, McHugo, & Mueser, 2007). A more recent meta-
analysis found small to moderate effects for cognition and functioning, which were 
durable and did not vary as a result of intervention characteristics (Wykes et al., 2011). 
Cognitive remediation interventions also lead to reductions in the negative symptoms of 
schizophrenia (Cella, Preti, Edwards, Dow, & Wykes, 2017) and significantly greater 
employment and productivity outcomes for patients with schizophrenia and other severe 
mental illnesses (Chan, Hirai, & Tsoi, 2015), potentially through improved 
neurobiological functioning in frontal brain regions (Isaac & Januel, 2016). However, a 
recent methodological critique of systematic reviews and meta-analyses of cognitive 
remediation for schizophrenia found some consistent areas of methodological weakness, 
including lack of protocol registration, uncertainty regarding the use of independent data 
extraction procedures, and a lack of publication bias assessment, warranting the careful 
interpretation of these results (Bryce, Lee, Rossell, Sloan, & Ponsford, 2016). 
 A systematic review and meta-analysis of cognitive remediation in ABI 
populations found short-term improvements in divided attention following stroke, but no 
improvements in any other domain of attention across populations (Virk et al., 2015). A 
meta-analysis investigating the effects of occupation-based cognitive rehabilitation for 
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traumatic brain injury found small effect sizes for cognition and activities of daily life 
(Park, Maitra, & Martinez, 2015). 
 In contrast to cognitive remediation, another approach to cognitive training 
utilises computerised training platforms, with a primary focus on the drill and practice 
approach, generally to the exclusion of strategy-based methods. In this thesis, the term 
computerised cognitive training will be used to refer to cognitive training interventions 
that utilise drill and practice methods only. Brain training represents one such area in 
which computerised cognitive training is commercially marketed as a method to improve 
cognitive abilities in healthy populations (Simons et al., 2016). Although improvements 
in the targeted cognitive tasks are observed, there is a lack of evidence to suggest that 
transfer of these improvements to untrained but closely related tasks occurs (Owen et al., 
2010; Simons et al., 2016). A separate line of research has investigated the effects of 
computerised working memory training in learning disorder and nonclinical populations, 
with findings indicating only short-term benefits of training with regard to the targeted 
cognitive domains and also a lack of transfer to untrained, clinically meaningful tasks 
(Melby-Lervåg, Redick, & Hulme, 2016). Despite the lack of empirical evidence for the 
effectiveness of brain training in healthy populations and working memory training, 
preliminary evidence suggests that computerised cognitive training may be beneficial in 
certain psychiatric disorder populations. For example, computerised cognitive training 
has been used in major depressive disorder populations, producing moderate-large effects 
for global cognition, attention, and working memory, as well as small-moderate effects 
for symptom severity and daily functioning (Motter et al., 2016). Additionally, 
computerised working memory training was investigated in a sample of individuals with 
elevated trait anxiety, with findings suggesting improvements in attentional control, and 
with some transfer effects observed (Sari, Koster, Pourtois, & Derakshan, 2015). There 
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is also preliminary evidence supporting the use of cognitive training interventions (i.e., 
mixed cognitive remediation and computerised cognitive training) in eating disorder 
populations (Brockmeyer et al., 2014; Brockmeyer et al., 2016; Dingemans et al., 2013; 
Tchanturia, Lounes, & Holttum, 2014), schizoaffective disorders (Anaya et al., 2012), 
mild cognitive impairment and dementia populations (Coyle, Traynor, & Solowij, 2015), 
and borderline personality disorder (Vita et al., 2016). 
 While there is a lack of evidence suggesting that computerised cognitive training 
produces improvements in untrained tasks in healthy populations, some studies have 
found beneficial effects on untrained tasks and improvements in functioning in some 
clinical populations. It is important to consider potential explanations for this 
discrepancy. Recent theories of transfer implicate two key concepts: content and contexts, 
and their interaction (Simons et al., 2016). Content refers to what is learnt as a result of 
computerised cognitive training interventions and contexts refer to the environments in 
which learning and potential future transfer of this learning occurs. The skills taught 
through computerised cognitive training interventions may vary in level of specificity, 
with some interventions focussing on a narrow range of highly specific skills, and others 
targeting broader sets of skills. The context of learning may also vary significantly across 
intervention studies in terms of knowledge domain (e.g., working memory training vs. 
mixed cognitive training), physical location of the training intervention, intended 
purposes of the training, and whether individuals use acquired skills individually or in the 
context of other people. In this way, it may be that highly specific computerised cognitive 
training interventions may result in less transfer to untrained tasks, whereas broader more 
strategy-based interventions result in a greater likelihood of transfer and improved 
functional outcomes (Simons et al., 2016). Differences in study design and 
methodological quality may also account for the discrepancies between studies reporting 
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beneficial outcomes from computerised cognitive training interventions; crucially, these 
may be related to the wide variety of interventions employed (Bryce, Lee, Ponsford, et 
al., 2016; Simons et al., 2016). Selection of outcome measures may also significantly 
influence findings and where multiple measures of a targeted cognitive construct are 
included, there may be a greater likelihood of detecting improvements in cognition 
(Simons et al., 2016). Finally, the improvements in cognition and functional outcomes 
displayed in computerised cognitive training for certain clinical populations vs. healthy 
populations may indicate potential ceiling effects for healthy populations who 
presumably demonstrate less cognitive dysfunction and problems in everyday 
functioning. 
 In summary, evidence suggests beneficial effects of cognitive training in various 
populations, most notably schizophrenia and ABI, but also preliminary evidence for 
major depressive disorder, individuals with elevated trait anxiety, eating disorders, 
schizoaffective disorders, mild cognitive impairment and dementia populations, and 
borderline personality disorder. 
 
1.6.1. COGNITIVE TRAINING FOR SUD 
 While cognitive training interventions have demonstrated beneficial effects in 
other populations, only recently have these interventions been investigated as a potential 
treatment for SUD populations. This is theoretically coherent in light of the significant 
cognitive deficits and executive dysfunction observed in SUD populations, and their 
deleterious effects on the process of treatment (Bates, Bowden, & Barry, 2002). Emerging 
research has evaluated cognitive training interventions to improve cognition and self-
regulation, with the ultimate goal of increasing treatment retention and facilitating long-
term recovery from SUD. 
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 A recent review of the literature regarding cognitive training for SUD identified 
studies that investigated the effects of four specific types of cognitive training 
intervention: cognitive bias modification (CBM), response inhibition, working memory, 
and goal-directed interventions (Verdejo-García, 2016). With regard to proposed 
underlying mechanisms of these training interventions, they were classified into two 
distinct classes: a bottom-up reorientation of tendencies towards impulsive behaviours 
through training effects on the medial prefrontal cortex and amygdala (i.e., CBM and 
response inhibition) and a top-down strengthening of EFs through training effects on the 
dorsolateral and ventrolateral prefrontal cortices (i.e., working memory and goal-directed 
interventions). Findings indicated that CBM resulted in decreased alcohol-approach 
biases and reduced alcohol use in the long-term; response inhibition training also resulted 
in reduced alcohol-approach biases and reduced alcohol use in community samples; 
working memory training resulted in reduced heavy alcohol use in a community sample 
partially through its effects in moderating impulsive responding; and goal-directed 
approaches resulted in increased working memory capacity and cognitive control. 
 While these findings represent significant preliminary evidence for the 
effectiveness of cognitive training for SUD, there are many gaps in this emerging area of 
research. For example, there is a notable lack of studies investigating the effects of 
working memory training and goal-directed approaches, and studies that examine not 
only cognitive outcomes but also significant clinical outcomes (e.g., craving, quality of 
life, relapse to substance use, treatment retention) are required (Verdejo-García, 2016). 
Furthermore, there is a lack of studies investigating the effects of cognitive training 
interventions that include participants with psychiatric comorbidities or who have a 
history of head injury, both common comorbidities in SUD populations. Additionally, 
there is also a lack of studies that have investigated the long-term effects of cognitive 
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training for SUD through the inclusion of a longitudinal follow-up of outcomes. As the 
research investigating cognitive training for SUD grows, an important objective will be 
gathering further data to inform an understanding of the mechanisms through which 
cognitive training interventions exert their effects (e.g., Gladwin, Wiers, & Wiers, 2017) 
and also understanding the complex relationships between cognition, particularly EFs, 
and self-regulation capacities. 
 
1.7. RESEARCH AIMS 
 The broad aims of this thesis were to assess cognitive functioning in an SUD 
sample attending residential treatment and determine the effectiveness of a 
neuropsychologically based intervention. Initially, the cognitive functioning of residents 
in SUD TC treatment was explored and characterised. This served to inform the next aim 
of this thesis; the implementation and evaluation of a cognitive training intervention 
within this residential SUD sample. Given the impairment of EFs in SUD populations, 
the proposed link between EFs and self-regulation, and preliminary evidence suggesting 
a role for cognitive training interventions in improving SUD treatment outcomes, a 
cognitive remediation intervention specifically targeting executive dysfunction was 
developed and evaluated. With regard to the lack of studies investigating the effects of 
cognitive training in SUD populations with comorbid psychiatric diagnoses and history 
of head injury, participants with these comorbidities were included. Additionally, clinical 
outcome measures relating to cravings, quality of life, and relapse to substance use were 
included, given the lack of prior studies assessing these outcomes. Along with the aim of 
evaluating a cognitive remediation intervention, an additional aim of this thesis was to 
investigate the long-term effects of cognitive remediation through the inclusion of a 
longitudinal follow-up study. Finally, this thesis aimed to explore the relationships 
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between EFs and emotion regulation, to provide further data that may inform the 
development of novel cognitive training interventions.  
 This thesis comprises three studies, forming four publications included as 
chapters. The findings of study one are presented in Chapter 2, those of study two are 
presented in Chapters 3 and 4, and those of study three in Chapter 5. Chapter 2 provides 
an overview of cognitive functioning in a snapshot sample of Australian TC residents in 
treatment for SUD, exploring variation with regard to demographic characteristics and 
other comorbidities. This was an important starting point for this thesis, and provided 
significant data regarding the prevalence and nature of cognitive impairment among 
typical clients residing in Australian SUD TCs at any given time, with no exclusions. 
These data, along with the findings of the existing literature presented during this chapter, 
contributed to the development and implementation of a cognitive remediation 
intervention in this population. 
 Chapter 3 is comprised of the evaluation of a novel cognitive remediation 
intervention to address executive dysfunction in an SUD sample in residential therapeutic 
community treatment, including those with psychiatric comorbidities and history of head 
injury.  
 Chapter 4 contributes longitudinal data to this research area by investigating 
outcomes of the cognitive remediation intervention at three-month follow-up, including 
measures of self-regulation, quality of life, and clinical outcomes measures, such as 
quality of life and relapse to substance use. 
 Given the important role of emotion dysregulation in SUD, and the proposed link 
between self-regulation capacities such as emotion regulation and EFs, Chapter 5 
explores the relationships between EFs and emotion regulation, with the aim of 
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elucidating ways in which specific basic EFs (i.e., working memory, task-switching, 
and/or inhibition) may be related to effective emotion regulation. 
 Finally, Chapter 6 provides an overview and synthesis of the findings presented 
in the previous chapters, clinical implications, limitations and future research directions 
in the area of cognitive training for SUD populations. 
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CHAPTER 2: COGNITION AND COMORBIDITIES IN AN AUSTRALIAN 
THERAPEUTIC COMMUNITY 
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Montreal Cognitive Assessment (MoCA) is sensitive to head injury and cognitive 
impairment in a residential alcohol and other drug therapeutic community. 
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2.1. ABSTRACT 
Introduction: Retaining clients in residential alcohol and other drug (AOD) treatment is 
difficult and cognitive impairment has been identified as a significant predictor of 
treatment dropout. The application of extensive screening for cognitive impairment is 
cost-prohibitive for most AOD treatment services. The current study aimed to explore 
cognitive functioning and impairment-associated factors in a typical sample of residential 
AOD clients using a free brief screening tool that could be utilised by front-line AOD 
services. 
Methods: Residents of an AOD therapeutic community (n = 128) and a non-substance 
using control group (n = 37) were administered a brief cognitive screening measure, the 
Montreal Cognitive Assessment (MoCA). MoCA total and domain scores were compared 
between these groups and within the AOD group examined in association with primary 
substance of misuse, severity of dependence, gender, psychological distress, and history 
of head injury. 
Results: Almost half (43.8%) of the AOD sample were identified as cognitively impaired, 
compared to 16.2% of the control group. Furthermore, 67.2% of the AOD sample had 
sustained head injuries and 50% of the sample required hospitalization for head injury. 
History of head injury was a significant determinant of cognitive impairment, and 
associated with greater levels of psychological distress. 
Conclusions: There are high rates of inter-related cognitive impairment, head injuries, 
and psychological distress among clients in residential AOD treatment. Routine screening 
of clients at intake for cognitive impairment by means of a brief screening measure such 
as the MoCA, in combination with the assessment of history of head injuries and 
comorbid psychological disorders, could inform treatment modifications or adjunct 
interventions to increase retention and improve long-term outcomes. 
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2.2. INTRODUCTION 
 Therapeutic communities (TCs) are a form of residential rehabilitation for 
individuals experiencing chronic and severe alcohol and other drug (AOD) problems and 
may particularly suit clients with associated comorbidities and other complexities as they 
place an emphasis on fostering social support within the community of residents in order 
to promote treatment engagement and completion. Dropout from AOD treatment in 
general is estimated to be as high as 57% in inpatient settings (Darke, Campbell, & 
Popple, 2012; Deane, Wootton, Hsu, & Kelly, 2012; Vergara-Moragues, Gonzalez-Saiz, 
Lozano, & Verdejo-García, 2013). Importantly, length of stay in TCs has been shown to 
be related to neurocognitive capacity (Fals-Stewart & Lucente, 1994; Fals-Stewart & 
Schafer, 1992; Fernández-Serrano, Pérez-García, Perales, & Verdejo-García, 2010). An 
extensive systematic review reported that cognitive deficits were one of the most 
consistently reported risk factors for dropout from AOD treatment, alongside personality 
disorder, low treatment alliance, and younger age (Brorson, Ajo Arnevik, Rand-
Hendriksen, & Duckert, 2013). 
 It is likely that most residential substance misuse programs deliver treatments that 
work optimally in those who possess intact cognitive abilities; that cognitive impairment 
among residents may hinder treatment success requires further consideration. 
Components of residential AOD treatment often rely on capacities such as executive 
function (defined broadly as “those capacities that enable a person to engage successfully 
in independent, purposive, self-directed, and self-serving behavior”; Lezak, Howieson, 
Bigler, & Tranel, 2012, p. 37) and working memory (Fernández-Serrano, Pérez-García, 
Río-Valle, & Verdejo-García, 2010; Yücel & Lubman, 2007), as clients are required to 
integrate new information, formulate goals, establish new behavioural strategies, and plan 
for the future in overcoming addiction. 
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 However, most misused substances impair attention, learning and memory, 
visuospatial abilities, and executive functioning, with perhaps the most robust deficits 
across all substances evident in inhibitory control, working memory, and decision-
making (Fernández-Serrano, Pérez-García, Río-Valle, et al., 2010; Yücel & Lubman, 
2007; Yücel, Lubman, Solowij, & Brewer, 2007). Structural and functional brain changes 
may occur after substance misuse (Broyd, van Hell, Beale, Yücel, & Solowij, 2016; 
Caplan, Epstein, Quinn, Stevens, & Stern, 2007; Ersche & Sahakian, 2007; Gonzalez, 
2007; Gruber, Silveri, & Yurgelun-Todd, 2007; Lorenzetti, Solowij, & Yücel, 2016; 
Oscar-Berman & Marinković, 2007; Scott et al., 2007). Traumatic brain injury (TBI) is 
also highly prevalent in substance misuse populations, leading to significant complexities 
in the process of AOD treatment (Sacks et al., 2009; Solomon & Malloy, 1992; Walker, 
Cole, Logan, & Corrigan, 2007; West, 2011). 
 Although cognitive dysfunction is common in AOD samples and increasingly 
recognized by staff, there is often insufficient time or resources to implement detailed 
neuropsychological assessments. Cognitive assessment may be instrumental in 
facilitating the detection of AOD clients with clinically significant cognitive impairment, 
irrespective of etiology. Assessing clients' cognitive capacities can inform subsequent 
implementation of strategies aimed at improving treatment retention and outcomes. 
 In the AOD treatment environment a brief but valid and reliable measure is 
required. This would provide an indication of potential cognitive dysfunction and alert 
staff to the possibility that further neuropsychological assessment and/or treatment 
modifications may be indicated. The Montreal Cognitive Assessment (MoCA; 
Nasreddine et al., 2005) comprises 12 items that tap five key neuropsychological 
domains: executive function, working memory, short-term memory, language, and 
visuospatial ability. The MoCA takes 15 minutes to administer, is a free resource 
	 43	
(Nasreddine, 2015), and can be administered by staff without formal neuropsychological 
training. Initial studies have found evidence supporting the use of the MoCA in AOD 
treatment settings (Copersino et al., 2009; Copersino et al., 2012). 
 The current study was exploratory in nature and sought to provide a naturalistic 
overview of a sample of Australian TC residents, with the MoCA administered as a brief 
screening measure to assess neuropsychological functioning. Performance on the MoCA 
was investigated in relation to demographic, substance use, psychological, and other 
variables related to impairments in cognition, including TBI. 
 
2.3. MATERIAL AND METHODS 
2.3.1. PARTICIPANTS 
 The AOD group was recruited from We Help Ourselves (WHOs), a large provider 
of residential AOD treatment in Australia that uses the therapeutic community model of 
treatment. Participants were recruited across seven WHOs sites in New South Wales 
(Sydney, Hunter Valley) and Queensland (Sunshine Coast). The response rate was 
approximately 90%. Specific inclusion and exclusion criteria were not applied in order to 
capture the heterogeneous and complex presentations of residential AOD treatment 
populations and to increase the generalizability of results. Although there was no formal 
assessment of substance use disorders using the Diagnostic and Statistical Manual of 
Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 2013) criteria it 
was assumed that residents would meet these criteria given their attendance at a high-
intensity residential program. 
 A control group was recruited through the University of Wollongong College, a 
provider of educational programs to persons who have not completed high school 
matriculation, as an alternative pathway to tertiary study. All students were invited to 
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participate and the response rate was approximately 60%. Control participants, all native 
English speakers, were excluded for any lifetime dependence on or treatment for alcohol 
or other drugs, and any psychiatric or neurological diagnoses. 
 
2.3.2. PROCEDURE 
 After a group information session, interested participants provided written 
consent and were individually assessed in a quiet testing room. This was conducted within 
the TC facility for the AOD group, and at a University psychology clinic for the control 
group. The MoCA was administered in approximately 15 minutes, adhering to the 
administration and scoring guidelines (Nasreddine, 2015). Additional information (e.g., 
basic demographics, history of head injury, current and past substance use for controls) 
was obtained through a 10-minute semi-structured interview and the Kessler 
Psychological Distress Scale (K10; Kessler et al., 2002) was administered, as well as the 
Severity of Dependence Scale (SDS; Gossop et al., 1995) for the AOD group. Control 




 The MoCA was used to assess neuropsychological functioning across its 
purported five domains (executive function, working memory, short-term memory, 
language and visuospatial ability). Executive function is assessed using trail-making, 
phonemic fluency, and verbal abstraction tasks. Working memory is assessed using 
sustained attention, serial subtraction, and digit span forward/backward tasks. Short-term 
memory is assessed through the delayed recall of five nouns. Language is assessed using 
naming (low familiarity animals), sentence repetition, and the phonemic fluency task. 
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Visuospatial ability is assessed using clock-drawing and cube-copying tasks. The MoCA 
has displayed acceptable reliability in clinical groups (Bernstein, Lacritz, Barlow, 
Weiner, & DeFina, 2011; Freitas, Simões, Marôco, Alves, & Santana, 2012). Outcome 
measures included total MoCA score and domain subscores. 
 
2.3.3.2. Clinical variables 
 The SDS (Gossop, Best, Marsden, & Strang, 1997) measured AOD participants' 
level of dependence on their primary substance of misuse. The K10 was used to capture 
level of psychological distress experienced by all participants. The K10 has been 
extensively used in both community and clinical samples as an indicator of a potential 
psychological disorder, and has demonstrated acceptable psychometric properties 
(George, Kinner, Bruno, Degenhardt, & Dunn, 2010; Hides et al., 2007; Sunderland, 
Mahoney, & Andrews, 2012). Relevant demographic and substance use data routinely 
collected by WHOs were accessed, following participants and the director of the service 
providing written consent. 
 
2.3.4. DATA ANALYSIS 
 All data were analyzed using IBM Statistical Package for the Social Sciences 
(version 19; IBM Corp, 2010). The primary goals of the analysis were to compare the 
performance of residents and controls on the MoCA and to explore variation in MoCA 
scores and potential predictors (e.g., primary substance of misuse, gender effects) within 
the AOD sample. 
 Shapiro–Wilk statistics and visual inspection of histograms and boxplots 
determined that total MoCA score, MoCA domain subscores, age, years of education, 
K10 and SDS scores were not normally distributed for both AOD and control groups. 
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Consequently, nonparametric techniques were employed for most of the analyses. 
Nonparametric analysis of covariance was required for some analyses to enable covarying 
demographic characteristics that differed between groups. Quade’s (1967) distribution-
free procedure was used as a nonparametric alternative to analysis of covariance (see 
Olejnik & Algina, 1985). This involved ranking the dependent variable and all covariates 
for all cases, ignoring the grouping variable. Following this, the linear regression of the 
ranked dependent variable on the ranked covariate measure was calculated and the 
unstandardized residuals saved, again ignoring the grouping factor. To calculate Quade's 
F statistic, a one-way analysis of variance using the residuals from the regression as the 
dependent variable and the grouping variable as the factor was performed. 
 Total MoCA score and cognitive domain subscores were the primary dependent 
variables for analysis. However, factor analyses of the MoCA have demonstrated that 
domains may be grouped differently (e.g., Duro, Simões, Ponciano, & Santana, 2010; 
Freitas et al., 2012). Given the multi-process nature of neuropsychological tasks, whereby 
any single task may tap into a range of perceptual, cognitive and motor abilities, and the 
overlapping nature of the cognitive domains assessed by the MoCA (Freitas et al., 2012), 
we created an additional score for analysis of executive function. This was of particular 
interest because executive dysfunction is especially common in substance misusing 
individuals (e.g., Fernández-Serrano, Pérez-García, Río-Valle, et al., 2010; Gierski et al., 
2013; Hester, Lubman, & Yücel, 2010; Perry et al., 2011). As such, we utilized the 
standard measure of executive function from the MoCA as well as an extended measure 
that included performance on the visuospatial cube-copying and clock-drawing tasks, 
with the rationale that these tasks rely on key component processes of executive function. 
 All AOD residents were compared to controls in the first instance. Residents were 
then compared in terms of gender and primary substance of misuse. Primary substance of 
	 47	
misuse groupings were formed by choosing the three largest representative groups in 
residence at the time of testing (alcohol, heroin and amphetamines). A broader opiates 
group was then formed by the addition of clients on methadone maintenance and 
buprenorphine users. Cocaine users, minimal in Australian AOD samples (Australian 
Institute of Health and Welfare, 2005), were grouped with amphetamine users to form a 
stimulants group. This strategy maximized group sizes for comparison, grouping together 
substances with similar chemical properties. However, primary users of cannabis, 
tranquilisers and benzodiazepines were not grouped or included in these comparisons due 
to insufficient sample sizes of these subgroups (see Results). Finally, AOD users 
hospitalized after a head injury were compared to those without serious head injuries. 
 
2.4. RESULTS 
2.4.1. PRELIMINARY ANALYSES 
 MoCA data were available for 128 AOD residents and 37 controls. For some 
analyses, the AOD sample was reduced to 95 due to missing data (e.g. primary substance 
of misuse, n = 16; SDS and K10 scores, n = 33). Table 1 displays demographic, substance 
use, psychological, and cognitive functioning variables for the AOD group. AOD 
residents were in their mid-thirties on average and predominantly male. Alcohol was the 
primary substance of misuse for almost one-third of the sample, followed by heroin and 
amphetamine misuse, with these three substances accounting for approximately 80% of 
the entire AOD sample. The mean K10 score indicated very high levels of psychological 
distress and the mean SDS score indicated high levels of psychological dependence on 
participants' primary substance of misuse, although the range extended to 0 in some cases, 
reflecting that some residents had progressed further in their treatment. The prevalence 
of head injuries was particularly high in the sample. 
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Table 1. Demographic, substance use, psychological, and clinical variables for the AOD group (n = 
128). 
Age (Mdn, range)    35 (19-56) 
Gender (% male)     70.3 
Education (Mdn, range)    10 (7-16) 
Unemployed (%)     90.5    
Homelessa (%)         7.4    
Arrested during last three monthsa (%)  43.2           
Primary substance of misuseb (%)     
Alcohol     30.4    
       Heroin     27.7    
       Amphetamines    20.5    
      Cannabis       8.9    
      Tranquilisers        4.5    
      Methadone       2.7    
      Buprenorphine        1.8    
       Cocaine        1.8    
       Benzodiazepines        1.8    
SDSc scorea (Mdn, range)    11 (0-15)   
History of overdose (%)    60.2    
Injected during last three months (%)  52.6    
K10d scorea (M, SD)    29.2 (7.8)    
Hospitalised after head injury (%)   50.0    
Lost consciousness/concussion after head injury (%) 67.2    
a n = 95. 
b n = 112. 
c Severity of Dependence Scale. 
d Kessler Psychological Distress Scale. 
 
Of the 67.2% who had either lost consciousness or sustained a concussion after a head 
injury, the mean number of times this had occurred was 4.98 (SD = 5.95). Half of the total 
sample had been hospitalized after sustaining a head injury. 
 All control participants were screened to ensure that they had not been dependent 
on alcohol or other substances and/or received treatment for substance use disorder in the 
past. No control participant currently used any substance (excluding alcohol and tobacco) 
on a regular basis (i.e., greater than once a month), with minimal prior experimentation 
with drugs, and 76% drank alcohol less than twice per week. The 24% of control 
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participants who drank alcohol more than once per week were screened to ensure that 
their current drinking was not occurring at a problematic level that caused clinically 
significant impairment or distress. Despite attempts to match sample characteristics, 
controls were significantly younger (Mdn = 25 years, range 21–61) than the AOD group 
(Mdn = 35 years, range 19–56), z = −5.21, p < .001, and had significantly more years of 
education (Mdn = 12 years vs. Mdn = 10 years), z = −4.26, p < .001. Gender distribution 
did not differ significantly between groups (54% male in controls vs. 70.3% male in 
AOD). Age and education were therefore included as covariates for group comparisons. 
Psychological distress was low to moderate in controls (K10 mean 17), and was 
significantly higher in AOD residents (K10 mean 29), F(1, 130) = 33.33, p < .001. 
 
2.4.2. PRIMARY ANALYSES 
2.4.2.1. Covariates 
 Despite the group difference in age, age was not significantly correlated with total 
MoCA score, p = .16. It was also not correlated with any MoCA subscores, all p > .05, in 
the entire sample as well as in the AOD group alone. There were significant correlations 
between years of education and total MoCA score, r = .18, p = .02, executive function, r 
= .36, p < .001, short-term memory, r = .18, p = .02, working memory, r = .21, p = .006, 
and language, r = .26, p = .001. Age and education were both included as covariates in 
analyses, but while education was consistently significant in the models, age was not. 
Age was subsequently dropped from the analyses and results are reported here with 





2.4.2.2. MoCA scores 
 Comparison of the AOD and control group determined a significant difference in 
total MoCA score, F(1, 163) = 5.28, p = .023, the combined executive 
function/visuospatial subscore, F(1, 163) = 6.91, p = .009, and the visuospatial domain 
alone, z = −2.43, p = .015, with poorer performance in the AOD group (Table 2). None 
 
Table 2. Comparison of MoCA scores between AOD and control groups, for entire AOD sample and 
those without head injuries: mean (SD). 
   Head injuries included  Head injuries excluded  
   AOD group (n = 128)  AOD group (n = 64)           Control (n = 37) 
Total score  25.60 (3.13)*   26.39 (2.56)  26.94 (3.10) 
Executive/Visuospatial   5.13 (1.57)**     5.53 (1.47)    6.14 (1.64) 
Executive    2.48 (1.05)     2.73 (1.03)    3.08 (0.92) 
STMa     3.63 (1.33)     3.78 (1.23)    3.92 (1.23) 
WMb     5.36 (1.06)     5.50 (1.04)    5.43 (0.99) 
Visuospatial    2.64 (1.01)*     2.80 (0.98)    3.05 (1.13) 
Language    5.01 (0.94)     5.16 (0.88)    5.35 (0.82) 
*p < .05 **p < .01  
a Short-term memory. 
b Working memory. 
 
of the other cognitive domain subscores differed between groups: short-term memory, 
F(1, 163) = .25, p = .62, working memory, F(1, 163) = .27, p = .60, and language, F(1, 
163) = 1.04, p = .31. There was a trend toward poorer executive function in the AOD 
group, F(1, 163) = 3.01, p = .08. 
 
2.4.2.3. Gender effects 
 There were no significant differences between male and female AOD participants 
in age, years of education, or SDS scores (all p > .28). Females tended to have higher K10 
scores (M = 31.25, SD = 7.89) than males (M = 28.21, SD = 7.60), t(93) = − 1.82, p = .07. 
MoCA outcomes for males vs. females were not significantly different (all p > .10) 
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although females tended to score slightly higher than males (Mdn 3 vs. 2) on executive 
subscores, z = −1.68, p = .09. 
 
2.4.2.4. Primary substance of misuse 
 There were significant differences between primary substance of misuse groups 
in age, F(2, 92) = 8.25, p = .001, but not years of education, H(2) = 4.15, p = .13, or SDS 
scores, H(2) = 1.59, p = .45; age was therefore included as a covariate in the analysis. 
There were no significant differences in total MoCA score, F(2, 92) = .04, p = .96, short-
term memory, F(2, 92) = .09, p = .92, language, F(2, 92) = .15, p = .86, executive function, 
F(2, 92) = 1.37, p = .26, visuospatial abilities, F(2, 92) = 1.61, p = .21, or combined 
executive function/visuospatial abilities, F(2, 92) = 1.30, p = .28, between primary 
substance of misuse groups (Table 3). There was a marginally significant difference for 
working memory performance, F(2, 92) = 2.98, p = .056, with the poorest performance 
in the stimulants group. K10 scores were significantly different across substance of 
misuse groups, F(2, 77) = 5.96, p = .004, being higher in the stimulant group relative to 
the opiate group (p = .022) and the alcohol group (p = .07), with no difference between 
alcohol and opiate groups (p = .69). 
 
Table 3. Comparison of MoCA scores across primary substance of misuse groups: mean (SD). 
   Alcohol (n = 34)   Opiates (n = 36)   Stimulants (n = 25)  
Total score  25.85 (3.49)  25.92 (2.55)  25.88 (3.23) 
Executive/Visuospatial   5.09 (1.73)    5.14 (1.51)    5.60 (1.58) 
Executive    2.26 (1.14)    2.64 (1.05)    2.68 (1.11) 
STMa     3.76 (1.18)    3.69 (1.35)    3.64 (1.31) 
WMb     5.53 (1.08)    5.56 (0.69)    5.00 (1.22) 
Visuospatial    2.82 (0.94)    2.50 (1.06)    2.92 (0.91) 
Language    5.12 (0.95)    4.94 (1.01)    4.96 (0.93) 
a Short-term memory. 
b Working memory; trend toward greater impairment in the stimulants group: p = .056. 
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2.4.3. EXPLORATORY ANALYSES 
2.4.3.1. Psychological distress and substance dependence 
 There were significant negative correlations between K10 scores and total MoCA 
scores, r = −.22, p = .012, executive function/visuospatial abilities, r = −.21, p = .015, and 
language scores, r = −.20, p = .021, and a trend for working memory, r = −.16, p = .06, 
in the overall AOD sample. K10 and SDS scores were positively correlated, r = .20, p = 
.049, but SDS scores were not correlated with any MoCA scores (all p > .05), other than 
a trend toward a correlation with executive function, r = .18, p = .085. This pattern 
indicates that greater psychological distress (but not greater drug dependence) is 
associated with greater cognitive impairment. 
 
2.4.3.2. Head injuries 
 Given that 50% of the AOD sample had been hospitalized for a head injury, the 
impact of head injuries on cognitive function was imperative to investigate further. There 
were no significant differences in age, z = −1.24, p = .22, education, z = −.94, p = .35, or 
K10 scores, t(93) = −.23, p = .82, between AOD residents who had versus had not been 
hospitalized after a head injury, but those who had not been hospitalized for head injury 
had higher SDS scores, z = −2.10, p = .035, (Mdn = 11 vs. 10). AOD participants who 
had been hospitalized had lower total MoCA scores (Mdn = 25.5 vs. 26), z = −2.59, p = 
.01, than those who had not. The hospitalized group also had lower executive/visuospatial 
(Mdn = 5 vs. 6, z = −2.97, p = .003), working memory (mean rank = 58.38 vs. 70.62, z = 
−2.18, p = .03), and executive (Mdn = 2 vs. 3, z = −2.66, p = .008) subscores, than the 
non-hospitalized group, with trends toward lower language, z = −1.67, p = .095, and 
visuospatial subscores, z = − 1.71, p = .088, but no difference in short-term memory 
subscores, z = −1.17, p = .24. Figure 1 displays standardized (out of 6) MoCA domain 
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scores for AOD participants hospitalized for head injuries, non-hospitalized AOD 
participants and controls. 
 
 
Figure 1. Standardised (out of 6) MoCA domain scores for the AOD patients who were hospitalised for 
head injuries, non-hospitalised for any head injury (includes those who never had a head injury or 
may have sustained head injuries not requiring hospitalisation), and control participants. 
 
2.4.3.3. Analysis of sample without significant head injuries 
 After exclusion of those who had been hospitalized after a head injury, the primary 
analyses were repeated to compare only those AOD residents who had not sustained head 
injures requiring hospitalization with controls (Table 2). The AOD group in this reduced 
sample (n = 64) were significantly older than controls (Mdn = 34 vs. 25, respectively), z 
= −4.82, p < .001, and less educated (Mdn = 10 vs. 12), z = −3.65, p < .001. With age and 
education included as covariates, there were no significant differences in total MoCA 
score, F(1, 99) = .38, p = .54, or any MoCA subscores (all p > .20) between AOD residents 
without significant head injuries and controls. Significant differences remained for K10 
scores between these AOD residents (Mdn = 29) and controls (Mdn = 16), F(1, 82) = 
33.51, p = < .001. Other than males scoring significantly higher (mean rank = 36.43) in 












other effects of gender or primary substance of misuse were found in this sample without 
head injuries. 
 
2.4.3.4. Clinical significance of impairment 
 To investigate the clinical significance of impairment, total MoCA scores were 
recoded as a dichotomous variable to indicate either the presence or absence of cognitive 
impairment according to the cut-off score suggested by Copersino et al. (2009) as ≥ 26 
reflecting no evidence of cognitive impairment. Within the overall AOD group, 43.8% 
met criteria for cognitive impairment. After removing those hospitalized for head injuries, 
37.5% met criteria for impairment and this represented a significantly greater proportion 
than the 16.2% of controls meeting criteria for impairment, 2(1, N = 101) = 5.09, p = 
.019. However, after removing a further 27 participants in the AOD sample who had 
sustained concussion or lost consciousness after a head injury but had not been 
hospitalized, the prevalence of impairment dropped to 29.7% and this did not represent a 
statistically significant difference when compared to the 16.2% of impaired controls (p = 
.13). Subsequently, it was deemed appropriate to examine the prevalence of impairment 
within the AOD group who had been hospitalized after a head injury. Of those who had 
been hospitalized (n = 64), only 50% met criteria for cognitive impairment, indicating 
that hospitalization for head injuries alone may not predict cognitive impairment. There 
was no difference in the total number of head injuries (including those that did not require 
hospitalization) sustained by those who met criteria for impairment (Mdn = 3) vs. those 




 This study used a brief screening tool, the MoCA, to provide an overview of 
cognitive functioning in residents of a substance misuse TC. The major findings were that 
43.8% of the AOD group met criteria for cognitive impairment and head injuries were a 
significant determinant of this impairment. Within the AOD group, 50% had been 
hospitalized after a head injury and were more cognitively impaired than those who had 
not sustained head injuries requiring hospitalization. Greater psychological distress in the 
AOD group was also associated with greater cognitive deficits. 
 
2.5.1. NEUROPSYCHOLOGICAL FUNCTIONING 
 AOD residents overall scored significantly lower on the MoCA and showed 
greater deficits in executive function and visuospatial abilities than controls. No other 
cognitive domains differed between residents and controls. Within the AOD group, there 
were no gender effects other than a trend toward males displaying greater executive 
dysfunction than females and females tended to have higher levels of psychological 
distress than males. MoCA outcomes did not differ according to primary substance of 
misuse, other than stimulant users showing marginally poorer working memory ability 
and higher levels of psychological distress. The lack of observed differences in 
neuropsychological outcomes between substance of misuse groups may be explained by 
the prevalence of polysubstance use in clients undergoing residential AOD treatment; 
differences may not be detected between groups in which substance use has reached a 
level necessitating residential treatment. Generally, clients in residential AOD treatment 
have extensive histories of substance use with considerable variability between 
individuals. Another possible explanation is that differences do exist between substance 
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of misuse groups in residential treatment but that the current study did not possess group 
sizes large enough to detect these differences. 
 
2.5.1.1. Head injuries 
 Half of the AOD sample in the current study had been hospitalized after a head 
injury and were more cognitively impaired than those who had not, with lower total 
MoCA scores, and poorer executive/visuospatial and working memory abilities. When 
the hospitalized group were excluded from the analysis, there were no differences in any 
neuropsychological outcomes between AOD residents and controls, and no differences 
between primary substance of misuse groups, but females in this subset displayed poorer 
working memory performance than males. 
 In general, these findings are congruent with the literature suggesting that 
cognitive impairments exist in AOD populations (Caplan et al., 2007; Ersche & Sahakian, 
2007; Fernández-Serrano, Pérez-García, Río-Valle, et al., 2010; Gonzalez, 2007; Gruber 
et al., 2007; Oscar-Berman & Marinković, 2007; Scott et al., 2007; Yücel & Lubman, 
2007; Yücel et al., 2007) and may be detected by a brief cognitive impairment-screening 
tool (the MoCA). In assessing a residential AOD sample, arguably we accessed those 
most severely affected by their addiction, and also those with a high prevalence of head 
injuries requiring hospitalization. The level of cognitive impairment detected in this 
sample, as measured by the MoCA, was not severe and was largely associated with TBI, 
a factor that has not routinely been considered in previous studies and may account for a 




 This study showed that having sustained a TBI requiring hospitalization 
accounted for the majority of cognitive impairment detected in the sample. There are two 
major implications: first, simply asking clients whether they have ever sustained a head 
injury requiring hospitalization may be the most time-efficient way to informally gauge 
the possibility of cognitive deficits. Clients may be unable, however, to provide accurate 
accounts due to the high rate of TBIs occurring during intoxication that may remain 
undetected and receive no medical intervention. While half of the AOD group in the 
current study had sustained a head injury requiring hospitalization, 50% of this subgroup 
did not meet criteria for impairment based on the MoCA score threshold. As such, 
screening for head injuries alone without subsequent cognitive assessment may lead to 
inflated estimates of impairment. Furthermore, this type of screening would not capture 
approximately one third of the AOD sample that had never sustained head injuries and 
yet met criteria for cognitive impairment. Thus, the second implication is that cognitive 
deficits may also exist independently of head injuries in AOD samples and hence require 
screening in their own right. 
 These complex findings highlight the importance of brief cognitive screening as 
a standardized assessment procedure for all clients entering residential treatment. In this 
way, treatment planning may account for the presence of cognitive deficits. Further 
neuropsychological assessment may be recommended and modifications to treatment 
and/ or targeted interventions may be implemented. 
 Regardless of the etiology of cognitive impairment, cognitive screening has the 
potential to inform interventions aimed at alleviating these deficits. For example, adjunct 
interventions to remediate cognitive deficits together with better-tailored specific 
treatments may bolster residential services, reducing dropout rates and consequently 
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improving treatment outcomes. Evidence suggests that the neuropsychological deficits 
associated with TBI can be alleviated through cognitive remediation interventions (Maas 
et al., 2013; Manley & Maas, 2013; Tsaousides & Gordon, 2009), and there is emerging 
evidence for the use of cognitive remediation programs in substance misuse populations 
as a way to improve treatment retention (Bates, Buckman, & Nguyen, 2013; Fals-Stewart 
& Lam, 2010; Rupp, Kemmler, Kurz, Hinterhuber, & Fleischhacker, 2012; Verdejo-
García, 2011; Wexler, 2011). Further research aimed at developing and trialling cognitive 
remediation programs for AOD populations is required and providing these interventions 
within residential treatment services would be most ideal (e.g., Gonçalves et al., 2014). 
 
2.5.3. LIMITATIONS AND FUTURE DIRECTIONS 
 There are several limitations of the current study. There were clear differences 
between the AOD group and controls (e.g., age, education, inferred socioeconomic 
status). While some of these differences were accounted for statistically, future research 
would benefit from the inclusion of better-matched control groups. The exploration of 
primary substance of misuse groups resulted in small sample sizes with reduced statistical 
power for comparison; larger samples in future studies may reveal substance-specific 
impairment. Another limitation of the current study is its failure to assess for psychiatric 
comorbidities, which are common in AOD populations and add substantial complexity to 
the process of treatment. The current study utilized the K10 as a measure of psychological 
distress and higher scores were associated with greater cognitive impairment. Future 
studies should include formal psychiatric diagnoses in order to examine their interaction 
with substance use disorders and head injuries in terms of cognitive outcomes. 
Additionally, the current study focused on hospitalization and frequency of head injuries, 
but not their nature, severity or age of occurrence, which could be further examined in 
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future studies. Also, despite the AOD sample being abstinent from AOD, there was no 
assessment of their duration of abstinence or length of stay in residential services prior to 
cognitive assessment; this, along with a more detailed substance use history (including 
age of onset and number of years of substance use) and objective measures of abstinence 
(e.g. urine testing in both AOD and control samples), could have provided further 
information regarding the nature and extent of the observed cognitive deficits. Finally, 
the potential lack of sensitivity of the MoCA to more specific cognitive deficits in AOD 
populations cannot be underestimated; the scores observed in this sample were not 
substantially below the cut-off indicative of impairment. Nevertheless, the MoCA can 
serve as a cost-effective screening tool that would detect severe deficits in those most 
requiring further neurocognitive assessment. 
 
2.6. CONCLUSION 
 The current study identified that the MoCA may be usefully applied in the AOD 
treatment setting as a brief screening tool. We showed in a naturalistic snapshot of clients 
in AOD residential treatment that cognitive impairment is common and may be related to 
the effects of head injuries, which are also highly prevalent. Cognitive abilities such as 
executive function and working memory are important for AOD residents to engage 
meaningfully in treatment and achieve successful outcomes. If these capacities are 
compromised, residents may be more likely to drop out from treatment and fail to recover 
from their addiction. The first step in rectifying this situation is to improve the assessment 
and detection of those who present with cognitive deficits. This will help to inform 
modifications to treatment and/or cognitive remediation interventions that may be 
beneficial in accommodating and potentially remediating impairments in cognition, 
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increasing the likelihood of treatment engagement and retention, and hopefully leading 
to long-term recovery from addiction. 
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3.1. ABSTRACT 
Background: Executive dysfunction is common in substance use disorder (SUD) 
populations and hinders treatment. We previously found that 50% of residents in SUD 
therapeutic communities had been hospitalized for head injuries; this was a significant 
determinant of cognitive impairment. The current study aimed to establish whether 
cognitive remediation improves executive functions (EFs) and self-regulation in an 
ecologically valid sample of female residents attending SUD therapeutic community 
treatment, including those with past head injuries and psychiatric comorbidities. 
Methods: Controlled sequential groups design with residents (N = 33, all female) 
receiving treatment as usual (TAU). The intervention group (n = 16) completed four 
weeks of cognitive remediation (CR) and the control, TAU only (n = 17). Outcome 
measures assessed pre- and post-intervention included both performance- and inventory-
based measures of EFs, and self-reported self-regulation and quality of life. 
Results: CR relative to TAU significantly improved performance-based assessment of 
inhibition (Color-Word Interference Test; F = 4.29, p = 0.047), inventory-based 
assessment of EFs (Behavior Rating Inventory of Executive Function - Adult Version: 
Global Executive Composite; F = 6.38, p = 0.017), impulsivity (Barratt Impulsiveness 
Scale; F = 4.61, p = 0.040), self-control (Brief Self-Control Scale; F = 5.53, p = 0.026) 
and quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire - Short 
Form; F = 7.68, p = 0.010). 
Conclusions: Findings suggest that CR improves EFs in a heterogeneous sample of 
female residents in therapeutic community SUD treatment. Future research may explore 
the possibility of tailoring CR interventions for various SUD subgroups. 
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3.2. INTRODUCTION 
 Self-regulation is a protective factor in ameliorating many social and mental 
health problems and is understood as the capacity “to make plans, choose from 
alternatives, control impulses, inhibit unwanted thoughts and regulate social behavior” 
(Heatherton & Wagner, 2011, p. 132). Individuals in residential rehabilitation treatment 
for substance use disorders (SUDs) must possess some capacity for self-regulation in 
order to meaningfully engage in treatment and ultimately change their behavior. This is 
particularly true of therapeutic community treatment (Vanderplasschen et al., 2013), 
which entails significant social participation and shared responsibility for activities of 
daily life. 
 Cognitive deficits are one of the four biggest risk factors for dropout from SUD 
treatment (Brorson, Ajo Arnevik, Rand-Hendriksen, & Duckert, 2013), and executive 
function (EF) impairment is commonly observed in individuals experiencing SUDs 
(Fernández-Serrano, Pérez-García, Río-Valle, & Verdejo-García, 2010; Hester, Lubman, 
& Yücel, 2010). Diverse definitions of EFs exist (Friedman & Miyake, 2017) but they 
are broadly understood as “those capacities that enable a person to engage successfully 
in independent, purposive, self-directed, and self-serving behavior” (Lezak, Howieson, 
Bigler, & Tranel, 2012, p. 37). An influential threefold model of EFs includes ‘working 
memory’, ‘inhibition’, and ‘shifting’ (Miyake et al., 2000). Working memory refers to 
the capacity to monitor and alter information held in mind temporarily, inhibition 
involves overriding an unwanted distraction to maintain task-focus, and shifting pertains 
to flexibly switching attention between tasks or mental sets (Hofmann, Schmeichel, & 
Baddeley, 2012). These basic EFs are intricately linked to and may subserve effective 
self-regulation (Hofmann et al., 2012). 
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 Individuals in residential treatment for SUDs often have psychiatric and medical 
comorbidities, including history of head injury. For example, we previously found that 
67.2% of residents in SUD therapeutic community treatment (70.3% male) had sustained 
one or more head injuries, while 50% required hospitalisation following a head injury 
(Marceau, Lunn, Berry, Kelly, & Solowij, 2016). History of head injury was a significant 
determinant of cognitive impairment and was associated with higher levels of 
psychological distress. Psychiatric comorbidities are also frequently observed in SUD 
populations and add further complexity to the process of addiction recovery (Baingana, 
al'Absi, Becker, & Pringle, 2015). Personality disorders are particularly prevalent (e.g., 
Pennay et al., 2011) and are not only associated with global neurocognitive and specific 
EF deficits, (Fertuck, Lenzenweger, Clarkin, Hoermann, & Stanley, 2006; Ruocco & 
Carcone, 2016; Unoka & Richman, 2016), but also with dropout from SUD treatment 
(Brorson et al., 2013). 
 Given the high rates of head injury and psychiatric comorbidities in SUD 
populations, and the positive relationship of these variables with cognitive impairment, 
the application of evidence-based neuropsychological interventions designed for use in 
both brain injury (usually referred to as cognitive rehabilitation) and mental health 
(usually referred to as cognitive remediation) populations might be expected to result in 
reductions of cognitive impairment, and potentially lead to better SUD treatment 
outcomes. It has been recommended that these interventions be adapted for use in SUD 
treatment populations (Bates, Buckman, & Nguyen, 2013) and there have been a number 
of attempts at this to date (e.g., Alfonso, Caracuel, Delgado-Pastor, & Verdejo-García, 
2011; Bickel, Yi, Landes, Hill, & Baxter, 2011; Houben, Wiers, & Jansen, 2011; Valls-
Serrano, Caracuel, & Verdejo-García, 2016). 
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Neuropsychological interventions for SUD populations have tended to adopt 
either a drill and practice (e.g., Houben et al., 2011) or strategy-based (e.g., Valls-Serrano, 
Caracuel, et al., 2016) approach. To our knowledge, there are no published studies 
incorporating a combined approach that utilises both domains. The cognitive remediation 
literature within psychiatry has suggested that whilst drill and practice approaches (e.g., 
computerized cognitive training) may lead to greater gains on cognitive test scores, 
strategy-based training (e.g., instruction in specific strategy use) leads to greater 
functional outcomes for individuals with schizophrenia (Paquin, Wilson, Cellard, 
Lecomte, & Potvin, 2014; Wykes, Huddy, Cellard, McGurk, & Czobor, 2011). 
Combining approaches in an SUD population may result in greater gains across a range 
of measures. This study aimed to determine the effectiveness of a cognitive remediation 
intervention that incorporated both drill and practice and strategy-based training for a 
treatment seeking SUD population, inclusive of those with psychiatric and head injury 
comorbidities. 
 Assessment of EFs may be performance- (i.e., assessing performance on working 
memory, inhibition, and shifting tasks) or inventory-based (i.e., based on self-reports of 
executive functioning). Whilst performance-based measures of EFs are sensitive to brain 
impairment that implicates the frontal lobes (Jurado & Rosselli, 2007), some may 
demonstrate limited ecological validity and may not capture problems with everyday 
functioning as well as inventory-based measures (Isquith, Roth, & Gioia, 2013). 
Inventory- and performance-based measures of EFs are minimally correlated and may 
assess distinct components of EFs that contribute independently to clinical problems 
(Toplak, West, & Stanovich, 2013). For example, to determine the relative sensitivities 
of performance- and inventory-based EFs measures in an SUD treatment population, 
Hagen and colleagues (2016) showed that inventory-based assessment using the Behavior 
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Rating Inventory of Executive Function – Adult Version (BRIEF-A; Roth, Isquith, & 
Gioia, 2005) better distinguished polysubstance users from controls and was more 
strongly associated with real-world social adjustment outcomes compared to 
performance-based measures, which included the Iowa Gambling Task (Bechara, 
Damasio, Damasio, & Anderson, 1994), the Trail-Making Test (Strauss, Spreen, & 
Sherman, 2006), and the Stroop test (Golden, 1978). In light of these findings and to 
provide a more comprehensive assessment of EFs, the current study included both 
performance- and inventory-based measures. 
 The current study aimed to examine the effectiveness of cognitive remediation vs. 
treatment-as-usual (TAU) in: (1) improving performance- and inventory-based measures 
of EFs and (2) improving self-report measures of self-regulation. Quality of life was 
included as a secondary clinical outcome measure, as it plays an important role in 
sustained remission from SUDs (Laudet, Becker, & White, 2009). We hypothesized that 





 Fifty participants were recruited from a women’s residential treatment facility in 
Sydney run by We Help Ourselves (WHOs) – a large provider of residential SUD 
rehabilitation in Australia, utilising the therapeutic community model of treatment. 
Inclusion criteria for the study were: (i) diagnosis of substance abuse/dependence, based 
on DSM-IV-TR criteria, assessed using the Mini-International Neuropsychiatric 
Interview (MINI-Plus; Sheehan et al., 1998), (ii) a minimum abstinence period of 7 days 
(with confirmation of detoxification a prerequisite of entry to treatment), (iii) absence of 
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any neurological, infectious, or other disease affecting the central nervous system (e.g., 
epileptic seizures, stroke, brain tumour, meningitis, encephalitis, multiple sclerosis, HIV 
positive), and (iv) English as native language. A condition of staying at the residential 
facility is that participants remain abstinent from substances of abuse and this is 
monitored through routine urinalysis (random resident checks occurring several times per 
week) and 24-hour observation from experienced staff and co-residents. 
 
3.3.2. DIAGNOSTIC AND CLINICAL ASSESSMENT 
 Diagnostic and clinical assessment at baseline included the following: Psychiatric 
comorbidities (DSM-IV-TR) were assessed using the MINI-Plus and Standardised 
Assessment of Personality – Abbreviated Scale (Moran et al., 2003), as shown to be 
appropriate for SUD populations (Gonzalez, 2014; Hesse & Moran, 2010; Hesse, 
Rasmussen, & Pedersen, 2008). Questions were adapted from the Addiction Severity 
Index – Fifth Edition (ASI; McLellan et al., 1992) to assess lifetime substance use history. 
Additionally, a brief semi-structured interview was used to assess history of head injury. 
The Test of Premorbid Functioning (TOPF; Pearson Assessment, 2009) was used to 
estimate overall level of intellect. 
 
3.3.3. OUTCOME MEASURES 
3.3.3.1. Executive functions – performance-based 
Working memory: Working Memory Index (WMI; Wechsler Adult Intelligence Scale, 
fourth edition: WAIS-IV; Wechsler, 2008). The WMI of the WAIS-IV assesses 
components of working memory and is comprised of 2 subtests, which were administered 
according to standard instructions. The digit span subtest requires participants to recall 
various sequences of numbers (forward, backward, and in sequence) and the arithmetic 
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subtest involves participants solving numerical problems within 30 seconds, after they 
have been read aloud by the examiner. The subtest scores were summed to yield a total 
score, which was then scaled to provide an index score, as per standardized scoring 
instructions. 
Inhibition: Color-Word Interference Test (Delis-Kaplan Executive Function System: D-
KEFS; Delis, Kaplan, & Kramer, 2001). This subtest of the D-KEFS assesses response 
inhibition and provides an auxiliary measure of shifting. Participants are instructed to 
read the items presented in each of four conditions as quickly and accurately as possible. 
Performance is measured in time (seconds). The first condition presents patches of 
colours and requires participants to name the colours. The second condition presents the 
words “red”, “blue”, and “green” and requires participants to read the words. The third 
condition presents words printed in incongruent colours and requires the participant to 
ignore the word and say the colour. The fourth condition presents words printed in 
incongruent colours and requires the participant to switch between two rules: (a) ignore 
the word and say the colour; and (b) ignore the colour and say the word. Outcome 
variables were contrast scaled scores of inhibition (condition 3 scaled score minus 
condition 1 scaled score) and inhibition/shifting (condition 4 scaled score minus condition 
1 scaled score). 
Shifting: Trail-Making Test (TMT; Strauss et al., 2006). This test provides a measure of 
shifting, with Part A assessing simple psychomotor ability and Part B assessing 
psychomotor ability and shifting. In part A, participants connect 25 numbered circles in 
ascending order. In part B, 13 numbers and 12 letters have to be alternately connected in 
their numerical and alphabetical order. Participants are notified of any errors immediately 
and must correct them without assistance. The outcome variable was the difference in 
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time (seconds) to complete part B versus part A (time B minus time A), which specifically 
reflects shifting. 
 
3.3.3.2. Executive functions – inventory-based 
Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A; Roth et al., 
2005). The BRIEF-A is a 75-item self-report questionnaire consisting of nine subscales. 
Participants are instructed to answer each question by selecting “never”, “sometimes”, or 
“often”, in relation to whether they have had problems with any of the listed behaviors in 
the past month. Example items include: “I have trouble getting ready for the day”; “I have 
trouble coming up with ideas for what to do with my free time”. The Global Executive 
Composite (GEC) provides an overall summary score. The Behavioral Regulation Index 
(BRI) includes the subscales Inhibit; Shift; Emotional Control; Self-Monitor. The 
Metacognition Index (MI) includes subscales Initiate; Working Memory; Plan/Organize; 
Task Monitor; Organisation of Materials. Elevated scores indicate executive dysfunction. 




Barratt Impulsiveness Scale – Version 11 (BIS-11; Patton, Stanford, & Barratt, 1995). 
The BIS-11 is a 30-item self-report questionnaire that assesses trait and behavioral aspects 
of the construct of impulsivity. There are six first-order factors: Attention, Cognitive 
Instability, Motor, Perseverance, Self-Control, and Cognitive Complexity. These first-
order factor scores were summed to yield a total score, which was used as the outcome 
variable. 
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Brief Self-Control Scale (BSCS; Tangney, Baumeister, & Boone, 2004). The BSCS is a 
13-item self-report questionnaire that assesses individual differences in the construct of 
self-control. The outcome variable was total score. 
Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). The DERS is 
a 41-item self-report questionnaire that assesses clinically relevant difficulties in emotion 
regulation. There are six subscales (Nonacceptance of Emotional Responses, Difficulties 
Engaging in Goal-Directed Behavior, Impulse Control Difficulties, Lack of Emotional 
Awareness, Limited Access to Emotion Regulation Strategies, and Lack of Emotional 
Clarity) contributing to a total score, which was used as the outcome variable. 
Penn Alcohol Craving Scale (PACS; Flannery, Volpicelli, & Pettinati, 1999). The PACS 
is a 5-item self-report questionnaire that assesses level of cravings for alcohol and other 
drugs. Participants were asked to respond to all items in relation to their primary 
substance of misuse. The outcome variable was total score. 
Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (Q-LES-Q-SF; 
Endicott, Nee, Harrison, & Blumenthal, 1993). The Q-LES-Q-SF is a 16-item self-report 
questionnaire that assesses quality of life across areas of daily functioning. Total score 
was used as the outcome variable. 
 
3.3.4. DESIGN AND PROCEDURES 
 The study employed a controlled sequential groups design and was a naturalistic 
study, capturing a snapshot of residents in treatment at the time of recruitment. This 
design was chosen due to resource constraints and logistic difficulty of having the small 
sample of residents in treatment at any one time being allocated to differing treatment 
regimes. All residents in the treatment facility were invited to participate in the study and 
the response rate was 96%. Those who met inclusion criteria and provided consent took 
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part in either: (a) a cognitive remediation (CR; n = 23) group program or (b) treatment as 
usual (TAU; n = 27). The CR group were recruited first followed by the TAU group, 
allowing sufficient time for a new cohort of residents to become available. Unexpectedly, 
the CR group had spent more time in treatment prior to baseline assessment (Mdn = 67 
days) than the TAU group (Mdn = 25 days). 
 Both groups engaged in the usual therapeutic community model of treatment 
(Vanderplasschen et al., 2013). In addition to this, the CR group attended a total of 12 x 
2-hour group sessions across 4 weeks (3 sessions per week held on Mondays, 
Wednesdays, and Fridays). All participants in the CR group attended these sessions at the 
same time, with all sessions facilitated by the second author (JB) and co-facilitated by the 
first author (EM). The first hour of each session was dedicated to strategy training, which 
included traditional instructional pedagogical approaches, modelling, exercises to 
demonstrate concepts, and role-plays. The second hour included group computerized 
cognitive training using the Lumosity application (Lumosity, 2016) on iPads. Although 
Lumosity has not previously been used in SUD populations, it has been utilized across a 
broad range of other clinical populations (e.g., multiple sclerosis (Charvet, Shaw, Haider, 
Melville, & Krupp, 2015), mild cognitive impairment (Dannhauser et al., 2014), and 
childhood cancer-related brain injury (Kesler, Lacayo, & Jo, 2011)) and was chosen for 
its web-based platform and ease of access. Participants played specific games during 
which they were instructed to use and practice certain strategies that linked to the strategy-
based learning in the previous hour. They were asked to share other strategies they may 
have found useful during the cognitive exercises and this was discussed and sometimes 
integrated with the learning material by the facilitators. The amount of time spent training 
on each game was held constant, rather than the number of trials of each game. This 
allowed participants to progress through the exercises at their own pace. The CR 
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intervention was developed with a strong emphasis on the training of EFs and self-
regulation in view of the finding that EFs are particularly impaired in an SUD treatment 
population. The intervention incorporated elements from well researched CR 
interventions designed for an acquired brain injury (ABI) population, including self-alert 
training (O’Connell et al., 2008; Robertson, Tegnér, Tham, Lo, & Nimmo-Smith, 1995), 
goal management training (Levine et al., 2011), time pressure management (Fasotti, 
Kovacs, Eling, & Brouwer, 2000), and multifaceted treatment of executive dysfunction 
(Spikman, Boelen, Lamberts, Brouwer, & Fasotti, 2010). Other relevant evidence-based 
interventions originally designed for a non-ABI population were also incorporated, such 
as mental contrasting and implementation intentions (Duckworth, Grant, Loew, 
Oettingen, & Gollwitzer, 2011). Barkley’s (2001, 2012) evolutionary model of EFs was 
used to structure a large component of the program. The modules covered the following 
topics: levels of brain functioning, attention, learning and memory, executive functions, 
self-awareness, inhibition, visual and verbal working memory, emotion regulation, 
decision-making and problem-solving. The facilitators followed a manual (available on 
request) to ensure treatment consistency. 
 The CR group completed baseline assessments in the week prior to the 
commencement of the intervention and post-intervention assessments in the week 
following its completion. Similarly, the TAU group completed baseline assessments 
followed by a period of approximately 4 weeks and were reassessed during the 
subsequent week. There was a 5-day difference between groups in the interval between 
baseline and post-intervention assessments (CR: Mdn = 34 days; TAU: Mdn = 29 days). 
The final sample size, accounting for treatment dropout, was 33: n = 16 (CR group) and 
n = 17 (TAU group). During the study period, the rates of unplanned discharges from the 
residential program did not significantly differ between groups (CR = 30%, TAU = 37%, 
	 77	
X2 = 0.24, p = 0.62) and are comparable to those observed in SUD therapeutic community 
treatment (Darke, Campbell, & Popple, 2012). 
 
3.3.5. STATISTICAL METHODS 
 All statistical analyses were performed using IBM Statistical Package for the 
Social Sciences (SPSS version 21; IBM Corp, 2012). Standardized residuals were 
assessed to detect possible outliers (values greater than ± 3). Two outliers were found in 
the Inhibition condition of the Color-Word Interference Test and one was found in the 
Trail Making Test B-A. With exclusion of these outliers from analyses, the pattern of 
results did not change and therefore outliers were retained. One missing value was 
detected in the TAU group (PACS) and three were detected in the CR group (BSCS; 
DERS; Q-LES-Q-SF). 
 Socio-demographic characteristics of the CR vs. TAU groups were compared 
using Student’s t-test and Mann-Whitney U tests as a nonparametric alternative. Chi-
square and Fisher’s exact tests were used to compare percentage variables. 
 Despite significant differences in treatment duration and days from baseline to 
post-intervention between groups, these variables were not included as covariates in 
subsequent analyses. This is based on the recommendations of Kraemer (2015) that 
covariates should be selected a priori and be as few in number as possible, with a 
subsequent option of examining moderators of treatment response separately (see 
Discussion). However, any potential influence of these variables was probed in a series 
of separate preliminary exploratory analyses using analysis of covariance (ANCOVA) to 
compare all outcome variables between groups, including the covariates of baseline score, 
treatment duration, and days from baseline to post-intervention. 
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 ANCOVA (with baseline score as covariate) was the preferred method of primary 
analysis for all outcome variables (Egbewale, Lewis, & Sim, 2014; Kraemer, 2015; 
Overall & Ashby, 1991), which were analysed separately. 
 ANCOVA could not be applied to two analyses (Inhibition/Shifting vs. Colour 
Naming and Q-LES-Q-SF) due to non-normal distributions, as determined by Shapiro-
Wilk tests of within-group and overall model standardized residuals. Subsequently, 
Quade’s (1967) rank ANCOVA was conducted as a nonparametric ANCOVA alternative 
(Olejnik & Algina, 1985). In a further two analyses (TMT and DERS), ANCOVA was 
deemed to be inappropriate due to violation of statistical assumptions. As a result, two 2 
(Time: Pre- vs. Post-intervention) x 2 (Treatment: CR vs. TAU) mixed-design analyses 
of variance (ANOVAs) were conducted with a logarithmic data transformation for one 
variable (TMT) whereas the other (DERS) was not able to be transformed and is reported 
despite violation of the assumption of homogeneity of variances, as assessed by Levene's 
test of homogeneity of variance (p < .05). 
Finally, a series of Mann-Whitney U tests were performed to examine potential 
baseline demographic characteristic differences between those who completed the 
intervention (n	= 33) vs. those who dropped out of treatment (n = 17). Nonparametric 
group comparisons were chosen on account of the small and unbalanced group size. 
 
3.4. RESULTS 
 Table 4 presents socio-demographic characteristics and substance use and head 
injury history for CR vs. TAU groups. There were no significant differences in age (CR: 
Mdn = 32.5 years, range 22–56; TAU: Mdn = 33 years, range 19–53), education (CR: 
Mdn = 12 years, range 7–15; TAU: Mdn = 12 years, range 7–20), intelligence, 
employment, marital status, or history of losing consciousness/concussion or 
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hospitalisation after a head injury. Additionally, primary substance of misuse did not 
significantly differ between groups, with significant heterogeneity observed. The 
descriptive data regarding substance use history presented in Table 4 suggest that 
participants used a variety of substances over many years, with particularly high rates of 
polysubstance use. Treatment duration was significantly longer (p = .003) for participants 
in the CR group (Mdn = 67 days, range 16–160) compared to the TAU group (Mdn = 25 
days, range 2–82). Additionally, there was a 5-day difference between groups in the 
interval between baseline and post-intervention assessments (p = .005) (CR: Mdn = 34 
days, range 33–36; TAU: Mdn = 29 days, range 26–36). 
 Psychiatric comorbidity data for the CR vs. TAU groups are displayed in Table 5. 
No significant differences between groups were found for the proportions meeting criteria 
for current or past Axis I diagnoses (other than SUDs), personality disorders, or the full 
range of other psychiatric comorbidities. 
 The exploratory ANCOVA analyses of all outcome variables including baseline 
score, treatment duration, and days from baseline to post-intervention as covariates, found 
treatment duration to be significant in only one analysis (BIS-11, p = .045) and the 
interval between baseline and post-intervention in only one other (BSCS, p = .036). These 
variables conferred only a small effect, with BIS-11 decreasing by .07 units for every 
one-day increase in treatment duration, and BSCS increasing by .06 units for every one-
day increase in assessment interval. 
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Table 4. Baseline socio-demographic, substance use and head injury characteristics of residents of a 
female-only substance use therapeutic community. 
Characteristic    Cognitive Remediation  Treatment As Usual p 
      (n = 16)   (n = 17) 
Age (M, SD)a       33.6 (10.1)    32.9 (7.6) .85 
Education (M, SD)a      11.3 (2.4)    11.6 (2.6) .82 
Test of Premorbid Functioning (M, SD)    96.0 (11.7)    99.1 (12.9) .48 
Unemployed (%)b      81.2     82.4                1.00 
Marital status (% single)b      75.0     82.4  .69 
Primary substance of misuse (%)c        .20 
Methamphetamine     50.0     29.4 
Alcohol       18.8     35.3   
       Amphetamines      12.5       0 
 Heroin         6.2     11.8   
       Cannabis         0     17.6   
 Sedatives      12.5       5.9 
Years of regular use (M, Mdn, SD; n) 
    Alcohol (any use)     12.9 (13.5, 9.0; 12)     9.5 (6.5, 7.0; 16) 
    Alcohol (to intoxication)       10.0 (8.0, 7.2; 11)     8.0 (5.0, 7.0; 16) 
    Heroin         16.0 (n = 1)      9.7 (8.0, 8.6; 5) 
    Methadone            8.0 (n = 1)      8.3 (8.3, 11.0; 2) 
   Other opiates/analgesics        11.5 (12.0, 4.3; 3)     7.2 (6.0, 5.7; 5) 
    Sedatives/hypnotics/tranquilizers    10.6 (12.0, 4.4; 5)     6.3 (3.5, 6.0; 8) 
    Cocaine             7.0 (4.0, 7.9; 3)     7.0 (8.5, 4.2; 4) 
    Amphetamines             7.8 (8.0, 5.6; 14)      9.2 (10.5, 6.1; 12) 
    Cannabis         11.2 (10.0, 7.7; 13)   10.5 (12.5, 6.6; 13) 
    Hallucinogens            5.2 (3.0, 6.1; 5)     8.0 (8.0, 5.7; 2) 
    More than one substance per day      9.5 (9.5, 4.9; 12)   10.6 (10.0, 6.7; 15) 
Lost consciousness/concussion after head injury (%)c   50.0     58.8  .61 
Hospitalized after head injury (%)c     25.0     47.1  .19 
a Mann-Whitney U test. b Fisher’s exact test. c Chi-square test. 
 
	 81	
Table 5. Psychiatric comorbidities of residents of a female-only substance use therapeutic community. 
Psychiatric Comorbiditya   Cognitive Remediation  Treatment As Usual p 
      (n = 16)   (n = 17) 
Current Axis I psychiatric diagnosisb (%)    56.2     76.5  .22 
Past Axis I psychiatric diagnosisb (%)    68.8     64.7  .81 
Personality disorder screen (met criteria)b, c (%)   50.0     41.2  .61 
Major depressive episodeb         .81 
   Never (lifetime)      50.0    35.3 
   Major depressive episode (past 2 weeks)    18.7    11.8 
   Substance-induced mood disorder (past 2 weeks)     0      5.9 
   Mood disorder due to medical condition      0      5.9 
      (past 2 weeks) 
   Past major depressive episode     25.0    35.3  
   Past mood disorder due to medical condition     6.2      5.9 
Dysthymiab             .40 
   Never (lifetime)      56.2    76.5 
   Dysthymia (past 2 years)     25.0    17.6 
   Past dysthymia       18.8      5.9 
Manic episodeb             .54 
   Never (lifetime)      87.5    70.6  
   Current manic episode        0      0 
   Past manic episode        0    11.8 
   Past hypomanic episode        6.2      5.9 
   Past substance-induced hypomanic episode     6.2      5.9 
   Past hypomanic episode due to medical condition     0      5.9 
Panic disorderb             .63 
   Never (lifetime)      62.5    70.6 
   Panic disorder (past month)       6.2      0 
   Substance-induced anxiety disorder with 
      panic attacks (past month)       0      5.9 
   Anxiety disorder with panic attacks due to 
      a medical condition (past month)      6.2      5.9 
   Panic disorder (lifetime)      18.8      5.9 
   Panic disorder symptoms (lifetime)      6.2    11.8 
Agoraphobiab           .29 
   Never (lifetime)      43.8    70.6    
   Current agoraphobia      31.2    17.6 
   Agoraphobia (lifetime)      25.0    11.8 
Social phobiad (past month)      18.8    17.6  1.0 
Specific phobiad (past month)        12.5      0  .23 
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Table 5. Psychiatric comorbidities of residents of a female-only substance use therapeutic community. 
(continued) 
Psychiatric Comorbiditya   Cognitive Remediation  Treatment As Usual p 
      (n = 16)   (n = 17) 
Obsessive compulsive disorder (past month)      0      0 
Posttraumatic stress disorderd (past month)      18.8    11.8  .66 
Substance-induced psychotic disorderd (lifetime)     25.0    23.5  1.0 
Anorexia nervosa  (past 3 months)       0      0   
Bulimia nervosad (past 3 months)       0    11.8  .49 
Generalized anxiety disorderb (past 6 months)    25.0    17.6  .16 
   Substance-induced generalised 
      anxiety disorder        0    23.5 
   Generalised anxiety disorder due to 
      medical condition        6.2      0 
Antisocial personality disorderd (lifetime)    25.0    35.3  .71 
Somatization disorder (lifetime)       0      0 
Hypochondriasisd  (past 6 months)       0      5.9  1.0 
Pain disorder (current)        0      0 
Adult attention deficit/hyperactivity disorderd (lifetime)18.8    23.5  1.0 
Probable premenstrual dysphoric disorderd (past year)   25.0    11.8  .40 
a Mini-International Neuropsychiatric Interview. b Chi-square test. c Standardised Assessment of 
Personality – Abbreviated Scale. d Fisher’s exact test. 
 
 Primary ANCOVA and mixed-design ANOVA results are displayed in Table 6. 
With baseline scores included as covariates, post-intervention scores in the CR group 
relative to the TAU group were significantly higher for the Color-Word Interference Test 
(Condition Three: Inhibition vs. Colour Naming) and significantly lower for GEC and MI 
of the BRIEF-A, with a trend also for BRI; a pattern of results indicating that the CR vs. 
TAU group displayed improvements in executive functions. The CR group also differed 
from the TAU group on the self-regulation measures, with lower BIS-11 and higher BSCS 
scores, as well as higher Q-LES-Q-SF scores, and a trend towards lower PACS scores. 
These results indicate that the CR group relative to the TAU group displayed reduced 
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impulsivity, higher self-control, and higher quality of life, as well as a trend towards 
reduced cravings. 
 ANCOVA results indicated no significant differences between groups for WMI 
and Inhibition/Shifting vs. Color Naming, and mixed-design ANOVA results indicated 
no significant Time x Treatment interactions for TMT and the DERS. 
With regards to baseline demographic differences between the group of 
participants who completed the intervention (n = 33) vs. those who dropped out of 
treatment (n = 17), completers had significantly higher levels of education (Completers: 
Mdn = 12 years, range 7–20; Non-completers: Mdn = 10 years, range 6–13, p = .008) and 
Test of Premorbid Functioning scores (Completers: Mdn = 97, range 76–122; Non-
completers: Mdn = 82, range 50–117, p = < .001). Age did not significantly differ (p = 
.72) between those who completed the intervention (Mdn = 33 years, range 19–56) vs. 
those who dropped out of treatment (Mdn = 30 years, range 19–41).
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Table 6. Post-intervention effects of cognitive remediation vs. treatment as usual on executive functions, self-regulation and quality of life in residents of a female-only 
substance use therapeutic community. 
Dependent measures    Cognitive Remediation (CR)  Treatment As Usual (TAU)  F p Partial 
      (n = 16)     (n = 17)       η2    
      Baseline  Post-intervention  Baseline  Post-intervention    
      M (SD)  Adjusted M (SD)  M (SD)  Adjusted  M (SD)  
Executive functions      
 WMI     91.88 (10.61) 96.97 (6.08)  93.53 (13.01) 95.85 (6.08)  0.28 0.60 0.009  
 Inhibition vs. Colour Naming    9.44 (3.01) 11.44 (1.73)  10.47 (2.00) 10.18 (1.73)  4.29 0.047* 0.125 
 Inhibition/Shifting vs. Colour Naminga   9.31 (3.14) 11.44 (2.19)  10.41 (2.27) 10.77 (2.05)  1.41 0.25 0.043 
 †TMT (B-A; time s)b,c   38.47 (17.63) 35.27 (20.79)  31.50 (9.27) 21.13 (7.78)  1.80 0.19 0.058 
BRIEF-A 
    †Global Executive Composite   59.44 (11.19) 53.07 (6.94)  67.59 (12.47) 59.35 (6.93)  6.38 0.017* 0.175     
    †Behavioral Regulation Index   60.63 (12.40) 55.28 (7.74)  67.59 (10.24) 60.32 (7.73)  3.34 0.08 0.100 
    †Metacognition Index    57.31 (10.36) 51.46 (6.50)  66.41 (13.78) 57.04 (6.49)  5.69 0.024* 0.160  
Self-regulation 
 †BIS-11     75.44 (12.15) 70.57 (7.39)  77.76 (14.08) 76.11 (7.39)  4.61 0.04* 0.133 
 BSCSd       2.81 (0.90)   2.90 (0.42)    2.13 (0.87)   2.55 (0.40)  5.53 0.026* 0.160 
 †DERSb,d,e    94.93 (33.15) 88.60 (31.10)  94.47 (16.37) 92.47 (14.02)  0.44 0.51 0.014 
 †PACSf       9.31 (8.47)   7.84 (5.54)  11.56 (6.01) 11.48 (5.54)  3.41 0.08 0.105 
Quality of life 
 Q-LES-Q-SFa,d      0.62 (0.12)     0.71 (0.06)    0.55 (0.18)   0.61 (0.16)  7.68 0.01** 0.204  
* p ≤ .05 ** p ≤ .01 
ANCOVA analyses: Post-intervention adjusted means determined using baseline values as covariates. 
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Partial η2 effect size interpretation guidelines (Cohen, 1988): 0.01 = small; 0.06 = medium; 0.14 = large. 
† Lower scores reflect better performance. 
a Quade’s nonparametric rank analysis of covariance: post-intervention unadjusted M (SD), Quade’s F statistic. 
b 2 x 2 mixed-design analysis of variance: post-intervention unadjusted M (SD), F-Interaction. 
c Logarithmic data transformation (n = 31 as 2 cases unable to be transformed). 
d CR group n = 15. 
e Data could not be transformed. 
f TAU group n = 16. 
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3.5. DISCUSSION 
 This study aimed to test the effectiveness of cognitive remediation to improve 
executive functions, self-regulation and quality of life in female residents of an SUD 
therapeutic community. It was based on a theoretical framework positing that basic EFs 
underpin effective self-regulation (i.e., the capacity for effective goal-directed behavior 
in everyday life; Hofmann et al., 2012). Results indicated that the group receiving the CR 
intervention improved performance on an inhibition task, facets of self-regulation (i.e., 
impulsivity and self-control) and quality of life post-intervention relative to the TAU 
group. CR also improved self-reported EFs (i.e., GEC and MI of the BRIEF-A, with a 
trend towards BRI) compared to TAU. Additionally, there was a trend towards reduced 
cravings in the CR vs. TAU group. These results provide significant new evidence for the 
potential utility of neuropsychological interventions in SUD treatment contexts. 
Importantly, the current study suggests that CR may be a viable intervention in SUD 
treatment settings where high rates of comorbidities such as past head injuries and 
psychiatric diagnoses are common. 
 Inhibition is one of the EFs recognized as making a significant contribution to the 
development and maintenance of SUD (Jentsch & Pennington, 2014). The core inhibitory 
deficits contributing to SUD are increased tendencies to approach substances and/or the 
inability to suppress this approach-behavior, which manifest at different levels of analysis 
and have been assessed via behavioral task-specific and trait self-report methods (Gullo, 
Loxton, & Dawe, 2014). There is ongoing debate over the use of self-report vs. behavioral 
laboratory task assessment methodology, with strengths and weakness of each method 
noted (Cyders & Coskunpinar, 2011). The current study utilized task-specific assessment 
of inhibition and inventory-based measurement of impulsivity (i.e., BIS-11), with 
improvements in task-performance and reduced levels of trait impulsivity reported in the 
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CR group. Although these findings may seem to converge, it has been noted that self-
report measures vs. behavioral laboratory tasks may assess divergent components of the 
construct (Cyders & Coskunpinar, 2011). 
 Self-control is inversely related to trait impulsivity and refers to the capacity to 
overcome unwanted urges to achieve goal-directed behavior (Hofmann et al., 2012). Self-
control plays an important role in SUD (Volkow, Wang, Tomasi, & Baler, 2013) and 
interacts dynamically with cravings in contributing to problematic substance use 
(Grasman, Grasman, & van der Maas, 2016). Decreased self-control is associated with 
cumulative stress and this relationship is moderated by self-reported, but not behavioral, 
impulsivity (Hamilton, Sinha, & Potenza, 2014). The CR group in the current study 
reported increased self-control, which may have played a role in the marginal decrease 
also reported for cravings. Interventions that bolster self-control in SUD populations, 
such as CR, may help to shield against the deleterious effects of cravings (Fatseas et al., 
2015) and stress (Sinha, Shaham, & Heilig, 2011) in relapse to substance use. 
 Unlike previous cognitive remediation interventions that focused on one 
component of cognition (e.g., working memory training in Houben et al., 2011), the 
current study incorporated training exercises that involved a range of cognitive skills 
(e.g., working memory, selective attention, divided attention, planning, inhibition, and 
flexibility). As such, the reduced total training time on some components may partly 
explain the absence of effects on some EF domains. It is possible that the domains that 
showed gains had more time dedicated to them during the strategy and drill practice 
components of the program. 
 The CR group also demonstrated improvements in EFs as measured by the 
BRIEF-A. Specifically, these improvements were observed in the overall summary score 
(GEC) and one of the index scores (MI), with a trend towards improvement in the other 
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index score (BRI). Given the minimal correlation between inventory- and performance-
based measures of EFs and likelihood that such methods of assessment may be capturing 
distinct components of EFs (Toplak et al., 2013), the improvements observed across both 
types of measures in the current study may indicate a robust change in EF. Further 
research, however, is needed to tease apart the complex relationship between various 
components of EFs and self-regulation. This endeavour could involve diverse 
methodologies and several levels of analysis (e.g., self-report, laboratory tasks, 
neuropsychological assessment, neuroimaging techniques, clinical outcomes). 
 Quality of life spans broad areas of psychological wellbeing, physical health, level 
of independence, and social connectedness, and has been defined as “an individual's 
perception of their position in life in the context of the culture and value systems in which 
they live and in relation to their goals, expectations, standards and concerns” (Feelemyer, 
Des Jarlais, Arasteh, Phillips, & Hagan, 2014, p. 251). Findings from the current study 
showed that CR impacted positively upon quality of life. This is a promising preliminary 
finding as quality of life is an important predictor of sustained remission from SUD 
(Laudet et al., 2009). 
 A recent study found that cognitive training improved EFs (i.e., working memory 
and reflection-impulsivity/decision-making) in polysubstance users in therapeutic 
community treatment (Valls-Serrano, Caracuel, et al., 2016). Importantly, that study was 
the first to also demonstrate improved self-regulation performance in an ecologically 
valid task of goal-directed behavior, the Multiple Errands Test − contextualized version 
(Shallice & Burgess, 1991; Valls-Serrano, Verdejo-García, & Caracuel, 2016). The study 
excluded participants with psychiatric comorbidities and those with a history of head 
injury to capture efficacy of cognitive training. In a previous study we demonstrated that 
50% of residents in residential treatment for SUD had been hospitalized after sustaining 
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a head injury and this was a significant determinant of cognitive impairment (Marceau et 
al., 2016). Psychiatric comorbidities are common (Baingana et al., 2015), with Borderline 
Personality Disorder diagnosed in up to 65% of individuals with SUDs (Pennay et al., 
2011). Similarly, the current study found that over 50% of the overall sample met criteria 
for a current Axis I diagnosis, while over 40% had a positive screen for personality 
disorder. Over 50% of the sample had lost consciousness or been concussed after a head 
injury and over 30% had been hospitalized after a head injury. The current study extends 
the findings of Valls-Serrano and colleagues (2016) to a research context high in 
ecological validity by including participants with psychiatric or head injury 
comorbidities. In the present study, there were improvements on conventional 
neuropsychological tests (e.g., inhibition task), whereas that was not the case in the Valls-
Serrano (2016) study. This may be due to the inclusion of computerized cognitive training 
and/or because the present sample were more impaired by virtue of greater comorbidities. 
These preliminary results suggest that cognitive remediation may be a viable option to 
improve EFs and self-regulation for SUD populations, including those with psychiatric 
and/or head injury comorbidities. 
 A strength of the current study is that it shows significant promise for the use of 
CR interventions as adjunct treatments for SUD. To the best of our knowledge, this is the 
first study to inclusively demonstrate feasibility and effectiveness of neuropsychological 
intervention for female residents that engage in SUD therapeutic communities, without 
exclusion of those with psychiatric and head injury comorbidities. Certain limitations, 
however, must be noted. The sample size of the current study was small and it used a 
controlled sequential groups design. Related to the constraints of this design, the 
significant difference in length of treatment and assessment interval between groups was 
not ideal. This is particularly relevant to the observed improvements in impulsivity and 
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self-control, as these improvements were, to some degree, respectively related to variance 
in treatment length and assessment interval observed between groups. Future studies 
should investigate the benefit of CR in groups matched on interval between assessments 
and treatment duration, accounting for the heterogeneity of treatment length occurring 
across SUD populations in residential facilities. Specifically, studies should further 
examine the role of treatment and/or abstinence length in relation to the neurocognitive 
and self-regulation improvements that may occur as a result of cognitive training. It is 
also important to note that while statistical tests revealed no significant differences in 
socio-demographic, psychiatric, head injury, and primary substance of misuse 
characteristics between CR vs. TAU groups, there were apparent differences in history of 
substance use (i.e., years of regular use across substances) which were not compared 
statistically due to insufficient subgroup sample sizes. Taken together, and particularly in 
light of the small sample size of this study, these limitations raise the possibility of 
significant between-group variability due to the range of potential confounding factors 
(e.g., treatment duration and hence abstinence length, assessment interval, primary 
substance of misuse, and substance use history). Also of note were the observed baseline 
demographic differences between participants who completed the intervention vs. those 
who dropped out of treatment. While these groups did not differ in age, those who 
completed the intervention had more years of education and higher levels of premorbid 
functioning. This finding is congruent with literature suggesting that cognitive deficits 
are one of the most consistently reported risk factors for dropout from SUD treatment 
(Brorson et al., 2013). At the same time, it points toward the need for further studies to 
investigate characteristics that may predict response to cognitive training (e.g., premorbid 
cognition). For these reasons, it is imperative that future studies aim to replicate the 
current findings in larger, multi-site, randomized controlled trials, with the inclusion of a 
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well-matched, active control group. It is hoped that this study prompts much-needed 
further research that may aim to replicate these findings and more thoroughly investigate 
the effectiveness of cognitive training in SUD populations with comorbid conditions such 
as psychiatric diagnoses and history of head injury. 
 Rates of cognitive recovery across the first year of SUD treatment have been 
investigated at group and individual levels, with qualitatively different trajectories of 
change observed between individuals (Bates, Buckman, Voelbel, Eddie, & Freeman, 
2013). This has implications for the development and implementation of 
neuropsychological interventions in SUD treatment contexts. As this area of research 
grows, studies could begin to explore the effectiveness of interventions for SUD across 
varying subgroups, in order to ascertain the influence of individual differences that are 
present in the often heterogeneous makeup of SUD populations, and tailor interventions 
accordingly. Studies that also track clinical outcomes related to sustained remission from 
SUDs (e.g., quality of life, length of stay in treatment, program completion, dropout, 
relapse to substance use) will be beneficial in further informing neuropsychological 
interventions as a strategy to reduce the individual and collective harms associated with 
SUDs. Nevertheless, the preliminary evidence from the current study suggests that CR 
may improve EFs, self-regulation, and quality of life, and with further examination may 
be a promising intervention for use within residential SUD treatment settings. 
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CHAPTER 4: LONGITUDINAL FOLLOW-UP OF OUTCOMES FROM A 
COGNITIVE REMEDIATION INTERVENTION 
 
Marceau, E. M., Berry, J., Lunn, J., Kelly, P. J., & Solowij, N. (in preparation). A 
three-month follow-up of cognitive remediation for substance use disorder: 





Introduction: Cognitive training is currently being investigated as a viable intervention to 
address the highly prevalent cognitive deficits associated with substance use disorder 
(SUD). Few studies have included longitudinal follow-up of clinically meaningful 
outcomes. The current study presents three-month follow-up outcomes of a cognitive 
remediation (CR) intervention designed to improve executive functions (EFs) in a sample 
of female residents attending therapeutic community treatment for SUD. 
Methods: A controlled sequential groups design was utilised. All residents (N = 50, all 
female) attended a residential therapeutic community (i.e. treatment as usual, TAU) and 
completed baseline assessments. Of the completers in this trial, the first group (n = 16) 
completed four weeks of CR and the second group attended TAU only (n = 17). Outcomes 
assessed post-intervention (Marceau, Berry, Lunn, Kelly, & Solowij, 2017) and at three-
month follow-up (reported here: CR n = 12; TAU n = 12) included the Behavior Rating 
Inventory of Executive Function – Adult Version (BRIEF-A), self-regulation, and quality 
of life measures. A snapshot of participants’ treatment status at three-month follow-up 
was also obtained. 
Results: The CR group improved on BRIEF-A outcomes at post-intervention and 
improvements were sustained at three-month follow-up (Global Executive Composite; F 
= 15.25, p < .001). Mixed-effects models found no significant differences in self-
regulation or quality of life between the CR and TAU groups (all p > .34). Rates of 
treatment completion were significantly higher for the CR vs. TAU group (37.5% vs. 
5.9%, respectively; p = .039), but may have been confounded by unexpected differences 
in baseline treatment duration observed between groups. Other treatment outcomes did 
not differ between groups (all p > .20). 
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Conclusions: Although self-regulation and quality of life did not differ between groups 
at three-month follow-up, the CR group demonstrated improvements in EFs that were 
maintained over time. Future studies may seek to replicate these findings and explore 
longitudinal clinically meaningful outcomes for a range of cognitive training 
interventions for SUD. 
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4.2. INTRODUCTION 
 Enhancing cognition is a desirable treatment strategy for multiple psychiatric 
disorders and has led to the application of behavioural interventions to achieve this aim. 
These interventions are selectively known as cognitive training, cognitive remediation, 
and cognitive rehabilitation, with the terms often used interchangeably and inconsistently 
(Keshavan, Vinogradov, Rumsey, Sherrill, & Wagner, 2014). This may be partly related 
to the interdisciplinary nature of this research field, with multiple disciplines making 
significant contributions (e.g., clinical neuropsychology, cognitive psychology, and 
neuroscience). For the purposes of this article, the term cognitive training has been 
adopted to describe the broad spectrum of interventions that utilise “specifically designed 
and behaviorally constrained cognitive or socio-affective learning events, delivered in a 
scalable and reproducible manner, to potentially improve neural system operations” 
(Keshavan et al., 2014, p. 510). The ultimate goal of cognitive training is the translation 
of changes at neural and cognitive levels into clinically meaningful improvements in 
everyday functioning. 
 In a review of evidence for the efficacy of cognitive training in substance use 
disorder (SUD) populations, Verdejo-García (2016) proposed a framework to locate the 
variety of interventions recently trialled in the literature. They were classified into two 
broad classes based on proposed neuroscientific mechanisms: (1) retraining neural 
systems related to impulsivity to reduce approach and avoidance biases (i.e., cognitive 
bias modification and response inhibition) and (2) strengthening executive functions 
(EFs) to enhance goal-directed behaviour (i.e., working memory training and goal-
directed approaches). In the context of this framework, a selection of evidence pertaining 
to four intervention modalities was reviewed: cognitive bias modification (CBM), 
response inhibition, working memory training, and goal-directed approaches. Findings 
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indicated that these interventions generally demonstrated efficacy in improving the 
targeted cognitive outcomes, but the extent to which these improvements translate into 
clinically meaningful outcomes is inconclusive across studies. This issue is a source of 
ongoing debate in the wider cognitive training sphere, particularly regarding the benefit 
of working memory training (Melby-Lervåg, Redick, & Hulme, 2016; Owen et al., 2010). 
 In addition to the paucity of clinically meaningful outcomes included in cognitive 
training SUD research, there is a lack of studies that track the durability of outcomes over 
time. The few studies that have included longitudinal outcomes have conducted follow-
ups ranging from one-month to one-year post-intervention (Eberl et al., 2013; Houben, 
Wiers, & Jansen, 2011; Wiers, Eberl, Rinck, Becker, & Lindenmeyer, 2011). 
 In a study of alcohol users in inpatient treatment, Wiers and colleagues (2011) 
used a brief CBM intervention targeting approach bias for alcohol. Control conditions 
included no training and sham training. Post-intervention outcomes indicated that 
participants in the experimental group, but not controls, developed an avoidance bias 
towards alcohol, which generalised to novel stimuli. The study included relapse to alcohol 
use as a clinical outcome at one-year follow-up and there was a marginally significant 
difference between groups, with 46% of the experimental group relapsing, compared to 
59% of controls. In replication of this study, and to explore possible mediators and 
moderators, CBM was applied to a larger sample of alcohol users in inpatient treatment, 
with a treatment as usual control condition (Eberl et al., 2013). A one-year follow-up of 
relapse outcomes indicated that the training group had significantly lower rates of relapse, 
with 54.9% successfully remaining abstinent, compared to 45.1% of controls, and this 
was mediated by change in alcohol-approach tendencies. 
 A study investigating working memory training for a community sample of 
identified problem drinkers included both neuropsychological and clinical outcomes 
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assessed post-intervention and at one-month follow-up (Houben et al., 2011). Participants 
in the control condition also received working memory training but task-difficulty 
increased only in the experimental group. Findings indicated improvements in the 
experimental group’s working memory capacity and also fewer alcoholic drinks 
consumed per week at post-intervention, relative to controls. Furthermore, these 
improvements were retained at one-month follow-up. 
 As described above, only three studies – two of CBM and one of working memory 
training – have included longitudinal follow-up of neuropsychological and/or clinical 
outcomes in the emerging research area of cognitive training for SUD. To the best of our 
knowledge, longitudinal outcomes of response inhibition and goal-directed cognitive 
training interventions for SUD have not yet been explored in the literature. 
 Our team recently conducted a study investigating the effectiveness of cognitive 
remediation for females attending residential therapeutic community treatment for SUD 
(Marceau et al., 2017). This study included residents with psychiatric diagnoses and 
history of head injury, as these factors are associated with cognitive dysfunction 
(Marceau, Lunn, Berry, Kelly, & Solowij, 2016), but have been excluded from previous 
similar studies in order to establish the efficacy of cognitive training interventions for 
unconfounded SUD (e.g., Valls-Serrano, Caracuel, & Verdejo-García, 2016). In the 
context of the neuroscientific framework established by Verdejo-García (2016), our 
intervention is most appropriately located within the second class of proposed underlying 
mechanisms, which focuses on enhancing goal-directed behaviour through strengthening 
EFs. A unique aspect of this intervention was the inclusion of and synergy between both 
computerised and strategy-based goal-directed training approaches. Findings indicated 
that at post-intervention the cognitive remediation group demonstrated improvements in 
EFs, self-regulation, and quality of life, relative to the control group, who attended 
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treatment as usual only. With the aim of contributing to the existing literature of 
longitudinal outcomes investigating the benefit of cognitive training for SUD, the current 
paper presents the three-month follow-up outcomes of this study, which were collected 
for a subset of measures, including EFs and self-regulation. Clinically meaningful 
outcomes, treatment retention data and quality of life, were also captured at a snapshot 




 Participants (N = 50) were recruited from a women’s residential treatment facility 
in Sydney run by We Help Ourselves (WHOs) – a large provider of residential SUD 
rehabilitation in Australia. 
 Inclusion criteria were: (1) Diagnosis of substance abuse/dependence, based on 
DSM-IV-TR criteria, confirmed using the Mini-International Neuropsychiatric Interview 
(MINI-Plus; Sheehan et al., 1998); (2) Minimum abstinence period of 7 days; (3) Absence 
of any neurological, infectious, or other disease affecting the central nervous system (e.g., 
epileptic seizures, stroke, brain tumour, meningitis, encephalitis, multiple sclerosis, HIV 
positive); (4) English as native language. 
 
4.3.2. DIAGNOSTIC AND CLINICAL ASSESSMENT 
 Psychiatric comorbidities were assessed using the MINI-Plus and Standardised 
Assessment of Personality – Abbreviated Scale (Moran et al., 2003), shown to be an 
appropriate cost-effective and time-efficient personality disorder screening measure in 
SUD populations (Gonzalez, 2014; Hesse & Moran, 2010; Hesse, Rasmussen, & 
Pedersen, 2008). Questions were adapted from the Addiction Severity Index – Fifth 
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Edition (ASI; McLellan et al., 1992) to assess lifetime substance use history. A brief semi-
structured interview was used to assess history of head injury and the Test of Premorbid 
Functioning (TOPF; Pearson Assessment, 2009) was used to estimate overall level of 
premorbid intellect. 
 
4.3.3. DESIGN AND PROCEDURES 
 A non-randomised controlled sequential groups design was used and the study 
provided a naturalistic snapshot of residents in treatment at the time of recruitment. All 
residents were invited to participate in the study, with a response rate of 96%. Those who 
met inclusion criteria and provided consent took part in either: (a) a cognitive remediation 
(CR; n = 23) group program or (b) treatment as usual (TAU; n = 27). The CR group were 
recruited first, followed by the TAU group, allowing sufficient time for a new cohort of 
residents to become available. Unexpectedly, the CR group had spent more time in 
treatment prior to baseline assessment (Mdn = 62 days) than the TAU group (Mdn = 23 
days). 
 Both groups engaged in the usual therapeutic community model of treatment 
(Vanderplasschen et al., 2013), and the CR group participated in 12 x 2-hour group 
sessions across 4 weeks (3 sessions/week held on alternating weekdays), facilitated by 
the second author (JB) and co-facilitated by the first author (EM). The CR intervention 
was developed with a primary focus on training EFs and self-regulation, given that EFs 
are particularly impaired in SUD treatment populations (e.g., Fernández-Serrano, Pérez-
García, Perales, & Verdejo-García, 2010). Further details of the intervention have been 
reported elsewhere (Marceau et al., 2017). The facilitators followed a manual (available 
on request) to ensure treatment consistency. 
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 The CR group completed baseline assessments in the week prior to the 
commencement of the intervention and post-intervention assessments in the week 
following its completion. Similarly, the TAU group completed baseline assessments 
followed by a period of approximately 4 weeks and were reassessed during the 
subsequent week. The post-intervention sample size was 33 completers: n = 16 (CR 
group) and n = 17 (TAU group). The rates of dropout from the intervention study were 
30% and 37% respectively, did not significantly differ between groups (X2 = 0.241, p = 
0.623) and are comparable to those observed in SUD therapeutic community treatment 
(Darke, Campbell, & Popple, 2012). 
 Approximately three months after post-intervention assessments, contact with all 
participants who completed post-intervention assessments (n = 33) was attempted via 
phone to collect three-month follow-up data, with success rates of 75% (CR group; n = 
12) and 71% (TAU group; n = 12). Measures administered over the phone were the Brief 
Self-Control Scale (Tangney, Baumeister, & Boone, 2004), Penn Alcohol Craving Scale 
(Flannery, Volpicelli, & Pettinati, 1999), Drug-Taking Confidence Questionnaire: eight-
item version (Sklar & Turner, 1999), and EUROHIS-QOL 8-item index (Skevington, 
Lotfy, & O' Connell, 2004; WHOQOL Group, 1998), as well as relapse to substance use 
in the past month. At the end of each approximately 20-minute call, participants were 
given the option of receiving a final questionnaire, the Behavior Rating Inventory of 
Executive Function – Adult version (BRIEF-A; Roth, Isquith, & Gioia, 2005), via post 
with a reply paid envelope included and asked whether they would be willing to complete 
and return this questionnaire. All participants agreed and were subsequently mailed 
BRIEF-A questionnaires. After allowing sufficient time for participants to receive, 
complete, and return BRIEF-A questionnaires, 92% (n = 11) and 33% (n = 4), from the 
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CR and TAU groups respectively, were returned. Additionally, with consent of 
participants and service manager, treatment retention data were accessed. 
 
4.3.4. THREE-MONTH OUTCOME MEASURES 
4.3.4.1. Executive functions and self-regulation 
Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A; Roth et al., 
2005). The BRIEF-A is a self-report questionnaire consisting of 75 items and nine 
subscales. Participants are instructed to answer each question by selecting “never”, 
“sometimes”, or “often”, in relation to whether they have had problems with any of the 
listed behaviours in the past month. Example items include: “I am bothered by having to 
deal with changes”; “I say things without thinking”. The Global Executive Composite 
(GEC) provides an overall summary score. The Behavioral Regulation Index (BRI) 
includes the subscales Inhibit; Shift; Emotional Control; Self-Monitor. The 
Metacognition Index (MI) includes subscales Initiate; Working Memory; Plan/Organise; 
Task Monitor; Organisation of Materials. Elevated scores indicate executive dysfunction. 
The outcome variable used was GEC. 
Brief Self-Control Scale (BSCS; Tangney et al., 2004). The BSCS is a 13-item self-report 
questionnaire assessing individual differences in the construct of self-control and 
outcome variable was total score, with greater scores indicating higher levels of self-
control. 
Penn Alcohol Craving Scale (PACS; Flannery et al., 1999). The PACS is a 5-item self-
report questionnaire that assesses level of cravings for alcohol and other drugs, with 
greater scores indicating stronger cravings. Participants were asked to respond to all items 
in relation to their primary substance of misuse and outcome variable was total score. 
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Drug-Taking Confidence Questionnaire – Eight-Item Version (DTCQ-8; Sklar & Turner, 
1999). The DTCQ-8 is an 8-item self-report questionnaire that measures coping self-
efficacy by gauging the likelihood of abstinence from alcohol and other drugs across a 
number of hypothetical high-risk scenarios. The outcome variable was derived by 
dividing total scores by number of items (i.e., total score divided by 8), with higher scores 
indicating a greater likelihood of abstinence. 
 
4.3.4.2. Clinically meaningful outcomes 
Treatment retention data. Treatment retention outcome variables included rates of 
treatment completion (i.e., residents who were deemed to have finished the program, 
based on the assessment of all staff), dropout, and residents currently in treatment. Length 
of time in treatment (days) since post-intervention assessments was also included. Self-
reported relapse to substance use in the past month was included and coded as a 
dichotomous response. 
EUROHIS-QOL 8-Item Index (EUROHIS-QOL-8; Skevington et al., 2004; WHOQOL 
Group, 1998). The EUROHIS-QOL-8 is an 8-item self-report questionnaire used to 
assess quality of life across four domains of functioning, including physical health, 
psychological wellbeing, social relationships, and environment. Total score was used as 
the outcome variable, with higher scores indicating greater quality of life. 
 
4.3.5. STATISTICAL METHODS 
 Statistical analyses were performed using IBM Statistical Package for the Social 
Sciences (SPSS version 21; IBM Corp, 2012). Screening of baseline data indicated six 
missing BSCS values (CR = 1; TAU = 5). Post-intervention and three-month follow-up 
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data each contained one missing value in the TAU group (PACS and DTCQ, 
respectively). 
 Socio-demographic characteristics and substance use data of the CR vs. TAU 
groups were compared using Student’s t-test and Mann-Whitney U tests as a 
nonparametric alternative. Chi-square and Fisher’s exact tests were used to compare 
percentage variables, including psychiatric and head injury characteristics, as well as 
treatment retention data. 
 The three-month follow-up outcomes of CR vs. TAU groups were examined via 
a series of linear mixed-effects models. Intention-to-treat analyses were used, with all 
participants who completed at least baseline assessments included (N = 50). The models 
included fixed effects for group, time and the group x time interaction, and random effects 
for participants. Both random intercept and random intercept/random slope models were 
considered. Due to the low return of questionnaires from the TAU group, BRIEF-A GEC 
outcomes were examined only for the CR group, also via a series of linear mixed-effects 
models. 
 For each of the five outcome variables, a variety of mixed-effects models were 
fitted. Standard goodness-of-fit criteria (Honghu, Yan, & Jie, 2008) were used to guide 
model selection. The final models chosen included fixed effects for group, time and the 
group x time interaction, and a random intercept term for participants, and the model 
pertaining to GEC outcomes included fixed effects for time and a random intercept term 
for participants. An autoregressive error structure was utilised (Wolfinger, 1993). Based 
on the recommendation that covariates be selected a priori and be as few in number as 
possible (Kraemer, 2015), only treatment duration was included as a covariate. Treatment 
duration was found to improve model fit for only one analysis (DTCQ-8) and, therefore, 
this covariate was omitted for all other analyses. 
	 110	
4.4. RESULTS 
 Baseline socio-demographic characteristics and substance use, psychiatric, and 
head injury history for CR vs. TAU groups are presented in Table 7. No significant 
differences in age, education, current or past Axis I diagnoses, personality disorder 
screening, history of losing consciousness/concussion or hospitalisation after a head 
injury, primary substance of misuse, or years of regular substance use were found 
between groups. Treatment duration was significantly longer (p = .001) for participants 
in the CR group (n = 23, Mdn = 62 days, range 16–160) compared to the TAU group (n 
= 27, Mdn = 23 days, range 2–82). Additionally, there was a 5-day difference between 
groups in the interval between baseline and post-intervention assessments (p = .005) (CR: 
n = 16, Mdn = 34 days, range 33–36; TAU: n = 17, Mdn = 29 days, range 26–36). The 
interval between post-intervention assessments and three-month follow-up did not 
significantly differ between groups (p =  .67) (CR: n = 12, Mdn = 106.5 days, range 93–
183; TAU: n = 12, Mdn = 102 days, range 94–147). 
 Linear mixed-effects models results are displayed in Table 8. No significant 
differences were found between the CR group and TAU group at three-month follow-up, 
for all four dependent measures (BSCS, PACS, DTCQ-8, EUROHIS-QOL-8). 
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Table 7. Socio-demographic, substance use, psychiatric and head injury characteristics of residents of 
a female-only substance use therapeutic community at baseline. 
Characteristic    Cognitive Remediation  Treatment as Usual  p 
     (n = 23)   (n = 27) 
Age (Mdn, range)a     32 (22-56)    33 (19-53)  .79 
Education (Mdn, range)a     10 (6-15)    11 (7-20)  .21 
Test of Premorbid Functioning (M, SD)   91.0 (14.3)    94.2 (14.2)  .44 
Unemployed (%)b     73.9     81.5   .52 
Marital status (% single)b     69.6     77.8   .51 
Primary substance of misuse (%)c        .13 
Methamphetamine    43.5     44.4 
Alcohol      21.7     33.3   
       Amphetamines     17.4       0 
 Heroin        8.7       7.4   
       Cannabis        0     11.1   
 Sedatives       8.7       3.7 
Years of regular use (M, Mdn, SD; n) 
 Alcohol (any use) a    13.7 (16, 8.7; 17)     9.5 (7.0, 7.7; 26) .12 
 Alcohol (to intoxication)a    11.6 (13.5, 7.8; 16)     8.4 (5.5, 7.4; 26) .23 
 Heroin      13.0 (16.0, 8.9; 3)     8.4 (6.5, 8.3; 6) .47 
 Methadone       6.7 (7.0, 1.5; 3)     8.3 (8.3, 11.0; 2) 1.0 
 Other opiates/analgesics    11.1 (11.0, 3.6; 4)     5.3 (2.0, 5.7; 7) .10 
 Sedatives/hypnotics/tranquilisersa   10.4 (10.0, 3.6; 7)     7.5 (3.5, 7.7; 10) .24 
 Cocainea       4.7 (1.5, 6.4; 5)     8.1 (8.5, 4.7; 6) .27 
 Amphetaminesa       7.7 (8, 4.9; 20)      8.6 (9.0, 6.1; 22) .61 
 Cannabis     11.6 (11.0, 6.6; 20)   10.6 (10.0, 7.5; 23) .67 
 Hallucinogensa       4.8 (3.0, 5.6; 6)     6.3 (4.0, 4.9; 3) .36 
 More than one substance per day     9.2 (9.0, 4.9; 17)   10.4 (10.0, 7.0; 24) .56 
Psychiatric diagnostic assessmentand screening (%)b 
 Current Axis I psychiatric diagnosis   56.5     70.4   .31 
 Past Axis I psychiatric diagnosis    65.2     63.0   .87 
 Personality disorder screen (met criteria)  52.2     29.6   .11 
Lost consciousness/concussion after head injury (%)b   47.8     55.6    .59 
Hospitalised after head injury (%)b    30.4     44.4   .31 
a Mann-Whitney U test. b Chi-square test. c Fisher’s exact test. 
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Table 8. Three-month follow-up of cognitive remediation (CR) vs. treatment as usual (TAU) on self-regulation and quality of life outcomes in residents of a female-only 
substance use therapeutic community (N = 50). 
         Time point      Analysisa 
         Baseline  Month 1  Month 4       
Dependent measures    Treatment  M (SE)  M (SE)  M (SE)   F df p 
Brief Self-Control Scale    CR     2.73 (0.17)   3.12 (0.18)   3.63 (0.20)  1.02 2, 56 .37 
      TAU     2.19 (0.17)   2.34 (0.18)   2.97 (0.20)   
Penn Alcohol Craving Scale   CR     8.48 (1.63)   6.52 (1.82)   5.97 (1.95)  0.77 2, 47 .47 
      TAU   11.59 (1.50) 12.32 (1.76)   9.66 (1.90) 
Drug Taking Confidence Questionnaireb  CR   62.05 (5.99) 72.51 (6.86) 72.97 (7.92)  0.93 2, 64 .40 
      TAU   61.08 (5.59) 61.56 (6.57) 74.37 (7.76) 
EUROHIS-QOL 8-Item Index   CR   28.91 (1.18) 32.23 (1.27) 32.51 (1.42)  0.67 2, 51 .52 
      TAU   24.96 (1.08) 28.06 (1.21) 30.55 (1.41) 
a Results of linear mixed-effects models group x time interactions. Means are predicted from linear mixed-effect intention-to-treat models. 
b Days in treatment prior to baseline included as a covariate. 
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 Treatment outcomes are displayed in Table 9. Significantly higher rates of overall 
TC treatment completion were observed for participants in the CR group relative to the 
TAU group. Approximately 30% of participants in the CR group left treatment early 
compared to slightly over 50% of participants in the TAU group, yet this difference did 
not reach statistical significance. On average, the CR group remained in treatment longer 
(93.8 days) than the TAU group (76.1), but this difference was also not statistically 
significant. There was no difference in self-reported rates of relapse in the past month, 
with only one participant from each group reporting relapse to substance use. 
 
Table 9. Treatment retention data for female residents attending therapeutic community treatment for 
substance use at three-month follow-up after cognitive remediation (CR) vs. treatment as usual (TAU). 
Dependent measures    CR (n = 16)  TAU (n = 17) p 
Completed treatment (%)a    37.5     5.9  .039 
Left treatment early (%)b    31.2   52.9  .21 
Currently in treatment (%)b  31.3   41.2  .55 
Days in treatment post-intervention (M, SD)c 93.8 (54.9)  76.1 (33.4) .27 
Relapsed to substance use (% past month)a,d    8.3     8.3  1.00 
a Fisher’s exact test. b Chi-square test. c Independent t-test. d CR: n = 12; TAU: n = 12. 
 
 Figure 2a displays GEC outcomes for the CR group (N = 50), which changed 
significantly over time, F(2, 33) = 23.32, p < .001. GEC scores significantly reduced from 
baseline (M = 61.76, SE = 1.85) to post-intervention (M = 54.53, SE = 1.97; p < .001) and 
from baseline to three-month follow-up (M = 53.47, SE = 2.25; p < .001), and did not 
significantly differ from post-intervention to three-month follow-up (p = .54). Figure 2b 
is for visualisation purposes only and displays changes in GEC outcomes for the CR vs. 
TAU groups; the insufficient sample size for the TAU group at three-month follow-up (n 







Figure 2. Changes in Behavior Rating Inventory of Executive Function (BRIEF-A) Global Executive 
Composite (GEC) outcomes for residents of a female-only substance use therapeutic community after 
cognitive remediation (CR): a) CR group only; b) CR vs. treatment as usual (TAU) groups, for 
visualisation purposes only due to insufficient sample size of TAU group at 3-month follow-up (n = 4). 
Means are predicted from linear mixed-effect intention-to-treat models. 
 
4.5. DISCUSSION 
 The current study aimed to investigate the longer-term effectiveness of a cognitive 
remediation intervention in a female-only residential substance use disorder therapeutic 
community treatment context. A three-month follow-up, including assessment of 




















relative to treatment as usual, was conducted. In brief, it was found that the CR group 
demonstrated significant improvements in inventory-based assessment of EFs (i.e., 
BRIEF-A GEC) at post-intervention and these improvements were sustained three 
months later. Self-regulation and quality of life outcomes, however, did not significantly 
differ between the CR and TAU groups at three-month follow-up. A significantly greater 
proportion of the CR group (37.5%) were recorded as completing treatment relative to 
the TAU group (5.9%), at the particular snapshot in time that treatment retention data 
were accessed. While this occurred three months following the intervention for both CR 
and TAU groups, it is problematic to infer that these data are associated with completion 
of the CR intervention, due to the unexpected baseline imbalance in duration of treatment. 
There was no difference between groups for other treatment outcome measures, including 
rates of dropout from SUD treatment, number of days spent in treatment following the 
intervention, and relapse to substance use. 
 These results significantly contribute to the emerging body of literature 
investigating the effectiveness of cognitive training for SUD (Verdejo-García, 2016). Of 
note, few studies have included longitudinal outcomes and the current study, to the best 
of our knowledge, is the first to investigate this with regard to a CR intervention applied 
within a residential female-only SUD treatment context. 
 In our original study investigating the effectiveness of CR for SUD immediately 
post-intervention (Marceau et al., 2017), the CR group relative to the TAU group 
demonstrated improvements in inventory-based assessment of EFs, as measured by the 
BRIEF-A. The current study attempted to conduct a three-month follow-up of these 
BRIEF-A outcomes. While 92% of the CR group returned these questionnaires via mail, 
only 33% of questionnaires sent to the TAU group were returned. This did not permit 
meaningful comparison, due to insufficient sample size of the TAU group (Hox, 2010). 
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We did find that within the CR group the post-intervention improvements in EFs were 
sustained three months later. Furthermore, a purely visual comparison of BRIEF-A 
outcomes between the CR and TAU group (Figure 2b) showed potentially promising 
benefits of the cognitive remediation intervention leading to improved EFs outcomes in 
comparison to TAU. It must be acknowledged, however, that this graph shows potential 
baseline differences in BRIEF-A scores between groups, with the TAU group 
demonstrating greater levels of executive dysfunction at baseline (which were 
nevertheless accounted for in the analysis of post-intervention data, showing a significant 
difference between CR and TAU (Marceau et al., 2017; Chapter 3)).  
 EFs have been proposed as the neurocognitive basis of self-regulation capacity 
and subsequently training of EFs has been hypothesised to increase self-regulation 
capacity (Hofmann, Schmeichel, & Baddeley, 2012). The current study, however, found 
no corresponding improvements in self-regulation capacity, as assessed by self-reported 
measures including the BSCS, PACS, and DTCQ-8. These findings indicate that while 
CR may potentially produce lasting improvements on EFs, these improvements may not 
generalise to increased self-regulation capacity. Indeed, the debate regarding whether 
improvements in cognition following cognitive training generalise to untrained tasks and 
functional improvement is inconclusive (Melby-Lervåg et al., 2016; Owen et al., 2010; 
Verdejo-García, 2016). An alternate explanation is that the measures of self-regulation 
used in this study did not appropriately capture all relevant components of this broad 
concept. 
 There was also generally no difference between the CR and TAU groups at three-
month follow-up in terms of treatment outcomes and quality of life, an important clinical 
outcome related to sustained remission from substance use (Laudet, Becker, & White, 
2009). Of note, 37.5% of the CR group completed treatment compared to only 5.9% of 
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the TAU group. While this difference was statistically significant, it may be an artefact 
of the significantly longer duration of treatment observed in the CR group (67 days) 
relative to the TAU group (25 days) at baseline. Although not statistically significant, it 
was also observed that 31.2% of the CR group left treatment early, compared to 52.9% 
of the TAU group. Similarly, the CR group completed, on average, 17 more days of 
treatment compared to the TAU group (93.8 vs. 76.1 days, respectively), as assessed from 
completion of the intervention to three-month follow-up. These findings may indicate 
some beneficial effects of the CR intervention on treatment retention but it is also crucial 
to acknowledge that these results may be related to the unanticipated differences in 
duration of treatment observed between groups at baseline, but also significant variability 
in duration of treatment at baseline for both CR (range 16–160 days) and TAU (range 2–
82 days) groups. It is also important to acknowledge that expected length of treatment in 
SUD therapeutic communities may significantly vary between individuals, further 
affecting interpretation of the treatment retention data presented in this study. 
 It is also important to consider the ways in which the current study differs from 
those previously reported in the literature. First, the intervention utilised a goal-directed 
approach that incorporated both computerised and strategy-based training. Such 
approaches tend to be utilised individually, rather than simultaneously, and each approach 
assumes a differential underlying mechanism of action. Strategy-based approaches 
operate on the premise that teaching participants problem-solving techniques and 
strategies is what ultimately leads to improvements, whereas computerised training most 
often utilises drill-practice, which presumably leads to gains via restoring dysfunctional 
neuronal circuitry (Paquin, Wilson, Cellard, Lecomte, & Potvin, 2014). A second point 
of departure concerns the role of gender in cognitive training for SUD. In contrast to the 
longitudinal studies reported in the literature (Eberl et al., 2013; Houben et al., 2011; 
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Wiers et al., 2011), the sample of the current study consisted solely of females. The study 
investigating working memory training (Houben et al., 2011) incorporated an 
approximately equal male vs. female ratio. The original CBM study (Wiers et al., 2011) 
was only 20% and 28% female in the training and control groups, respectively, whereas 
the replication of this study (Eberl et al., 2013) did not specify the gender ratio of the 
sample. Finally, participants in the current study were not excluded on the basis of 
psychiatric diagnoses or history of head injury. Psychiatric diagnoses (Grant et al., 2015; 
Grant et al., 2016) and history of head injury (Marceau et al., 2016) are commonly 
observed in SUD populations, and this study contributes to the longitudinal literature on 
SUD cognitive training through inclusion of participants with these comorbidities. 
 As there is a paucity of research including longitudinal follow-up of clinically 
meaningful outcomes for the range of cognitive training interventions for SUD, future 
studies are required to clarify the extent of long-term benefits and functional 
improvement. Limitations of the current study include the small sample size, minimal 
follow-up data, non-randomised design, and lack of an active control group (as opposed 
to TAU). In the future, larger multi-site randomised controlled trials, including 
thoughtfully planned active control conditions in addition to treatment as usual, are 
required. It is also recommended that future studies investigate the role of length of 
treatment more thoroughly, to determine the benefit of cognitive training in light of the 
diversity in treatment length commonly observed in residential treatment settings. This 
may be best achieved by ensuring that treatment and control groups are matched on length 
of treatment, perhaps through enrolment into intervention studies at entry to treatment. In 
this way, it would be possible to ascertain whether cognitive training is related to 
improved treatment outcomes. Despite best intentions, and in light of the constraints of 
real-world applied research in SUD treatment populations, the current study was 
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unfortunately unable to extract meaningful treatment completion outcomes, primarily due 
to the unanticipated baseline imbalance in duration of treatment between the CR and TAU 
groups. Future studies may also seek to examine potential differences in baseline EFs 
measures and other sample characteristics (e.g., age, education, premorbid functioning, 
substance use history variables, length of abstinence) and how these may influence the 
effectiveness of cognitive training interventions for SUD. 
 As per the recommendations of Verdejo-García (2016), future studies should 
investigate a range of cognitive training interventions with clearly articulated 
mechanisms, and well-matched control groups to elucidate mechanisms of action. 
Moreover, diverse measures of EFs and self-regulation, including inventory- and 
performance-based assessments, as well as relevant neuroimaging measures should be 
utilised, in order to shed light on not only the potential benefits of cognitive training for 
SUD, but also the underlying mechanisms of these benefits. The current study, in spite of 
certain limitations, provides preliminary longitudinal data for the effectiveness of a 
combined CR intervention in a sample of females in residential SUD therapeutic 
community treatment, with improvements in EFs as assessed by the BRIEF-A sustained 
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CHAPTER 5: RELATIONSHIPS BETWEEN EXECUTIVE FUNCTIONS AND 
EMOTION REGULATION 
 
Marceau, E. M., Kelly, P. J., & Solowij, N. (in press). The relationship between 
executive functions and emotion regulation in females attending therapeutic 
community treatment for substance use disorder. Drug and Alcohol Dependence 
(accepted 11 October 2017)1. 
																																																						
1 Citation refers to the publication associated with this chapter, which was significantly 




Background: Difficulties in emotion regulation influence the development of substance 
use disorder (SUD), its severity and course, treatment outcomes, and relapse. Impaired 
executive functions (EFs) are common in SUD populations and may relate to emotion 
dysregulation. The current study tested whether performance on three basic EF tasks 
(‘working memory’, ‘inhibition’, and ‘task-switching’) and/or inventory-based 
assessment of EF predicted difficulties in emotion regulation in females attending 
residential SUD therapeutic community treatment. 
Methods: Cross-sectional design with participants (N = 50, all female) completing a 
questionnaire battery including the Difficulties in Emotion Regulation Scale (DERS) and 
Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A). 
Participants also completed neuropsychological assessment of EF including the Working 
Memory Index (WMI; Wechsler Adult Intelligence Scale), and measures of inhibition 
and task-switching (Color-Word Interference Test; Delis-Kaplan Executive Function 
System). 
Results: Executive dysfunction, as assessed by the Global Executive Composite (GEC; 
BRIEF-A), and personality disorder indicators (Standardised Assessment of Personality 
– Abbreviated Scale; SAPAS) were positively correlated with DERS scores, whilst task-
switching was negatively correlated. Sequential hierarchical regression indicated that 
task-switching, GEC, and SAPAS scores uniquely predicted DERS scores. Neither 
working memory nor inhibition predicted DERS scores. Mediation analysis indicated that 
there was a significant indirect effect of GEC scores and task-switching performance on 




Conclusions: Impairment of EF, particularly task-switching, contributes to difficulties in 
emotion regulation in a female sample attending residential SUD treatment. Cognitive 
training interventions that improve task-switching performance may be beneficial in 





 When an emotion arises, a complex interplay between subjective experience, 
cognition, physiological changes, and behavioral components takes place, with neural 
bases such as the lateral prefrontal and parietal cortices and the ventral anterior cingulate 
and ventromedial prefrontal cortices implicated (Etkin, Büchel, & Gross, 2015). The 
pursuit of desired emotional states in everyday life is ubiquitous and “emotion regulation” 
denotes this process; that of modifying the intensity or duration of existing emotions in 
order to maintain goal-directed behavior (Tamir, 2016). 
 Emotion dysregulation is implicated in various forms of psychopathology (Aldao, 
Nolen-Hoeksema, & Schweizer, 2010), including substance use disorder (SUD; 
Cheetham, Allen, Yücel, & Lubman, 2010), in which it has a significant effect on the 
initiation, severity, and prognosis of the disorder (Wilcox, Pommy, & Adinoff, 2016). 
For example, the capacity for effective emotion regulation is under development during 
adolescence and may, in combination with other risk factors, increase the likelihood of 
early initiation of substance use, disruption of neuromaturational processes, and 
subsequent poor prognosis (Gladwin, Figner, Crone, & Wiers, 2011; Lubman, Yücel, & 
Hall, 2007; Smith & Cyders, 2016; Wills, Simons, Sussman, & Knight, 2016). 
 Individuals with affective disorders (e.g., anxiety and mood disorders) commonly 
experience comorbid SUD and, conversely, SUDs also contribute to the development of 
affective disorders (Cheetham et al., 2010). Additionally, SUD populations experience 
greater difficulties with emotion regulation relative to controls (Wilcox & Adinoff, 2015) 
and substance use may develop as a mechanism to relieve negative affect (Blevins, 
Abrantes, & Stephens, 2016). Emotion dysregulation increases the severity of SUD (Tull, 
Bardeen, DiLillo, Messman-Moore, & Gratz, 2015) and predicts relapse to substance use 
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(Witkiewitz & Wu, 2010), while reductions in negative affect predict reduced SUD 
severity following treatment completion (Mo & Deane, 2016). 
 Akin to the role of emotion dysregulation in SUD, cognitive deficits are 
commonly observed and also impede the treatment process. Cognitive impairment is one 
of the four most common risk factors for dropout from SUD treatment (Brorson, Ajo 
Arnevik, Rand-Hendriksen, & Duckert, 2013) and the specific impairment of executive 
function (EF) is well documented in SUD populations (Fernández-Serrano, Pérez-García, 
Perales, & Verdejo-García, 2010; Hester, Lubman, & Yücel, 2010). 
 Along with the challenges to effective SUD treatment associated with emotion 
dysregulation and cognitive deficits, comorbid personality disorder is a significant risk 
factor for early dropout (Brorson et al., 2013) and is highly prevalent in SUD populations 
(Grant et al., 2015; Grant et al., 2016). Further to this, personality disorder is 
independently associated with cognitive deficits, with the most commonly observed 
deficits in memory, decision-making, and EFs (Unoka & Richman, 2016). 
 While several conceptualisations of EF exist, Miyake et al. (2000) proposed the 
unity/diversity framework of EF, which posits three separable, basic EFs: ‘working 
memory’, ‘inhibition’, and ‘task-switching’ (Friedman & Miyake, 2017; Miyake & 
Friedman, 2012). Working memory refers to the capacity to monitor and alter the contents 
of working memory, inhibition is the ability to override an unwanted distraction to 
maintain task-focus, and task-switching involves flexibly switching attention between 
tasks or mental sets (Hofmann, Schmeichel, & Baddeley, 2012). 
 It has been proposed that these basic EFs (i.e., working memory, inhibition, and 
task-switching) may subserve effective emotion regulation (Hofmann et al., 2012; 
Schmeichel & Tang, 2015). The contributions of working memory, inhibition, and task-
switching to emotion regulation have been explored in a number of studies, 
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predominantly drawing from nonclinical populations. For example, a series of studies 
explored the role of working memory (assessed using the operation span task) in emotion 
regulation within a university student sample (Schmeichel & Demaree, 2010; 
Schmeichel, Volokhov, & Dernaree, 2008). Participants with a higher working memory 
capacity were better able to appraise emotional stimuli and, consequently, more 
effectively experience and express emotion (Schmeichel et al., 2008); these abilities were 
not confounded with higher working memory capacity leading to participants being better 
able to follow instructions (Schmeichel & Demaree, 2010). Another study in a 
community sample found that effective reappraisal of emotions was predicted by higher 
working memory capacity in a modified operation span task (McRae, Jacobs, Ray, John, 
& Gross, 2012). The specific role of updating the contents of working memory in emotion 
regulation was explored in university students using the emotional 2-back task (Pe et al., 
2015). Participants with better updating abilities displayed higher levels of emotional 
reactivity, but were more quickly and effectively able to regulate their emotions and 
return to a baseline level of arousal. 
 Several studies have demonstrated links between inhibition and emotion 
regulation. Inhibition performance, as measured by the Stroop task, was found to predict 
effective restraint of socially inappropriate behaviors in university students (von Hippel 
& Gonsalkorale, 2005). Similarly, university students who demonstrated poorer 
inhibition performance in the stop-signal task experienced larger increases in negative 
emotions following an emotion induction paradigm, relative to those with better 
inhibition performance (Tang & Schmeichel, 2014). In a sample of 5- to 7-year-old 
children, inhibition performance assessed by a go/no-go task predicted effort exerted in 
regulating emotions (Hudson & Jacques, 2014), with similar findings demonstrated in 
preschool-aged children (Carlson & Wang, 2007). In a clinical sample of patients with 
	 129	
frontal lobe damage, inhibition performance via a go/no-go task mediated the relationship 
between prefrontal lobe damage and maladaptive emotion regulation strategies (Falquez 
et al., 2015). 
 There is a paucity of studies investigating the role of task-switching in emotion 
regulation (Schmeichel & Tang, 2015). The previously mentioned study of working 
memory by McRae and colleagues (2012), also included a measure of task-switching (i.e., 
set-shifting costs based on a standardized global/local task), and found that as well as 
working memory capacity, task-switching also predicted effective reappraisal of 
emotions. 
 While a range of studies have investigated the role of working memory, inhibition, 
and, to a lesser extent, task-switching, these studies have primarily involved nonclinical 
populations and to the best of our knowledge, the role of these basic EFs in emotion 
regulation have not been explored in an SUD population. 
 While these basic performance-based EF tasks are sensitive to impairment of the 
frontal lobes (Jurado & Rosselli, 2007), some tasks may arguably have limited ecological 
validity and may not capture impaired functioning as effectively as inventory-based (i.e., 
self-report) assessment of EFs (Isquith, Roth, & Gioia, 2013). Furthermore, performance- 
and inventory-based measures of EFs are minimally correlated and may assess distinct 
components of EFs (Toplak, West, & Stanovich, 2013). For example, inventory-based 
assessment of EFs, using the Behavior Rating Inventory of Executive Function – Adult 
Version (BRIEF-A; Roth, Isquith, & Gioia, 2005), more effectively distinguished 
polysubstance users from controls and was more strongly associated with social 
adjustment outcomes, compared to performance-based measures (Hagen et al., 2016). In 
light of these considerations, the current study included both performance- and inventory-
based assessment of EFs. 
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 Given the importance of emotion regulation in SUD treatment and the potential 
connection between EFs and effective emotion regulation, the current study sought to 
ascertain whether inventory-based assessment of EFs, and/or performance-based 
assessment of working memory, inhibition, and task-switching performance were related 
to difficulties in emotion regulation in an all-female residential SUD population. A further 
aim of the current study was to explore the role of personality disorder in the relationship 
between EFs and emotion dysregulation, given its high prevalence in SUD populations, 
deleterious effect on SUD treatment, and independent association with cognitive deficits. 
 
5.3. MATERIAL AND METHODS 
 5.3.1. PARTICIPANTS 
 Participants (N = 50) were recruited from We Help Ourselves (WHOs), a large 
provider of residential SUD treatment in Australia, which utilises the Therapeutic 
Community model of treatment (De Leon, 1989). Participants from this study were drawn 
from baseline assessments of a subsequent study that investigated the effects of cognitive 
remediation in residents of an SUD therapeutic community (Marceau, Berry, Lunn, Kelly, 
& Solowij, 2017). Inclusion criteria for the study were: (i) diagnosis of substance 
abuse/dependence, based on DSM-IV-TR criteria, assessed using the Mini-International 
Neuropsychiatric Interview (MINI-Plus; Sheehan et al., 1998), (ii) a minimum abstinence 
period of 7 days (with confirmation of detoxification a prerequisite of entry to treatment), 
(iii) absence of any neurological, infectious, or other disease affecting the central nervous 
system (e.g., epileptic seizures, stroke, brain tumour, meningitis, encephalitis, multiple 
sclerosis, HIV positive), and (iv) English as native language. Limited leave from the 
residential facility, close observation by staff and other residents, and random urine tests 
assured abstinence during the course of participation in this study. 
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 5.3.2. PROCEDURE 
 All residents in the treatment facility were invited to participate in the study and 
the recruitment rate was 96%. Participants were female, aged between 19 and 56 years 
(M = 32.5, SD = 8.1), and had completed an average of 10.8 years of education (SD = 2.5, 
range 6-20). Participants had been in treatment for an average of 46.9 days (SD = 38.9, 
range 2-160). 
 
 5.3.3. SCREENING, DIAGNOSTIC AND CLINICAL ASSESSMENT 
 Diagnostic and clinical assessment at baseline included the following: Diagnoses 
of substance abuse/dependence and other current and past Axis I diagnoses were assessed 
using the MINI-Plus. Screening for personality disorder diagnoses was conducted using 
the Standardised Assessment of Personality – Abbreviated Scale (SAPAS; Moran et al., 
2003), as shown to be an appropriate time-efficient and cost-effective assessment for 
SUD populations (Gonzalez, 2014; Hesse & Moran, 2010; Hesse, Rasmussen, & 
Pedersen, 2008). The SAPAS is an 8-item scale including questions such as, “In general, 
do you have difficulty making and keeping friends?” and “In general, do you trust other 
people?”. Participants were instructed that the questions were about “how you behave 
and the way you think and feel things usually – in other words they are about your 
behavior and your way of being in general” and were asked to answer with a yes/no 
response. In the case of answering “yes” to a question, participants were then asked if 
their response applied “most of the time and in most situations” to which they also 
responded yes or no. SAPAS responses were scored as per the standardized instructions 
(i.e., one point assigned when participants endorsed both initial and follow-up questions). 
Scores ≥ 4 are considered to be an indicator of personality disorder, as this threshold 
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demonstrated correct classification of 73.6% of an inpatient SUD sample, with a 
sensitivity of 81.8% and a specificity of 67.7% (Gonzalez, 2014). The SAPAS 
demonstrated concurrent validity in an SUD sample, as it correlated with other 
personality disorder measures after controlling for psychiatric symptoms and recent 
substance use (Hesse & Moran, 2010). Additionally, the SAPAS demonstrated modest 
internal consistency and test-retest correlation, and was shown to correlate with clinician-
report of externalising and global assessment of functioning (Hesse et al., 2008). The 
current study utilised SAPAS scores as a dimensional indicator of personality disorder, 
in light of research suggesting that personality disorder may be more accurately 
characterised as a dimensional, rather than categorical, construct (Karukivi, Vahlberg, 
Horjamo, Nevalainen, & Korkeila, 2017). Higher scores indicated greater likelihood and 
severity of personality disorder. 
 
 5.3.4. MEASURES 
5.3.4.1. Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 
2004) 
 The DERS is a 41-item self-report questionnaire that assesses clinically relevant 
difficulties in emotion regulation. Example items include: “When I’m upset, I become 
angry with myself for feeling that way”; “I experience my emotions as overwhelming and 
out of control”. There are six subscales contributing to a total score, which was used as 
the outcome variable: Nonacceptance of Emotional Responses, Difficulties Engaging in 
Goal-Directed Behavior, Impulse Control Difficulties, Lack of Emotional Awareness, 
Limited Access to Emotion Regulation Strategies, and Lack of Emotional Clarity. Higher 
scores denoted greater difficulties in emotion regulation. 
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5.3.4.2. Behavior Rating Inventory of Executive Function – Adult Version 
(BRIEF-A; Roth et al., 2005) 
 The BRIEF-A is a 75-item self-report questionnaire consisting of nine subscales 
(Inhibit; Shift; Emotional Control; Self-Monitor; Initiate; Working Memory; 
Plan/Organize; Task Monitor; Organisation of Materials). Participants are instructed to 
answer each question by selecting “never”, “sometimes”, or “often”, in relation to 
whether they have had problems with any of the listed behaviors in the past month. 
Example items include: “I don’t plan ahead for tasks”; “I forget what I am doing in the 
middle of things”. The outcome variable was the Global Executive Composite (GEC), 
which provides an overall summary score, with elevated scores indicating executive 
dysfunction. 
 
5.3.4.3. Working memory: Working Memory Index (WMI; Wechsler Adult 
Intelligence Scale, fourth edition: WAIS-IV; Wechsler, 2008) 
 The WMI of the WAIS-IV assesses components of working memory and is 
comprised of 2 subtests, which were administered as per the standardized instructions. 
The digit span subtest requires participants to recall various sequences of numbers 
(forward, backward, and in sequence) and the arithmetic subtest involves participants 
solving numerical problems within 30 seconds, after they have been read aloud by the 
examiner. The outcome variable was computed by following the standard scoring 
instructions and was the sum of the 2 subtests, which yielded a scaled index score, with 
higher scores corresponding to better performance. 
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5.3.4.4. Inhibition and task-switching: Color-Word Interference Test 
(Delis-Kaplan Executive Function  System: D-KEFS; Delis, Kaplan, & Kramer, 
2001) 
 These subtests of the D-KEFS assess response inhibition and task-switching. 
Participants are instructed to read the items presented in each of four conditions as quickly 
and accurately as possible. Performance is measured in time (seconds). The first condition 
presents patches of colors and requires participants to name the colors. The second 
condition presents the words “red”, “blue”, and “green” and requires participants to read 
the words. The third condition presents words printed in incongruent colors and requires 
the participant to ignore the word and say the color. The fourth condition presents words 
printed in incongruent colors and requires the participant to switch between two rules: (a) 
ignore the word and say the color; and (b) ignore the color and say the word. Outcome 
variables were scaled scores of inhibition (condition 3 scaled score) and task-switching 
(condition 4 scaled score minus condition 3 scaled score). Higher scores reflect better 
performance. 
 
 5.3.5. STATISTICAL METHODS 
 All statistical analyses were performed using IBM Statistical Package for the 
Social Sciences (SPSS version 21; IBM Corp, 2012). Three missing values were 
identified, one within each of the DERS, inhibition, and task-switching variables. 
 The data analysis strategy involved three stages. Initially, intercorrelations 
amongst study variables were calculated. Spearman’s rank-order correlations were 
performed as Shapiro-Wilk statistics indicated non-normal distributions for some 
variables. Subsequently, a sequential hierarchical regression was employed with DERS 
scores as the dependent variable, with the goal of ascertaining the role of unique EFs and 
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other variables of interest in predicting emotion dysregulation. All statistical assumptions 
were tested and satisfied (i.e., independence of observations; linear relationships between 
variables; homoscedasticity of residuals; multicollinearity; outliers, high leverage points, 
highly influential points; normal distribution of residuals). In the final stage, four 
mediation models based on the outcomes of the regression analysis were tested in order 
to explore the influence of comorbid personality disorders on the relationship between 
EFs and emotion regulation. The mediation models were tested using the PROCESS 
macro (release 2.16.2; Hayes, 2013), recommended as an alternative to the causal step 
approach (Hayes, 2009; Hayes & Rockwood, 2016), and indirect effect was calculated 
using a bias-corrected and accelerated (BCa) bootstrapped confidence interval (CI) 
method, based on 5000 samples. 
 
5.4. RESULTS 
 Socio-demographic, substance use, and psychiatric comorbidity characteristics of 
the sample are displayed in Table 10, along with emotion regulation and EF measures. 
Participants were, on average, in their early thirties (Mdn = 32.5 years, range 19–56) and 
had completed approximately 11 years of education (Mdn = 10.5 years, range 6–20). The 
majority of participants (44%) reported methamphetamine as their primary substance of 
misuse, followed by approximately 30% who reported alcohol, with smaller numbers of 
amphetamines, heroin, cannabis, and sedatives users. However, high rates of 
polysubstance use history were evident, with participants reporting using multiple 
substances over a number of years.  
Table 11 displays Spearman’s rank-order correlations between all continuous 
study variables. DERS scores were significantly positively correlated with SAPAS and 
GEC scores, and significantly negatively correlated with task-switching performance. No 
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significant correlations were found between DERS scores and age, education, treatment 
length, WMI scores, or inhibition performance. Education was, however, significantly 
correlated with GEC scores, WMI scores, and inhibition performance, and was, therefore, 
included as a predictor variable. Similarly, although WMI and inhibition performance 
were not significantly correlated with DERS scores, they were also included as predictor 
variables in light of the study aim of ascertaining the unique role of EFs in predicting 
difficulties in emotion regulation, based on the theoretical framework of Hofmann and 
colleagues (2012). 
Predictor variables for the sequential hierarchical regression were entered in the 
following order: years of education (Step 1); current Axis I diagnosis (excluding SUD; 
Step 2); global self-report measure of EFs: GEC scores (Step 3); three specific EF 
components: performance in WMI, inhibition, and task-switching tasks (Step 4); and 
personality disorder indicators, SAPAS (Step 5). At step 1, the model was non-
significant, F(1, 46) = 0.16, p = .690, with education accounting for only 0.03% of the 
variance in DERS, R = .059, R2 = .003. At step 2, presence of a current Axis I diagnosis 
(other than SUD) significantly improved prediction, explaining an additional 27.1% of 
the variance, R = .524, R2 = .274, F change (1, 45) = 16.78, p < .001. At step 3, the 
addition of GEC scores significantly improved prediction and explained an additional 
11.7% of the variance, R = .625, R2 = .291, F change (1, 44) = 8.44, p = .006. At step 4, 
the addition of WMI, inhibition, and task-switching performance significantly improved 
prediction and explained an additional 16.3% of the variance, R = .745, R2 = .554, F 
change (3, 41) = 5.01, p = .005. At the final step, the addition of SAPAS scores 
significantly improved prediction and explained a further 4.4% of the variance, R = .774, 
R2 = .599, F change (1, 40) = 4.44, p = .042. Table 12 displays unstandardized regression 
coefficients (B), standardized regression coefficients (ß), t scores, and R2 change for all 
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variables at each step, capturing the proportion of the variance in DERS scores uniquely 
explained by each variable at respective points of entry. In the final model task-switching 
performance, GEC scores, and SAPAS scores contributed to DERS scores in descending 
order of statistical significance. 
	 In light of these regression results highlighting the contribution of EFs in general, 
and the task-switching component of EFs in particular in the prediction of DERS scores, 
a series of mediation analyses were employed to examine the relationship between EFs 
and difficulties in emotion regulation. Specifically, the role of personality disorder, as 
indexed by SAPAS scores, was considered as a mediator. As shown in Figure 3, there 
was a significant indirect effect of GEC scores and task-switching performance on DERS 
scores, through SAPAS scores. The ratio of the indirect effect to the total effect was 
calculated to provide a measure of effect size: PM = ab ÷ c (Wen & Fan, 2015); GEC PM 
= 0.22; task-switching PM = 0.27. Further mediation models indicated that neither WMI 
nor inhibition performance predicted DERS scores (see Figures 3b and 3c, respectively), 
although WMI performance predicted SAPAS scores (b = 0.06, p = .002), and there was 
a trend toward inhibition performance predicting SAPAS scores (b = 0.15, p = .077). 
Additionally, SAPAS scores predicted DERS scores in both WMI (b = 7.06, p < .001) 




Table 10. Socio-demographic, substance use, and psychiatric comorbidity characteristics, and emotion 
regulation and executive functions measures of residents of a female-only substance use therapeutic 
community. 
Characteristic      N = 50 
Age (M, SD)      32.5 (8.1) 
Education (M, SD)     10.8 (2.5)  
Unemployed (%)      78.0 
Marital status (% single)     74.0 
Treatment length (M, SD)     46.9 (38.9) 
Primary substance of misuse (%)     
Methamphetamine    44.0 
Alcohol      28.0  
       Amphetamines       8.0 
 Heroin        8.0  
       Cannabis        6.0  
 Sedatives       6.0 
Years of regular use (M, Mdn, SD; n)  
 Alcohol (any use)    11.2 (10.0, 8.3; 43) 
 Alcohol (to intoxication)      9.6 (6.5, 7.6; 42) 
 Heroin        9.9 (8.0, 8.3; 9)  
 Methadone       7.3 (7.0, 5.7; 5) 
 Other opiates/analgesics      7.4 (7.0, 5.7; 11) 
 Sedatives/hypnotics/tranquilisers     8.7 (10.0, 6.3; 17)  
 Cocaine        6.6 (6.0, 5.6; 11) 
 Amphetamines       8.2 (8.0, 5.5; 42) 
 Cannabis     11.1 (10.0, 7.0; 43) 
 Hallucinogens       5.3 (3.0, 5.1; 9) 
 More than one substance per day     9.9 (10.0, 6.2; 41) 
Current Axis I psychiatric diagnosisb (%)   64.0 
Past Axis I psychiatric diagnosisb (%)   64.0 
Personality disorder screen (% met criteria)c     40.0 
SAPAS (M, SD)        3.0 (1.9) 
DERS (M, SD)      91.9 (25.2) 
GEC (M, SD)      61.8 (13.5) 
WMI (M, SD)      88.7 (12.5) 
Inhibitiona (M, SD)       9.7 (3.3) 
Task-switchinga (M, SD)     10.2 (2.8) 
DERS Difficulties in Emotion Regulation Scale, SAPAS Standardised Assessment of Personality – 
Abbreviated Scale, GEC Global Executive Composite: Behavior Rating Inventory of Executive Function 
– Adult version (BRIEF-A), WMI Working Memory Index: Wechsler Adult Intelligence Scale, fourth 
edition (WAIS-IV), Inhibition Condition 3 scaled score; Color-Word Interference Test: Delis-Kaplan 
Executive Function System (D-KEFS), Task-switching Condition 4 – Condition 3 contrast scaled score; 
Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS) a N = 49. b Mini-
International Neuropsychiatric Interview. c Standardised Assessment of Personality – Abbreviated Scale. 
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Table 11. Spearman’s correlations amongst study variables. 
  DERS  Age  Education Treatment length SAPAS  GEC  WMI  Inhibition         Task-switching 
DERS  1 
Age  .14  1   
Education .02  .17  1 
Treatment length -.07  .06  -.04  1 
SAPAS  .57***  .07  .22  -.02  1 
GEC  .60***  .19  .30*  -.41**  .36*  1 
WMI  .21  .15  .63***  .06  .38**  .22  1 
Inhibition .18  .27  .35*  -.40**  .29*  .25  .53***  1 
Task-switching -.37*  -.19  -.15  .14  -.28  -.22  -.28  -.49***  1 
DERS Difficulties in Emotion Regulation Scale, SAPAS Standardised Assessment of Personality – Abbreviated Scale, GEC Global Executive Composite: Behavior Rating 
Inventory of Executive Function – Adult version (BRIEF-A), WMI Working Memory Index: Wechsler Adult Intelligence Scale, fourth edition (WAIS-IV), Inhibition 
Condition 3 scaled score; Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS), Task-switching Condition 4 – Condition 3 contrast scaled score; 
Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS) 
* p ≤ .05; ** p ≤ .01; *** p ≤ .001 
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Table 12. Regression coefficients of education, executive functions, and psychiatric comorbidities in 
predicting Difficulties in Emotion Regulation Scale (DERS) scores. 
 Variable   B  ß  t  R2 change 
Step 1 Education   0.60   .06   0.40  .003 
Step 2 Education  -1.01  -.10  -0.74  .271 
 Axis I diagnosis  28.26   .54   4.10*** 
Step 3 Education  -1.23  -.12  -0.98  .117 
 Axis I diagnosis  15.51   .30   2.00 
 GEC    0.79   .43   2.90** 
Step 4 Education  -2.50  -.25  -1.83  .163 
 Axis I diagnosis  13.39  -.26   1.91 
 GEC    0.73   .39   2.96** 
 WMI    0.54   .27   1.84 
 Inhibition  -2.20  -.29  -2.03* 
 Task-switching  -3.99  -.45  -3.48*** 
Step 5 Education  -2.28  -.22  -1.74  .044 
 Axis I diagnosis  10.01   .19   1.45 
 GEC    0.67   .36   2.83** 
 WMI    0.34   .17   1.16 
 Inhibition  -2.02  -.26  -1.92 
 Task-switching  -3.53  -.40  -3.14** 
 SAPAS    3.46   .26   2.11* 
B unstandardized regression coefficients, ß standardized regression coefficients, GEC Global Executive 
Composite: Behavior Rating Inventory of Executive Function – Adult version (BRIEF-A), WMI Working 
Memory Index: Wechsler Adult Intelligence Scale, fourth edition (WAIS-IV), Inhibition Condition 3 
scaled score; Color-Word Interference Test: Delis-Kaplan Executive Function System (D-KEFS), Task-
switching Condition 4 – Condition 3 contrast scaled score; Color-Word Interference Test: Delis-Kaplan 
Executive Function System (D-KEFS), SAPAS Standardised Assessment of Personality – Abbreviated 
Scale 






b = -0.20, p = .044     b = 5.82, p = .001 
 




   Direct effect, b = -3.10, p = .009 
  Indirect effect, b = -1.17, 95% CI [-3.18, -0.06] 
   Total effect, b = -4.27, p = .001 




b = 0.06, p = .002     b = 7.06, p < .001 
 




   Direct effect, b = 0.00, p = .990 
  Indirect effect, b = 0.46, 95% CI [0.14, 0.96] 
   Total effect, b = 0.46, p = .114 




b = 0.15, p = .077     b = 6.92, p < .001 
 




   Direct effect, b = 0.51, p = .631 
  Indirect effect, b = 1.07, 95% CI [-0.14, 3.11] 
   Total effect, b = 1.58, p = .183 





b = 0.05, p = .019     b = 5.05, p = .002 
 




   Direct effect, b = 0.83, p < .001 
  Indirect effect, b = 0.23, 95% CI [0.04, 0.59] 
   Total effect, b = 1.06, p < .0001 
Figure 3d. Model of Global Executive Composite (GEC) scores as a predictor of DERS scores, mediated by SAPAS 
scores (N = 49). 
 
Figure 3. Models of EFs measures as predictors of Difficulties in Emotion Regulation Scale (DERS) 
scores, mediated by Standardised Assessment of Personality – Abbreviated Scale (SAPAS) scores. 
Confidence intervals (CIs) for the indirect effects are bias-corrected and accelerated (BCa) 























 This study sought to determine the role of working memory, inhibition, and task-
switching performance, as well as inventory-based assessment of EFs in predicting 
difficulties in emotion regulation in an all-female residential SUD sample attending 
therapeutic community treatment. This aim was based upon the theoretical framework 
proposing that the capacity for effective emotion regulation may be subserved by 
performance in basic EF tasks (Hofmann et al., 2012; Schmeichel & Tang, 2015). Results 
indicated that inventory-based executive dysfunction and personality disorder indicator 
scores were positively correlated with difficulties in emotion regulation. Additionally, 
task-switching performance was negatively correlated with emotion regulation 
difficulties. In the final hierarchical regression model, task-switching, executive 
dysfunction, and personality disorder indicator scores were the strongest predictors of 
difficulties in emotion regulation. Subsequent to this, four mediation models were 
employed to examine the relationship between inventory- and performed-based EFs, and 
difficulties in emotion regulation. There was a significant indirect effect of inventory-
based EFs and task-switching performance, respectively, on difficulties in emotion 
regulation, through personality disorder indicator scores. This suggests that the 
relationship between both inventory-based assessment of executive dysfunction and 
deficits in task-switching performance, respectively, and difficulties in emotion 
regulation may be partly explained by the role of personality disorder. 
 Emotion regulation plays a crucial role in the development, severity, treatment 
outcomes, and prognosis of SUD (Wilcox et al., 2016), and increased understanding of 
corresponding neurocognitive impairments and related neurobiological substrates (e.g., 
Okita et al., 2016) may serve to advance assessment strategies and the development of 
interventions that target emotion dysregulation in SUD treatment. Findings from the 
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current study indicate that, compared to other basic performance-based EFs (i.e., working 
memory and inhibition), task-switching plays a unique role in predicting difficulties in 
emotion regulation. Additionally, this relationship was partly explained by personality 
disorder. This finding can be understood in the context of evidence indicating that a range 
of cognitive deficits have been demonstrated in personality disorder populations; most 
notably EF deficits (Garcia-Villamisar, Dattilo, & Garcia-Martinez, 2017). Along with 
cognitive deficits, personality disorder diagnosis has been identified as one of the top four 
risk factors for dropout from SUD treatment (Brorson et al., 2013). There is a pressing 
need for adjunct interventions and modifications to treatment that bolster individuals with 
co-occurring SUD, personality disorder, and/or cognitive deficits and increase the 
likelihood of treatment engagement and completion. 
 Along with the unique role of task-switching as a performance-based EF that was 
predictive of difficulties in emotion regulation, inventory-based assessment of executive 
dysfunction also uniquely predicted difficulties in emotion regulation, with this 
relationship also partly explained by personality disorder. This finding is congruent with 
research suggesting that inventory- and performance-based measures of EFs may assess 
distinct components of EFs (Hagen et al., 2016; Toplak et al., 2013). 
 Recently, a number of studies have explored the potential for cognitive screening 
(e.g., Marceau, Lunn, Berry, Kelly, & Solowij, 2016) and training/remediation 
interventions to respectively facilitate the detection of cognitive dysfunction, and improve 
cognition, functional outcomes, and treatment retention in SUD populations (Manning, 
Verdejo-García, & Lubman, 2017; Marceau et al., 2017; Verdejo-García, 2016). Four 
main classes of interventions have been trialled based on two major proposed 
neuroscientific mechanisms: (i) reorienting biases towards impulsive action (i.e., bottom-
up approach) and (ii) strengthening EFs (i.e., top-down approach), with cognitive bias 
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modification and response inhibition training located within the former category, and 
working memory training and goal-directed interventions in the latter (Verdejo-García, 
2016). Identifying the neurobiological mechanisms of these interventions is an area 
currently under investigation, but it is proposed that all interventions share the common 
underlying elements of normalising dysfunctional activity related to reward circuitry and 
also the strengthening of the inhibitory control network (Zilverstand, Parvaz, Moeller, & 
Goldstein, 2016). 
 A range of cognitive domains have been targeted through cognitive training 
interventions for SUD, including working memory, inhibition, attention, sustained 
attention, logical reasoning, decision-making, and broad EFs (Marceau et al., 2017; 
Verdejo-García, 2016). Gaining a more in-depth understanding of the specific active 
ingredients of these interventions and how they relate to improvements in neurocognitive 
performance as well as meaningful clinical outcomes is an important area for further 
exploration. Given that findings from the current study suggest that task-switching 
predicts emotion regulation, future studies may wish to investigate this further, by 
assessing whether cognitive training interventions that specifically target improvement in 
task-switching performance are efficacious within SUD treatment and whether they also 
lead to improved emotion regulation capacity. 
 As per the recommendations of Hofmann and colleagues (2012), future research 
may seek to further examine the relationships between basic EFs and measures of self-
regulation more broadly, using a number of proposed theoretical models. Specific to the 
addiction field, this line of research may provide significant evidence that could serve to 
inform the development of targeted cognitive training interventions. For example, future 
studies could examine the relationships between basic EFs (i.e., working memory, 
inhibition, task-switching) and a range of other self-regulation outcomes (e.g., self-
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control, responding to cravings in the context of substance-cues, etc.), to explore potential 
nuances involving mediating or moderating factors. This endeavour may be enhanced by 
employing measures that capture data from multiple levels of analysis (e.g., self-report, 
neurocognitive, neuroimaging; for a recent example investigating self-control in a 
nonclinical population, refer to Paschke et al., 2016). Furthermore, the inclusion of 
functional outcomes pertaining to SUD treatment and recovery in studies exploring the 
relationships between basic EFs and self-regulation may enhance this line of research and 
lead to fruitful, clinically relevant findings.  
 Performance on EFs tasks is partly shaped by individual differences (Miyake & 
Friedman, 2012). Additionally, individual factors also shape the trajectory of cognitive 
recovery in SUD (Bates, Buckman, Voelbel, Eddie, & Freeman, 2013). There are a 
variety of pathways leading to the onset of drug and alcohol addiction based on pre-
existing individual differences in brain functioning; namely susceptibility to increased or 
decreased sensitivity in a range of executive systems in the brain (George & Koob, 2010). 
In relation to this, future studies may wish to examine the relationship between EFs, self-
regulation, and the transition to addiction, while ensuring sufficient power to explore 
mediating and moderating factors based on the characteristics of particular subgroups that 
reflect these individual differences in the often-heterogeneous SUD populations. 
 The limitations of the current study must be noted. First, the small sample utilised 
exclusively consisted of females in residential SUD treatment. Future research may wish 
to explore the relationship between basic EFs and emotion regulation in male or mixed 
samples to ascertain whether similar or contrasting relationships exist. Additionally, the 
current study utilised a screening measure of personality disorder and, although evidence 
suggests that this is an appropriate brief and cost-effective measure for SUD populations 
(Gonzalez, 2014; Hesse & Moran, 2010; Hesse et al., 2008), future studies may wish to 
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examine the relationship between basic EFs and emotion regulation using full diagnostic 
assessments and/or other dimensional measures (Karukivi et al., 2017) of personality 
disorder. A further limitation relates to the use of mediation analyses within a cross-
sectional design. This approach may produce bias (Maxwell, Cole, & Mitchell, 2011) and 
future studies may wish to examine mediators of the relationship between EFs and 
emotion regulation utilising longitudinal designs. 
 In conclusion, the current study demonstrated that task-switching performance in 
contrast to other basic EFs, working memory and inhibition, uniquely predicted 
difficulties in emotion regulation in an all-female sample of residents attending residential 
SUD treatment. This relationship was partly explained by personality disorder indicators. 
These findings have implications for the design and development of cognitive training 
interventions to address the neurocognitive dysfunction present in SUD populations. 
There is a pressing need for further research that seeks to explore the neurocognitive bases 
of self-regulation to support the development of cognitive training interventions that 
include efficacious and specific active ingredients. The development of new interventions 
that translate to improvements in clinically meaningful outcomes that support treatment 
retention in SUD, such as emotion regulation, may benefit those individuals seeking long-
term recovery from drug and alcohol addiction. 
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CHAPTER 6: SUMMARY, SYNTHESIS, AND CONCLUSIONS 
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 The purpose of this concluding chapter is to integrate the findings of the preceding 
chapters and explore the clinical implications and future research directions in the field 
of cognitive training for substance use disorder (SUD) populations. An understanding of 
the impairment of cognitive functioning in addiction, together with the specific 
dysfunction of executive processes, and subsequent design and implementation of an 
intervention to address these deficits, forms the core of this thesis. Interpretations and 
further hypothesising are underpinned by a neuroscience framework. The implications of 
these findings in relation to refining understanding of the mechanisms of action and 
potential benefit of cognitive training interventions designed to improve cognition in 
SUD will be discussed, as well as the limitations of this body of work. 
 
6.1. SUMMARY AND SYNTHESIS 
 This thesis is comprised of three major studies, forming four publications included 
as chapters. The findings of study one are detailed in Chapter 2 and provide an initial 
exploration of cognitive functioning in an Australian SUD sample in residential 
treatment. Study two involved the design and evaluation of a cognitive remediation 
intervention to improve executive functions (EFs) in an SUD sample in residential 
treatment (Chapter 3) with three-month follow-up outcomes (Chapter 4). In study three, 
the relationships between EFs and emotion regulation were examined at baseline for the 
largest available sample (Chapter 5). 
 
6.1.1. STUDY ONE 
Study one was informed by previous theoretical and empirical studies 
demonstrating that cognitive deficits are commonly found in SUD populations and 
interfere with the process of treatment (Brorson, Ajo Arnevik, Rand-Hendriksen, & 
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Duckert, 2013; Domínguez-Salas, Díaz-Batanero, Lozano-Rojas, & Verdejo-García, 
2016). This study was an important starting point to inform the development of a 
cognitive remediation intervention for an Australian SUD sample in residential 
therapeutic community (TC) treatment, as it investigated cognitive functioning and its 
relationship to other characteristics within the target population accessed naturalistically 
as a snapshot of all clients in residence at the time. A key outcome of study one was the 
identification of the high rates of cognitive impairment amongst people attending 
residential treatment for SUDs. Nearly half (43.8%) of the SUD group were identified as 
cognitively impaired, compared to 16.2% of healthy controls. This impairment was 
demonstrated by lower total MoCA scores and lower EFs subscores observed in the SUD 
group, relative to controls. A further significant finding was that 67.2% of the SUD group 
had a history of head injury, with 50% requiring subsequent hospitalisation. History of 
head injury was identified as a significant determinant of the cognitive impairment 
observed in the sample. Cognitive impairment was also associated with greater levels of 
psychological distress. 
 These findings provided empirical evidence for cognitive impairment in an 
Australian SUD sample in residential TC treatment, and are congruent with previous 
findings demonstrating the specific impairment of EFs in SUD populations (Fernández-
Serrano, Pérez-García, Perales, & Verdejo-García, 2010; Fernández-Serrano, Pérez-
García, Río-Valle, & Verdejo-García, 2010). The findings also highlighted that head 
injuries and high levels of psychological distress are also highly prevalent in SUD TCs 
and cannot be ignored in attempts to improve treatment nor in consideration of the 
cognitive deficits in residents. 
 With the need for an intervention that could improve EFs in this population 
established, study two sought to address this. The findings in study one pertaining to the 
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high prevalence of past head injuries and psychological distress, and their relationship to 
the observed cognitive impairment, significantly shaped the development of the cognitive 
remediation intervention. It was developed with the aim of specifically targeting 
improvements in EFs within a sample inclusive of those with comorbid psychiatric 
disorders and a history of head injury. 
Not only were the findings of study one used to inform the development of the 
cognitive remediation intervention, they also carry important clinical implications. Due 
to the common time- and resource-constraints within residential SUD treatment facilities, 
the inclusion of a brief, cost-effective screening measure within study one was 
strategically chosen in order to maximise the potential for clinical translation of this 
research. Therefore, an important objective of this study was to provide staff employed 
in residential SUD treatment facilities clear, practical guidance around identifying and 
responding to cognitive impairment in residents. The arising clinical recommendations 
outlined: (a) that brief cognitive screening may be beneficial as a routine intake 
procedure; (b) if brief cognitive screening is not feasible in the treatment environment, 
simply inquiring whether residents have previously sustained a head injury requiring 
hospitalisation may be the most time- and resource-efficient way to screen for the 
possibility of cognitive impairment; (c) those residents identified as displaying cognitive 
deficits may benefit from further neuropsychological assessment; (d) modifications to 
treatment and/or adjunct interventions may be useful in increasing the likelihood of 
residents effectively engaging in treatment. 
 In summary, study one demonstrated the prevalence of cognitive impairment, and 
particularly executive dysfunction, in an Australian SUD TC sample through the use of a 
brief cognitive screening measure. Major implications include the necessity of cognitive 
screening as a part of the standardised assessment protocol for all clients entering 
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treatment. Furthermore, this study highlighted the potential benefit of trialling adjunct 
interventions in residential SUD treatment settings to improve cognitive functioning, as 
has recently been explored in the literature (Manning, Verdejo-García, & Lubman, 2017). 
 
6.1.2. STUDY TWO 
 A number of cognitive training interventions have been trialled in SUD 
populations (Verdejo-García, 2016). With the completion of study one, an intervention 
designed to specifically address executive dysfunction in this population was developed. 
Study two consisted of the evaluation of this intervention and its longer-term outcomes, 
comprising of Chapters 3 and 4. Chapter 3 was focussed on the evaluation of this 
intervention immediately post-treatment, whereas Chapter 4 examined longitudinal 
outcomes in the form of a three-month follow-up for a subset of measures. 
 A recent framework characterising the existing cognitive training interventions 
for SUD populations with respect to the proposed neuroscientific mechanisms classified 
these interventions into two broad classes (Verdejo-García, 2016): (1) Reorienting 
impulsive biases with a focus on retraining those brain regions (e.g., amygdala and medial 
prefrontal cortex) involved in impulsive responding (i.e., a bottom-up approach: cognitive 
bias modification and response inhibition training); (2) Strengthening EFs (i.e., a top-
down approach: working memory training and goal-directed approaches). With regard to 
this framework, the cognitive remediation intervention evaluated in study two would be 
best classified as a top-down approach aimed at strengthening EFs. A novel aspect of this 
intervention was the inclusion of and synergy between both drill and practice and 
strategy-based approaches. The intervention was particularly targeted towards improving 
EFs and this was achieved through the use of a format that included an initial strategy-
based session followed by a drill and practice session in which participants completed 
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computer-based tasks that were specifically chosen to provide practice and reinforcement 
of the prior strategy-based learning. A further novel aspect of study two was the inclusion 
of participants meeting criteria for psychiatric diagnoses and with a history of head injury. 
Previous studies of cognitive remediation in SUD have tended to exclude participants 
with comorbidities such as this, in order to establish efficacy rather than effectiveness of 
cognitive training interventions (e.g., Valls-Serrano, Caracuel, & Verdejo-García, 2016). 
 With regard to evaluation of the cognitive remediation intervention examined in 
study two, Chapter 3 presents the post-intervention outcomes for the intervention group 
compared to a treatment as usual control group. Findings indicated that the intervention 
group (vs. controls) improved on measures of EFs (inventory-based assessment and 
performance on an inhibition task), self-regulation, and quality of life. These findings 
provide important preliminary evidence for the potential effectiveness of cognitive 
remediation in an SUD population in residential treatment, including those with comorbid 
psychiatric disorders and history of head injury. 
 The improvements in EFs, self-regulation, and quality of life associated with the 
cognitive remediation intervention may be understood in the context of a neuroscience 
framework. While it was not feasible within the scope of this thesis to implement methods 
to explore potential neurobiological changes that may underlie these observed 
improvements, a potential explanation for the beneficial effects on EFs, self-regulation, 
and quality of life, is that underlying neurobiological changes may have occurred as a 
result of the intervention: This is further discussed in section 6.1.4. below. 
 While initial studies investigating cognitive training for SUD populations have 
demonstrated some evidence for the potential benefit of these interventions (Manning et 
al., 2017), there is a need for further research that investigates whether improvements are 
durable over time. Although EFs, quality of life, and psychological distress improve with 
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abstinence over a one-year period (Hagen et al., 2017), relatively few studies have 
included longitudinal follow-up of cognitive training for SUD. These considerations 
formed the basis of Chapter 4, which presents a three-month follow-up of a subset of 
measures to assess the durability of the cognitive remediation intervention outcomes.  
 The longitudinal intervention outcomes presented in Chapter 4 indicated that there 
were generally no differences between the intervention and control group on measures of 
self-control, cravings for primary substance of abuse, and likelihood of relapse. While 
approximately 50% of controls left the treatment program early, compared to 30% of the 
intervention group, this difference was not statistically significant. Additionally, there 
were no differences between groups with regards to duration of treatment (days since 
post-intervention) or relapse to substance use. Within the intervention group, 37.5% of 
residents were identified as completing treatment, compared to only 5.9% of the TAU 
controls. While this difference was statistically significant, it may be confounded with 
the significant difference in duration of treatment unexpectedly observed between groups 
at baseline, with the intervention group having been in treatment longer than controls. 
Though there were insufficient numbers of inventory-based EFs data within the control 
group to enable comparison with the intervention group, participants in the intervention 
group demonstrated improved EFs immediately post-intervention, and these 
improvements were maintained at three-month follow-up. 
 Though the majority of these results did not provide conclusive support for the 
long-term benefit of this cognitive remediation intervention, it is important to note the 
small sample sizes for each group obtained at follow-up. Additional longitudinal studies 
with larger sample sizes may be beneficial in providing further evidence regarding the 
long-term benefit of cognitive training interventions for SUD populations. Another area 
of concern was the baseline difference in treatment duration between groups in relation 
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to the observed rates of treatment completion. Furthermore, while the result indicating 
that improvements in EFs for the intervention group were maintained over time is 
promising, there is a significant need for further research evaluating the long-term effects 
of cognitive training for SUD. The extent to which interventions that target both top-
down and bottom-up components produce durable improvements in cognition and 
functioning is an important area for future research in this field (Manning et al., 2017; 
Verdejo-García, 2016). A potential mechanism of longer-term improvements may be that 
through improving cognition, cognitive training interventions subsequently increase the 
likelihood of individuals with SUD engaging with and benefitting from traditional 
treatment approaches (Domínguez-Salas et al., 2016). 
 
6.1.3. STUDY THREE 
 Chapter 5 presents the final study of this thesis – an investigation of the 
relationship between basic EFs and emotion regulation. These relationships were 
explored in a cross-sectional design that utilised all baseline data from the same sample 
who commenced participation in the intervention study. This was based on the theoretical 
framework proposed by Hofmann and colleagues (2012) postulating that basic EFs (i.e., 
working memory, inhibition, and task-switching) may serve as the neurocognitive bases 
of a range of self-regulation capacities. Emotion regulation was selected as an important 
self-regulatory capacity in the context of SUD populations, due to the significant role it 
plays in the onset, maintenance, and prognosis of SUD (Wilcox, Pommy, & Adinoff, 
2016). 
 The major findings of this study indicated that poorer performance on a measure 
of task-switching predicted greater difficulties with emotion regulation, suggesting that 
task-switching may be one potential cognitive capacity that subserves effective emotion 
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regulation. No relationships between emotion regulation and either working memory or 
inhibition were observed. Additionally, mediation analyses indicated that the relationship 
between task-switching and difficulties in emotion regulation was partly explained by 
personality disorder indicators, as assessed by a screening measure. 
 These findings contribute to the literature by providing further data that may 
inform the development and refinement of novel cognitive training interventions for SUD 
populations, by identifying potential mechanistic drivers. For example, future research 
may explore whether targeted training of task-switching promotes effective emotion 
regulation. At a neural level, task-switching is believed to be subserved by a distributed 
frontoparietal network of brain regions (Kim, Cilles, Johnson, & Gold, 2012). 
Improvements in task-switching associated with cognitive training may have beneficial 
effects on emotion regulation through strengthening of these brain networks. This may 
be dependent, however, on the type of task-switching involved. Three distinct types of 
task-switching, perceptual, response, and context, have been documented, with dorsal 
premotor cortex activation implicated in perceptual task-switching and frontopolar cortex 
activation associated with context task-switching (Kim et al., 2012). 
 
6.1.4. FINDINGS INTERPRETED WITHIN A NEUROSCIENCE 
FRAMEWORK 
 Collectively, the three studies completed in the course of this thesis 
comprehensively investigate the rationale, utility, and future directions of cognitive 
training as a treatment for SUD populations. The benefit of targeted cognitive training 
interventions for SUD can be understood particularly in terms of recent neuroscientific 
frameworks of addiction. Neuroimaging methods have identified brain regions 
underlying the development and maintenance of addiction, along with associated 
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neurocircuitry (Koob & Volkow, 2016). It is believed that cognitive training interventions 
have the potential to enhance and/or attenuate activity in the salient regions involved and 
it is through this process that neurocognitive and, subsequently, self-regulation capacities 
and functional outcomes improve (Kelley, Wagner, & Heatherton, 2015; Verdejo-García, 
2016). 
 Neuroimaging studies may further assist in elucidating the mechanisms of action 
underlying improvements in cognition and functional outcomes associated with cognitive 
training. The neural correlates of cognitive training for other clinical populations, most 
notably schizophrenia (Isaac & Januel, 2016; Penadés et al., 2017; Ramsay & MacDonald 
III, 2015), but also mood disorders (Meusel, Hall, Fougere, McKinnon, & MacQueen, 
2013), have been documented; increased activity in prefrontal brain regions is 
consistently observed across studies. At present, however, only a limited number of 
studies have examined the neural correlates of cognitive training for SUD (Verdejo-
García, 2016). 
 A series of studies used functional magnetic resonance imaging (fMRI) to 
examine the neural changes occurring after cognitive bias modification (CBM) for SUD 
(Wiers, Ludwig, et al., 2015; Wiers, Stelzel, et al., 2015). Prior to training, participants 
demonstrated increased medial prefrontal cortex activity, which was related to alcohol 
approach bias. CBM resulted in greater reductions in approach bias-related medial 
prefrontal cortex activation, in comparison to placebo training, but had no effect on 
nucleus accumbens activation, contrary to study hypotheses (Wiers, Ludwig, et al., 2015). 
Additionally, the role of mesolimbic brain areas in approach bias triggered by alcohol 
cues was explored and CBM, compared to sham training, resulted in greater reductions 
in cue-evoked activation of the amygdala (Wiers, Stelzel, et al., 2015). 
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 There are no studies investigating potential neural correlates of response 
inhibition training in SUD, but a single study examined changes in 
electroencephalographic (EEG) recordings within a community sample of hazardous 
drinkers (Bowley et al., 2013). Inhibition training, compared to sham training and 
treatment as usual, resulted in non-significant increases in lateral prefrontal cortex 
activity associated with approach motivation, as hypothesised. 
 Of note, there are no neuroimaging studies of working memory training or goal-
directed approaches in SUD populations. These specific cognitive training interventions 
for SUD are proposed to work through strengthening of EFs (Verdejo-García, 2016). 
Exploration of the neural mechanisms of these interventions is crucial in furthering the 
development and effective implementation of goal-directed cognitive training 
interventions, but also for SUD cognitive training more widely, given the relative lack of 
neuroimaging studies investigating neural correlates. 
 While there are no neuroimaging studies of goal-directed cognitive training 
interventions for SUD, such as cognitive remediation, the neural correlates of cognitive 
remediation for schizophrenia populations have been explored (Isaac & Januel, 2016; 
Ramsay & MacDonald III, 2015). Cognitive remediation is associated with increased 
activation in frontal regions, particularly prefrontal areas, but also anterior cingulate and 
occipital regions (Isaac & Januel, 2016). Increased activation of the lateral and medial 
prefrontal cortex, parietal cortex, the caudate and thalamus, as well as the insula have 
been observed (Ramsay & MacDonald III, 2015). Structural changes in grey and white 
matter also suggest neuroprotective effects of cognitive remediation for schizophrenia 
populations (Penadés et al., 2017). 
 Based on neuroscience theories of addiction implicating two key brain systems in 
the development and maintenance of SUD, an impulsive amygdala-striatum system and 
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reflective prefrontal cortex system (Noël, Brevers, & Bechara, 2013), it is hypothesised 
that cognitive remediation for SUD, as a top-down approach utilising broad strategy-
based learning, may result in improved functioning of brain areas and networks related to 
the prefrontal cortex system, congruent with findings investigating the neural correlates 
of cognitive remediation for schizophrenia populations. In this way, cognitive 
remediation may serve to alleviate hypofunction of the ventromedial prefrontal cortex, 
which is associated with chronic substance use (Volkow & Morales, 2015). Conversely, 
the neurobiological underpinnings of successful abstinence implicate improved structure 
and function of prefrontal brain regions (Garavan, Brennan, Hester, & Whelan, 2013), 
indicating one potential treatment target for cognitive training interventions. 
 
6.2. LIMITATIONS AND FUTURE RESEARCH DIRECTIONS 
 While the findings of this thesis provide evidence for the use of cognitive training 
interventions within residential SUD treatment, certain limitations of the thesis as a whole 
must be acknowledged. Future research directions that may overcome these limitations 
and expand the existing evidence base in the field, along with clinical implications of 
findings, will also be discussed. 
Study one incorporated a mixed-gender sample while studies two and three were 
conducted in a female-only residential service. For this reason, the findings associated 
with studies two and three may only apply to females in residential SUD treatment. Future 
research incorporating males is necessary to empirically evaluate whether the findings of 
this thesis also extend to male populations in residential SUD treatment. This is important 
given the significant role of sex differences in SUD. Distinct pathways leading to the 
onset and maintenance of addiction for males vs. females are associated with 
neurobiological sex differences (Becker, Perry, & Westenbroek, 2012; Bobzean, 
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DeNobrega, & Perrotti, 2014), changes in brain functioning related to substance use are 
influenced by sex differences (Becker, McClellan, & Reed, 2017), and gender differences 
arise within a sociocultural context potentially influencing how men and women 
differentially respond to SUD treatment (Becker, McClellan, & Reed, 2016). For these 
reasons, treatment response and effectiveness of cognitive training interventions for 
males may differ considerably in comparison to females, and is an important area for 
future research to investigate. 
 Another limitation of this thesis concerns the evaluation of the intervention 
presented in Chapters 3 and 4. The differences between intervention and control groups 
regarding length of time in treatment at baseline prior to commencement of the 
intervention, as well as the period of time between baseline and post-intervention 
assessments, were problematic. Future studies would benefit from standardised 
recruitment times (e.g. enrolment at intake to the service) to ensure treatment groups are 
matched on duration of treatment. A matched interval between assessments is also 
important in terms of refining interpretations of the empirical findings for cognitive 
training in SUD populations. Furthermore, the inclusion of active control groups, as 
opposed to TAU, would provide further data that may be beneficial in clarifying the 
mechanisms of action driving any potential improvements in cognition and functioning 
following cognitive training interventions for SUD. With respect to this consideration, it 
may be argued that the control group from study two of this thesis could be considered as 
“active”. This is based on the notion of SUD TC treatment requiring a high level of 
engagement: residents actively participate in treatment, which emphasises their roles and 
responsibilities in not only the various components of treatment (e.g., multiple therapeutic 
groups) but also in coordinating activities of daily life (e.g., cleaning, cooking, organising 
leisure activities). These tasks require certain degrees of planning, monitoring, and 
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problem-solving, and may be underpinned by specific EFs. If this is the case, it serves to 
support the validity of the findings of the intervention study, given that controls were 
routinely and actively involved in other tasks that may serve to strengthen EFs. It is 
important to acknowledge, however, that an ideal active control condition would also 
include participants attending a specific group intervention matched on important 
variables such as session length and frequency, social interaction, and facilitator 
involvement. 
 A broader issue within this thesis concerns the use of self-report measures 
generally, and particularly with regard to reliable reporting of behavioural problems 
related to executive dysfunction and emotion dysregulation. While there is some evidence 
suggesting that the Behavior Rating Inventory of Executive Function (BRIEF-A) is an 
appropriate and sensitive measure of EFs in SUD populations (e.g., Hagen et al., 2016), 
further studies should investigate the reliability and validity of the BRIEF-A in SUD 
populations. Similarly, there are no large-scale validation studies that have investigated 
the reliability and validity of the Difficulties in Emotion Regulation Scale (DERS) in 
SUD populations. Given the prevalence of executive dysfunction in SUD populations, 
and the associated difficulties with insight, awareness, and self-monitoring, the question 
of whether self-report ratings of emotion regulation and behavioural problems are 
appropriate requires further empirical investigation. 
 As the trajectory of cognitive improvement observed in SUD shows variance at 
the individual-level, further studies identifying subgroups and potential predictors of 
cognitive recovery may inform the development and clinical translation of cognitive 
training interventions (Bates, Buckman, Voelbel, Eddie, & Freeman, 2013). Related to 
this, future studies assessing the effects of cognitive remediation for SUD would benefit 
from the inclusion of larger sample sizes in order to explore variation between subgroups 
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(e.g., those with vs. without history of head injury; psychiatric diagnostic groups; primary 
substance of abuse groups) and to examine mediating and moderating factors related to 
improvement. For example, a recent study utilised neuroimaging to investigate whether 
variability in brain structure predicted response to cognitive training in a healthy 
population (Verghese, Garner, Mattingley, & Dux, 2016). Response to training was 
predicted by volume of the rostral part of the left dorsolateral prefrontal cortex. This 
approach aligns well with recent research attempting to identify biomarkers with the 
capacity for clinical translation to enhance the process of treatment selection based on 
individual characteristics (Perlis, 2011). Relating to this, it will be important for future 
studies to delineate characteristics that may predict response to cognitive training. For 
example, premorbid cognitive impairment could influence the degree to which 
individuals with SUD benefit from cognitive training. In the future, research discoveries 
in this area may enable personalised cognitive training interventions for individuals with 
SUD (e.g., individually tailored modules based on an assessment of specific 
neurobiological and neuropsychological factors). 
 Another potentially fruitful line of future research concerns the use of assessment 
techniques from multiple disciplines that have the potential to provide data from different 
levels of analysis (e.g., self-report, neuropsychological, neuroimaging). This approach 
may provide a more comprehensive understanding of the mechanisms of action and 
potential benefits of cognitive training for SUD. As different assessment techniques may 
measure distinct aspects of the construct under investigation (e.g., Cyders & Coskunpinar, 
2011; self-report vs. behavioural laboratory task assessment of impulsivity), multimethod 
research studies may provide a more comprehensive understanding of the changes in 
cognitive processes and self-regulatory capacities observed following cognitive training 
interventions. The significance of multimethod research relates to an important area of 
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future investigation concerning not only whether cognitive training for SUD may produce 
improvements in cognition, presumably through enhancing neural functioning, but also 
whether these improvements increase self-regulation capacity. Studies that include 
relevant self-regulation measures (e.g., emotion regulation) and clinical outcomes (e.g., 
response to SUD treatment, relapse, quality of life) are essential in answering these 
questions. 
 Utilising neuroimaging methods in assessing the outcomes of cognitive training 
interventions may provide significant data to further elucidate mechanisms of action and 
establish neurobiologically based treatment targets for cognitive training (Cabrera et al., 
2016). As there are only a very small number of studies utilising neuroimaging methods 
to investigate cognitive training for SUD, there is still much to discover regarding 
neurobiological changes over the course of training and mechanisms of action. There are 
a variety of cognitive training interventions for SUD (Verdejo-García, 2016) and 
significant variability in the content and methods employed in strategy-based cognitive 
remediation interventions, in particular (Bryce, Lee, Ponsford, & Rossell, 2016). It is 
hypothesised that cognitive training for SUD may achieve its effects through two broad 
mechanisms: decreasing impulsive responding through reduced substance cue-related 
activation of the medial prefrontal cortex and amygdala, and increasing goal-related 
activation of the dorsolateral and ventrolateral prefrontal cortex (Verdejo-García, 2016). 
Neuroimaging methods could elucidate the mechanisms of action associated with 
particular cognitive training interventions. Furthermore, neuroimaging research utilising 
a functional connectome approach may be appropriate to investigate complex interactions 
of several brain regions, and any temporal changes that may occur with cognitive training 
for SUD (Taya, Sun, Babiloni, Thakor, & Bezerianos, 2015). Research of this kind may 
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inform the development of targeted SUD cognitive training interventions with clear 
mechanisms of action based on the neurobiology of addiction. 
 
6.3. CONCLUSIONS 
 In summary, this thesis aimed to investigate the potential for neuropsychological 
assessment and cognitive training interventions to improve SUD treatment outcomes. 
Findings from study one provided empirical evidence supporting the prevalence of 
cognitive deficits and, in particular, executive dysfunction in an SUD sample in 
residential treatment. In light of these findings, study two implemented a cognitive 
remediation intervention that targeted executive dysfunction, aiming to facilitate 
improvement in EFs as well as translation to clinically meaningful outcomes, with 
promising findings indicating improvement in EFs and self-regulation measures. The 
longitudinal outcomes of this intervention were investigated at three-month follow-up, 
although the long-term benefit of cognitive remediation was found to be inconclusive in 
the small sample available. Finally, the relationships between emotion regulation and 
basic EFs were investigated, with task-switching significantly predicting emotion 
regulation capacity. Taken together, the results of these studies provide further 
preliminary support for the use of cognitive remediation interventions in SUD 
populations and inform the replication and extension of research in the area of cognitive 
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Introduction: Retaining clients in residential alcohol and other drug (AOD) treatment is difficult and cognitive im-
pairment has been identified as a significant predictor of treatment dropout. The application of extensive screen-
ing for cognitive impairment is cost-prohibitive for most AOD treatment services. The current study aimed to
explore cognitive functioning and impairment-associated factors in a typical sample of residential AOD clients
using a free brief screening tool that could be utilised by front-line AOD services.
Methods: Residents of anAOD therapeutic community (n=128) and a non-substance using control group (n=37)
were administered abrief cognitive screeningmeasure, theMontreal CognitiveAssessment (MoCA).MoCA total and
domain scores were compared between these groups and within the AOD group examined in association with pri-
mary substance of misuse, severity of dependence, gender, psychological distress, and history of head injury.
Results: Almost half (43.8%) of the AOD sample were identified as cognitively impaired, compared to 16.2% of the
control group. Furthermore, 67.2% of the AOD sample had sustained head injuries and 50% of the sample required
hospitalization for head injury. History of head injury was a significant determinant of cognitive impairment, and
associated with greater levels of psychological distress.
Conclusions: There are high rates of inter-related cognitive impairment, head injuries, and psychological distress
among clients in residential AOD treatment. Routine screening of clients at intake for cognitive impairment by
means of a brief screeningmeasure such as theMoCA, in combinationwith the assessment of history of head injuries
and comorbid psychological disorders, could inform treatmentmodifications or adjunct interventions to increase re-
tention and improve long-term outcomes.
© 2016 Elsevier Inc. All rights reserved.
1. Introduction
Therapeutic communities (TCs) are a form of residential rehabilitation
for individuals experiencing chronic and severe alcohol and other drug
(AOD) problems and may particularly suit clients with associated comor-
bidities and other complexities as they place an emphasis on fostering so-
cial support within the community of residents in order to promote
treatment engagement and completion. Dropout from AOD treatment in
general is estimated to be as high as 57% in inpatient settings (Darke,
Campbell, & Popple, 2012; Deane, Wootton, Hsu, & Kelly, 2012; Vergara-
Moragues, Gonzalez-Saiz, Lozano, & Verdejo Garcia, 2013). Importantly,
lengthof stay in TCshas been shown tobe related toneurocognitive capac-
ity (Fals-Stewart & Lucente, 1994; Fals-Stewart & Schafer, 1992;
Fernández-Serrano, Pérez-García, Perales, & Verdejo-García, 2010). An ex-
tensive systematic review reported that cognitive deficits were one of the
most consistently reported risk factors for dropout from AOD treatment,
alongside personality disorder, low treatment alliance, and younger age
(Brorson, Ajo Arnevik, Rand-Hendriksen, & Duckert, 2013).
It is likely that most residential substance misuse programs deliver
treatments that work optimally in those who possess intact cognitive
abilities; that cognitive impairment among residents may hinder treat-
ment success requires further consideration. Components of residential
AOD treatment often rely on capacities such as executive function (de-
fined broadly as “those capacities that enable a person to engage suc-
cessfully in independent, purposive, self-directed, and self-serving
behavior”; Lezak, Howieson, Bigler, & Tranel, 2012, p. 37) and working
memory (Fernández-Serrano, Pérez-García, Río-Valle, & Verdejo-
García, 2010; Yϋcel & Lubman, 2007), as clients are required to integrate
new information, formulate goals, establish new behavioural strategies,
and plan for the future in overcoming addiction.
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However, most misused substances impair attention, learning and
memory, visuospatial abilities, and executive functioning, with perhaps
themost robust deficits across all substances evident in inhibitory control,
working memory, and decision-making (Fernández-Serrano, Pérez-
García, Río-Valle, et al., 2010; Yücel, Lubman, Solowij, & Brewer, 2007;
Yϋcel & Lubman, 2007). Structural and functional brain changes may
occur after substance misuse (Broyd, van Hell, Yücel, & Solowij, 2016;
Caplan, Epstein, Quinn, Stevens, & Stern, 2007; Ersche & Sahakian, 2007;
Gonzalez, 2007; Gruber, Silveri, & Yurgelun-Todd, 2007; Lorenzetti,
Solowij, & Yücel, 2016; Oscar-Berman & Marinković, 2007; Scott et al.,
2007). Traumatic brain injury (TBI) is also highly prevalent in substance
misuse populations, leading to significant complexities in the process of
AOD treatment (Sacks et al., 2009; Solomon & Malloy, 1992; Walker,
Cole, Logan, & Corrigan, 2007; West, 2011).
Although cognitive dysfunction is common in AOD samples and in-
creasingly recognized by staff, there is often insufficient time or re-
sources to implement detailed neuropsychological assessments.
Cognitive assessment may be instrumental in facilitating the detection
of AOD clients with clinically significant cognitive impairment, irrespec-
tive of etiology. Assessing clients' cognitive capacities can inform subse-
quent implementation of strategies aimed at improving treatment
retention and outcomes.
In the AOD treatment environment a brief but valid and reliable
measure is required. This would provide an indication of potential cog-
nitive dysfunction and alert staff to the possibility that further neuro-
psychological assessment and/or treatment modifications may be
indicated. The Montreal Cognitive Assessment (MoCA; Nasreddine
et al., 2005) comprises 12 items that tapfive keyneuropsychological do-
mains: executive function, working memory, short-term memory, lan-
guage, and visuospatial ability. The MoCA takes 15 minutes to
administer, is a free resource (Nasreddine, 2015), and can be adminis-
tered by staff without formal neuropsychological training. Initial studies
have found evidence supporting the use of the MoCA in AOD treatment
settings (Copersino et al., 2009; Copersino et al., 2012).
The current studywas exploratory in nature and sought to provide a
naturalistic overview of a sample of Australian TC residents, with the
MoCA administered as a brief screening measure to assess neuropsy-
chological functioning. Performance on the MoCA was investigated in
relation to demographic, substance use, psychological, and other vari-
ables related to impairments in cognition, including TBI.
2. Material and methods
2.1. Participants
The AOD group was recruited from We Help Ourselves (WHOs), a
large provider of residential AOD treatment in Australia that uses the
Therapeutic Community model of treatment. Participants were recruit-
ed across seven WHOs sites in New South Wales (Sydney, Hunter Val-
ley) and Queensland (Sunshine Coast). The response rate was
approximately 90%. Specific inclusion and exclusion criteria were not
applied in order to capture the heterogeneous and complex presenta-
tions of residential AOD treatment populations and to increase the gen-
eralizability of results. Although there was no formal assessment of
substance use disorders using the Diagnostic and Statistical Manual of
Mental Disorders (5th ed.; DSM-5; American Psychiatric Association,
2013) criteria it was assumed that residents would meet these criteria
given their attendance at a high-intensity residential program.
A control group was recruited through the University of Wollongong
College, a provider of educational programs to persons who have not
completed high school matriculation, as an alternative pathway to tertia-
ry study. All students were invited to participate and the response rate
was approximately 60%. Control participants, all native English speakers,
were excluded for any lifetime dependence on or treatment for alcohol
or other drugs, and any psychiatric or neurological diagnoses.
2.2. Procedure
After a group information session, interested participants provided
written consent and were individually assessed in a quiet testing
room. This was conducted within the TC facility for the AOD group,
and at a University psychology clinic for the control group. The MoCA
was administered in approximately 15 minutes, adhering to the admin-
istration and scoring guidelines (Nasreddine, 2015). Additional infor-
mation (e.g., basic demographics, history of head injury, current and
past substance use for controls) was obtained through a 10-minute
semi-structured interview and the Kessler Psychological Distress Scale
(K10; Kessler et al., 2002) was administered, as well as the Severity of
Dependence Scale (SDS; Gossop et al., 1995) for the AOD group. Control
participants received a $20 gift card as reimbursement for their time.
2.3. Measures
2.3.1. MoCA
TheMoCAwas used to assess neuropsychological functioning across
its purported five domains (executive function, working memory,
short-termmemory, language and visuospatial ability). Executive func-
tion is assessed using trail-making, phonemic fluency, and verbal ab-
straction tasks. Working memory is assessed using sustained
attention, serial subtraction, and digit span forward/backward tasks.
Short-term memory is assessed through the delayed recall of five
nouns. Language is assessed using naming (low familiarity animals),
sentence repetition, and the phonemic fluency task. Visuospatial ability
is assessed using clock-drawing and cube-copying tasks. The MoCA has
displayed acceptable reliability in clinical groups (Bernstein, Lacritz,
Barlow, Weiner, & DeFina, 2011; Freitas, Simões, Marôco, Alves, &
Santana, 2012). Outcome measures included total MoCA score and do-
main subscores.
2.3.2. Clinical variables
The SDS (Gossop, Best, Marsden, & Strang, 1997) measured AOD par-
ticipants' level of dependence on their primary substance of misuse. The
K10 was used to capture level of psychological distress experienced by
all participants. The K10 has been extensively used in both community
and clinical samples as an indicator of a potential psychological disorder,
and has demonstrated acceptable psychometric properties (George,
Kinner, Bruno, Degenhardt, & Dunn, 2010; Hides et al., 2007; Sunderland,
Mahoney, & Andrews, 2012). Relevant demographic and substance use
data routinely collected by WHOs were accessed, following participants
and the director of the service providing written consent.
2.4. Data analysis
All data were analyzed using IBM Statistical Package for the Social Sci-
ences (version 19; IBMCorp, 2010). The primary goals of the analysiswere
to compare the performance of residents and controls on theMoCA and to
explore variation in MoCA scores and potential predictors (e.g., primary
substance of misuse, gender effects) within the AOD sample.
Shapiro–Wilk statistics and visual inspection of histograms and
boxplots determined that total MoCA score, MoCA domain subscores,
age, years of education, K10 and SDS scores were not normally distrib-
uted for both AOD and control groups. Consequently, nonparametric
techniques were employed for most of the analyses. Nonparametric
analysis of covariancewas required for some analyses to enable covary-
ing demographic characteristics that differed between groups. Quade's
(1967) distribution-free procedure was used as a nonparametric alter-
native to analysis of covariance (see Olejnik & Algina, 1985). This in-
volved ranking the dependent variable and all covariates for all cases,
ignoring the grouping variable. Following this, the linear regression of
the ranked dependent variable on the ranked covariate measure was
calculated and the unstandardized residuals saved, again ignoring the
grouping factor. To calculate Quade's F statistic, a one-way analysis of
31E.M. Marceau et al. / Journal of Substance Abuse Treatment 66 (2016) 30–36
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variance using the residuals from the regression as the dependent vari-
able and the grouping variable as the factor was performed.
Total MoCA score and cognitive domain subscores were the primary
dependent variables for analysis. However, factor analyses of the MoCA
have demonstrated that domains may be grouped differently
(e.g., Duro, Simões, Ponciano, & Santana, 2010; Freitas et al., 2012).
Given the multi-process nature of neuropsychological tasks, whereby
any single task may tap into a range of perceptual, cognitive and
motor abilities, and the overlapping nature of the cognitive domains
assessed by the MoCA (Freitas et al., 2012), we created an additional
score for analysis of executive function. This was of particular interest
because executive dysfunction is especially common in substance
misusing individuals (e.g., Fernández-Serrano, Pérez-García, Río-Valle,
et al., 2010; Gierski et al., 2013; Hester, Lubman, & Yϋcel, 2010; Perry
et al., 2011). As such, we utilized the standard measure of executive
function from the MoCA as well as an extended measure that included
performance on the visuospatial cube-copying and clock-drawing
tasks, with the rationale that these tasks rely on key component pro-
cesses of executive function.
All AOD residentswere compared to controls in thefirst instance. Res-
idents were then compared in terms of gender and primary substance of
misuse. Primary substance ofmisuse groupings were formed by choosing
the three largest representative groups in residence at the time of testing
(alcohol, heroin and amphetamines). A broader opiates group was then
formed by the addition of clients on methadone maintenance and
buprenorphine users. Cocaine users, minimal in Australian AOD samples
(Australian Institute of Health and Welfare, 2005), were grouped with
amphetamine users to form a stimulants group. This strategy maximized
group sizes for comparison, grouping together substances with similar
chemical properties. However, primary users of cannabis, tranquilisers
and benzodiazepines were not grouped or included in these comparisons
due to insufficient sample sizes of these subgroups (see Results). Finally,
AOD users hospitalized after a head injury were compared to those with-
out serious head injuries.
3. Results
3.1. Preliminary analyses
MoCAdatawere available for 128 AOD residents and 37 controls. For
some analyses, the AOD sample was reduced to 95 due to missing data
(e.g. primary substance of misuse, n=16; SDS and K10 scores, n=33).
Table 1 displays demographic, substance use, psychological, and cogni-
tive functioning variables for the AOD group. AOD residents were in
their mid-thirties on average and predominantly male. Alcohol was
the primary substance of misuse for almost one-third of the sample,
followed by heroin and amphetamine misuse, with these three sub-
stances accounting for approximately 80% of the entire AOD sample.
The mean K10 score indicated very high levels of psychological distress
and the mean SDS score indicated high levels of psychological depen-
dence on participants' primary substance of misuse, although the
range extended to 0 in some cases, reflecting that some residents had
progressed further in their treatment. The prevalence of head injuries
was particularly high in the sample. Of the 67.2% who had either lost
consciousness or sustained a concussion after a head injury, the mean
number of times this had occurred was 4.98 (SD = 5.95). Half of the
total sample had been hospitalized after sustaining a head injury.
All control participants were screened to ensure that they had not
been dependent on alcohol or other substances and/or received treat-
ment for substance use disorder in the past. No control participant cur-
rently used any substance (excluding alcohol and tobacco) on a regular
basis (i.e., greater than once a month), with minimal prior experimenta-
tion with drugs, and 76% drank alcohol less than twice per week. The
24% of control participants who drank alcohol more than once per week
were screened to ensure that their current drinking was not occurring
at a problematic level that caused clinically significant impairment or
distress. Despite attempts to match sample characteristics, controls
were significantly younger (Mdn = 25 years, range 21–61) than the
AOD group (Mdn = 35 years, range 19–56), z = −5.21, p b .001, and
had significantly more years of education (Mdn = 12 years vs. Mdn =
10 years), z=−4.26, p b .001. Gender distribution did not differ signifi-
cantly between groups (54%male in controls vs. 70.3%male in AOD). Age
and education were therefore included as covariates for group compari-
sons. Psychological distress was low to moderate in controls (K10 mean
17), and was significantly higher in AOD residents (K10 mean 29), F(1,
130) = 33.33, p b .001.
3.2. Primary analyses
3.2.1. Covariates
Despite the group difference in age, agewas not significantly correlated
with total MoCA score, p= .16. It was also not correlated with any MoCA
subscores, all p N .05, in the entire sample as well as in the AOD group
alone. There were significant correlations between years of education and
total MoCA score, r = .18, p = .02, executive function, r = .36, p b .001,
short-term memory, r = .18, p = .02, working memory, r = .21, p =
.006, and language, r= .26, p= .001. Age and educationwere both includ-
ed as covariates in analyses, but while education was consistently signifi-
cant in the models, age was not. Age was subsequently dropped from the
analyses and results are reportedherewith education alone as the covariate
in analyses of MoCA outcomes for the AOD vs. control group.
3.2.2. MoCA scores
Comparison of the AOD and control group determined a significant
difference in totalMoCA score, F(1, 163)=5.28, p=.023, the combined
executive function/visuospatial subscore, F(1, 163) = 6.91, p = .009,
and the visuospatial domain alone, z = −2.43, p = .015, with poorer
performance in the AOD group (Table 2). None of the other cognitive
domain subscores differed between groups: short-term memory, F(1,
163)= .25, p= .62,workingmemory, F(1, 163)= .27, p= .60, and lan-
guage, F(1, 163) = 1.04, p = .31. There was a trend toward poorer ex-
ecutive function in the AOD group, F(1, 163) = 3.01, p = .08.
3.2.3. Gender effects
Therewere no significant differences betweenmale and female AOD
participants in age, years of education, or SDS scores (all p N .28).
Table 1
Demographic, substance use, psychological, and clinical variables for the AOD group
(n = 128).
Age (Mdn, range) 35 (19–56)
Gender (% male) 70.3
Education (Mdn, range) 10 (7–16)
Unemployed (%) 90.5
Homelessa (%) 7.4
Arrested during last 3 monthsa (%) 43.2










SDSc scorea (Mdn, range) 11 (0-15)
History of overdose (%) 60.2
Injected during last 3 months (%) 52.6
K10d scorea (M, SD) 29.2 (7.8)
Hospitalized after head injury (%) 50
Lost consciousness/concussion after head injury (%) 67.2
a n = 95.
b n = 112.
c Severity of Dependence Scale.
d Kessler Psychological Distress Scale.
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Females tended to have higher K10 scores (M=31.25, SD=7.89) than
males (M=28.21, SD=7.60), t(93)=−1.82, p=.07.MoCA outcomes
for males vs. females were not significantly different (all p N .10) al-
though females tended to score slightly higher than males (Mdn 3 vs.
2) on executive subscores, z = −1.68, p = .09.
3.2.4. Primary substance of misuse
There were significant differences between primary substance of
misuse groups in age, F(2, 92) = 8.25, p= .001, but not years of educa-
tion,H(2)= 4.15, p= .13, or SDS scores,H(2)= 1.59, p= .45; age was
therefore included as a covariate in the analysis. There were no signifi-
cant differences in total MoCA score, F(2, 92) = .04, p = .96, short-
term memory, F(2, 92) = .09, p = .92, language, F(2, 92) = .15, p =
.86, executive function, F(2, 92) = 1.37, p = .26, visuospatial abilities,
F(2, 92) = 1.61, p = .21, or combined executive function/visuospatial
abilities, F(2, 92)= 1.30, p= .28, between primary substance of misuse
groups (Table 3). There was a marginally significant difference for
working memory performance, F(2, 92) = 2.98, p = .056, with the
poorest performance in the stimulants group. K10 scores were signifi-
cantly different across substance of misuse groups, F(2, 77) = 5.96,
p = .004, being higher in the stimulant group relative to the opiate
group (p = .022) and the alcohol group (p = .07), with no difference
between alcohol and opiate groups (p = .69).
3.3. Exploratory analyses
3.3.1. Psychological distress and substance dependence
Therewere significant negative correlations between K10 scores and
total MoCA scores, r = − .22, p = .012, executive function/visuospatial
abilities, r = − .21, p = .015, and language scores, r = − .20, p = .021,
and a trend for working memory, r=− .16, p= .06, in the overall AOD
sample. K10 and SDS scores were positively correlated, r = .20, p =
.049, but SDS scores were not correlated with any MoCA scores (all
p N .05), other than a trend toward a correlationwith executive function,
r = .18, p = .085. This pattern indicates that greater psychological dis-
tress (but not greater drug dependence) is associated with greater cog-
nitive impairment.
3.3.2. Head injuries
Given that 50% of the AOD sample had been hospitalized for a head
injury, the impact of head injuries on cognitive function was imperative
to investigate further. There were no significant differences in age, z =
−1.24, p = .22, education, z = − .94, p = .35, or K10 scores, t(93) =
− .23, p = .82, between AOD residents who had versus had not been
hospitalized after a head injury, but those who had not been hospital-
ized for head injury had higher SDS scores, z = −2.10, p = .035,
(Mdn = 11 vs. 10). AOD participants who had been hospitalized had
lower total MoCA scores (Mdn = 25.5 vs. 26), z = −2.59, p = .01,
than those who had not. The hospitalized group also had lower execu-
tive/visuospatial (Mdn= 5 vs. 6, z=−2.97, p= .003), working mem-
ory (mean rank = 58.38 vs. 70.62, z = −2.18, p = .03), and executive
(Mdn = 2 vs. 3, z = −2.66, p = .008) subscores, than the non-
hospitalized group, with trends toward lower language, z = −1.67,
p=.095, and visuospatial subscores, z=−1.71, p=.088, but no differ-
ence in short-term memory subscores, z = −1.17, p = .24. Fig. 1 dis-
plays standardized (out of 6) MoCA domain scores for AOD
participants hospitalized for head injuries, non-hospitalizedAODpartic-
ipants and controls.
3.3.3. Analysis of sample without significant head injuries
After exclusion of thosewhohad been hospitalized after a head inju-
ry, the primary analyses were repeated to compare only those AOD res-
idents who had not sustained head injures requiring hospitalization
with controls (Table 2). The AOD group in this reduced sample (n =
64)were significantly older than controls (Mdn=34 vs. 25, respective-
ly), z = −4.82, p = b .001, and less educated (Mdn = 10 vs. 12), z =
−3.65, p = b .001. With age and education included as covariates,
there were no significant differences in total MoCA score, F(1, 99) =
.38, p= .54, or anyMoCA subscores (all p N .20) between AOD residents
without significant head injuries and controls. Significant differences
remained for K10 scores between these AOD residents (Mdn = 29)
and controls (Mdn = 16), F(1, 82) = 33.51, p = b .001. Other than
males scoring significantly higher (mean rank = 36.43) in working
memory subscores than females (mean rank = 25.50), z = −2.91,
p = .004, no other effects of gender or primary substance of misuse
were found in this sample without head injuries.
3.3.4. Clinical significance of impairment
To investigate the clinical significance of impairment, total MoCA
scores were recoded as a dichotomous variable to indicate either the
presence or absence of cognitive impairment according to the cut-off
score suggested by Copersino et al. (2009) as ≥26 reflecting no evidence
Table 2
Comparison of MoCA scores between AOD and control groups, for entire AOD sample and











Total score 25.60 (3.13)⁎ 26.39 (2.56) 26.94 (3.10)
Executive/visuospatial 5.13 (1.57)⁎⁎ 5.53 (1.47) 6.14 (1.64)
Executive 2.48 (1.05) 2.73 (1.03) 3.08 (0.92)
STMa 3.63 (1.33) 3.78 (1.23) 3.92 (1.23)
WMb 5.36 (1.06) 5.50 (1.04) 5.43 (0.99)
Visuospatial 2.64 (1.01)⁎ 2.80 (0.98) 3.05 (1.13)
Language 5.01 (0.94) 5.16 (0.88) 5.35 (0.82)
⁎ p b .05.











Total score 25.85 (3.49) 25.92 (2.55) 25.88 (3.23)
Executive/visuospatial 5.09 (1.73) 5.14 (1.51) 5.60 (1.58)
Executive 2.26 (1.14) 2.64 (1.05) 2.68 (1.11)
STMa 3.76 (1.18) 3.69 (1.35) 3.64 (1.31)
WMb 5.53 (1.08) 5.56 (0.69) 5.00 (1.22)
Visuospatial 2.82 (0.94) 2.50 (1.06) 2.92 (0.91)
Language 5.12 (0.95) 4.94 (1.01) 4.96 (0.93)
a Short-term memory.











Fig. 1. Standardized (out of 6) MoCA domain scores for the AOD patients who were hos-
pitalized for head injuries, non-hospitalized for any head injury (includes those who
never had a head injury or may have sustained head injuries not requiring hospitaliza-
tion), and control participants.
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of cognitive impairment. Within the overall AOD group, 43.8% met
criteria for cognitive impairment. After removing those hospitalized
for head injuries, 37.5%met criteria for impairment and this represented
a significantly greater proportion than the 16.2% of controls meeting
criteria for impairment, χ2(1, N = 101) = 5.09, p = .019. However,
after removing a further 27 participants in the AOD sample who had
sustained concussion or lost consciousness after a head injury but had
not been hospitalized, the prevalence of impairment dropped to 29.7%
and this did not represent a statistically significant difference when
compared to the 16.2% of impaired controls (p = .13). Subsequently, it
was deemed appropriate to examine the prevalence of impairment
within the AOD group who had been hospitalized after a head injury.
Of those who had been hospitalized (n = 64), only 50% met criteria
for cognitive impairment, indicating that hospitalization for head inju-
ries alone may not predict cognitive impairment. There was no differ-
ence in the total number of head injuries (including those that did not
require hospitalization) sustained by those whomet criteria for impair-
ment (Mdn = 3) vs. those who did not (Mdn = 3), p = .67.
4. Discussion
This study used a brief screening tool, theMoCA, to provide an over-
view of cognitive functioning in residents of a substancemisuse TC. The
major findings were that 43.8% of the AOD group met criteria for cogni-
tive impairment and head injurieswere a significant determinant of this
impairment. Within the AOD group, 50% had been hospitalized after a
head injury and were more cognitively impaired than those who had
not sustained head injuries requiring hospitalization. Greater psycho-
logical distress in the AOD group was also associated with greater
cognitive deficits.
4.1. Neuropsychological functioning
AOD residents overall scored significantly lower on the MoCA and
showed greater deficits in executive function and visuospatial abilities
than controls. No other cognitive domains differed between residents
and controls. Within the AOD group, there were no gender effects
other than a trend toward males displaying greater executive dysfunc-
tion than females and females tended to have higher levels of psycho-
logical distress than males. MoCA outcomes did not differ according to
primary substance of misuse, other than stimulant users showing mar-
ginally poorer workingmemory ability and higher levels of psychologi-
cal distress. The lack of observed differences in neuropsychological
outcomes between substance of misuse groups may be explained by
the prevalence of polysubstance use in clients undergoing residential
AOD treatment; differences may not be detected between groups in
which substance use has reached a level necessitating residential treat-
ment. Generally, clients in residential AOD treatment have extensive
histories of substance use with considerable variability between indi-
viduals. Another possible explanation is that differences do exist be-
tween substance of misuse groups in residential treatment but that
the current study did not possess group sizes large enough to detect
these differences.
4.1.1. Head injuries
Half of the AOD sample in the current study had been hospitalized
after a head injury and were more cognitively impaired than those
who had not, with lower total MoCA scores, and poorer executive/vi-
suospatial and working memory abilities. When the hospitalized
group were excluded from the analysis, there were no differences in
any neuropsychological outcomes between AOD residents and controls,
and no differences between primary substance ofmisuse groups, but fe-
males in this subset displayed poorer working memory performance
than males.
In general, these findings are congruent with the literature suggest-
ing that cognitive impairments exist in AOD populations (Caplan et al.,
2007; Ersche & Sahakian, 2007; Fernández-Serrano, Pérez-García, Río-
Valle, et al., 2010; Gonzalez, 2007; Gruber et al., 2007; Oscar-Berman
& Marinković, 2007; Scott et al., 2007; Yücel et al., 2007; Yϋcel &
Lubman, 2007) and may be detected by a brief cognitive impairment-
screening tool (theMoCA). In assessing a residential AOD sample, argu-
ably we accessed those most severely affected by their addiction, and
also thosewith a high prevalence of head injuries requiring hospitaliza-
tion. The level of cognitive impairment detected in this sample, as mea-
sured by the MoCA, was not severe and was largely associated with TBI,
a factor that has not routinely been considered in previous studies
and may account for a significant portion of the deficits observed in
the literature.
4.2. Implications
This study showed that having sustained a TBI requiring hospitaliza-
tion accounted for themajority of cognitive impairment detected in the
sample. There are two major implications: first, simply asking clients
whether they have ever sustained a head injury requiring hospitaliza-
tion may be the most time-efficient way to informally gauge the possi-
bility of cognitive deficits. Clients may be unable, however, to provide
accurate accounts due to the high rate of TBIs occurring during intoxica-
tion that may remain undetected and receive no medical intervention.
While half of the AOD group in the current study had sustained a head
injury requiring hospitalization, 50% of this subgroup did not meet
criteria for impairment based on the MoCA score threshold. As such,
screening for head injuries alone without subsequent cognitive assess-
ment may lead to inflated estimates of impairment. Furthermore, this
type of screening would not capture approximately one third of the
AOD sample that had never sustained head injuries and yet met criteria
for cognitive impairment. Thus, the second implication is that cognitive
deficits may also exist independently of head injuries in AOD samples
and hence require screening in their own right.
These complex findings highlight the importance of brief cognitive
screening as a standardized assessment procedure for all clients enter-
ing residential treatment. In this way, treatment planning may account
for the presence of cognitive deficits. Further neuropsychological as-
sessment may be recommended and modifications to treatment and/
or targeted interventions may be implemented.
Regardless of the etiology of cognitive impairment, cognitive screen-
ing has the potential to inform interventions aimed at alleviating these
deficits. For example, adjunct interventions to remediate cognitive defi-
cits togetherwith better-tailored specific treatmentsmay bolster residen-
tial services, reducing dropout rates and consequently improving
treatment outcomes. Evidence suggests that the neuropsychological defi-
cits associated with TBI can be alleviated through cognitive remediation
interventions (Maas et al., 2013; Manley & Maas, 2013; Tsaousides &
Gordon, 2009), and there is emerging evidence for the use of cognitive re-
mediationprograms in substancemisusepopulations as away to improve
treatment retention (Bates, Buckman, & Nguyen, 2013; Fals-Stewart &
Lam, 2010; Rupp, Kemmler, Kurz, Hinterhuber, & Fleischhacker, 2012;
Verdejo-García, 2011;Wexler, 2011). Further research aimed at develop-
ing and trialling cognitive remediation programs for AOD populations is
required and providing these interventions within residential treatment
services would be most ideal (e.g., Gonçalves et al., 2014).
4.3. Limitations and future directions
There are several limitations of the current study. There were clear
differences between the AOD group and controls (e.g., age, education,
inferred socioeconomic status). While some of these differences were
accounted for statistically, future researchwould benefit from the inclu-
sion of better-matched control groups. The exploration of primary sub-
stance of misuse groups resulted in small sample sizes with reduced
statistical power for comparison; larger samples in future studies may
reveal substance-specific impairment. Another limitation of the current
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study is its failure to assess for psychiatric comorbidities, which are
common in AODpopulations and add substantial complexity to the pro-
cess of treatment. The current study utilized the K10 as a measure of
psychological distress and higher scores were associated with greater
cognitive impairment. Future studies should include formal psychiatric
diagnoses in order to examine their interaction with substance use dis-
orders and head injuries in terms of cognitive outcomes. Additionally,
the current study focused on hospitalization and frequency of head inju-
ries, but not their nature, severity or age of occurrence, which could be
further examined in future studies. Also, despite the AOD sample being
abstinent from AOD, there was no assessment of their duration of absti-
nence or length of stay in residential services prior to cognitive assess-
ment; this, along with a more detailed substance use history
(including age of onset and number of years of substance use) and ob-
jective measures of abstinence (e.g. urine testing in both AOD and con-
trol samples), could have provided further information regarding the
nature and extent of the observed cognitive deficits. Finally, the poten-
tial lack of sensitivity of the MoCA to more specific cognitive deficits in
AOD populations cannot be underestimated; the scores observed in
this sample were not substantially below the cut-off indicative of im-
pairment. Nevertheless, the MoCA can serve as a cost-effective screen-
ing tool that would detect severe deficits in those most requiring
further neurocognitive assessment.
5. Conclusion
The current study identified that the MoCA may be usefully applied
in the AOD treatment setting as a brief screening tool. We showed in a
naturalistic snapshot of clients in AOD residential treatment that cogni-
tive impairment is common andmay be related to the effects of head in-
juries, which are also highly prevalent. Cognitive abilities such as
executive function and working memory are important for AOD resi-
dents to engage meaningfully in treatment and achieve successful out-
comes. If these capacities are compromised, residents may be more
likely to drop out from treatment and fail to recover from their addic-
tion. The first step in rectifying this situation is to improve the assess-
ment and detection of those who present with cognitive deficits. This
will help to informmodifications to treatment and/or cognitive remedi-
ation interventions that may be beneficial in accommodating and po-
tentially remediating impairments in cognition, increasing the
likelihood of treatment engagement and retention, and hopefully lead-
ing to long-term recovery from addiction.
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